data_2krm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2krm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.754 0.311 . . . . 30.68 111.104 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -83.61 157.51 22.24 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.242 -0.435 . . . . 27.210000000000001 111.196 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.632 ' HB2' HG21 ' A' ' 29' ' ' VAL . 7.4 m-85 -134.16 151.92 51.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.829 -0.623 . . . . 99.989999999999995 110.81 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.644 ' HB ' HD12 ' A' ' 57' ' ' ILE . 13.8 tt -113.81 134.03 57.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.402 -0.592 . . . . 24.600000000000001 109.402 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.529 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 37.0 t -76.67 123.63 33.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.917 0.389 . . . . 24.600000000000001 110.828 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -106.49 -21.18 13.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.931 -0.577 . . . . 30.579999999999998 111.002 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.92 141.26 48.27 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.521 -0.308 . . . . 99.989999999999995 110.436 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -74.75 129.3 37.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 24.600000000000001 110.984 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.545 ' HB3' HG12 ' A' ' 20' ' ' ILE . 54.2 t80 -127.11 132.94 50.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.928 -0.578 . . . . 99.989999999999995 110.183 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -100.02 116.65 32.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.009 -0.541 . . . . 26.050000000000001 110.638 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.83 107.33 0.96 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.016 -0.538 . . . . 26.149999999999999 111.143 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.7 t -77.66 -39.35 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.925 -0.58 . . . . 31.710000000000001 109.83 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.689 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 46.5 m-70 -98.31 178.15 5.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.753 -0.658 . . . . 99.989999999999995 110.712 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -81.71 -27.13 34.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.033 -0.531 . . . . 45.18 111.092 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -92.09 5.87 48.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.511 -0.313 . . . . 35.420000000000002 111.098 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.689 ' HG2' ' HB2' ' A' ' 14' ' ' HIS . 40.3 mm-40 -94.42 135.35 35.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 110.013 -0.366 . . . . 26.239999999999998 110.013 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.432 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -89.6 125.7 35.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.94 -0.573 . . . . 24.600000000000001 110.835 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.3 m -83.08 86.18 7.05 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.32 -0.622 . . . . 99.989999999999995 109.32 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.545 HG12 ' HB3' ' A' ' 10' ' ' TYR . 43.4 pt -84.7 136.82 21.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.161 -0.472 . . . . 24.600000000000001 111.906 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -119.8 137.78 53.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.862 -0.608 . . . . 99.989999999999995 110.187 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.5 t -45.72 122.51 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.078 0.399 . . . . 24.600000000000001 112.078 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.14 -18.22 36.63 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.846 -0.616 . . . . 24.600000000000001 113.69 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.448 ' HB3' HD12 ' A' ' 42' ' ' LEU . 32.8 mt-10 -78.31 152.76 32.24 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.395 0.598 . . . . 24.600000000000001 112.107 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.5 mm -112.38 125.23 69.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.493 -0.776 . . . . 24.600000000000001 109.743 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.586 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 40.4 mt -96.98 125.03 50.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 24.600000000000001 110.782 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 78.2 ttt180 -75.55 125.88 29.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.775 -0.648 . . . . 99.989999999999995 112.422 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 54.41 68.74 0.81 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.697 -0.683 . . . . 24.600000000000001 112.413 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.632 HG21 ' HB2' ' A' ' 4' ' ' TYR . 91.6 t -88.43 107.94 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 26.149999999999999 110.839 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -108.4 164.6 12.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.844 -0.616 . . . . 99.989999999999995 110.623 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -90.59 133.46 35.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.289 -0.414 . . . . 99.989999999999995 110.517 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.444 HD13 ' HG2' ' A' ' 48' ' ' MET . 94.5 mt -96.17 -177.77 4.1 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.976 -0.556 . . . . 37.710000000000001 110.955 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -81.83 -0.2 42.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.309 -0.405 . . . . 40.380000000000003 111.226 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 31.6 mt-10 -103.38 115.88 31.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.745 -0.465 . . . . 38.539999999999999 109.745 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -58.12 118.46 5.47 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.258 -0.428 . . . . 33.270000000000003 110.575 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.85 14.15 53.12 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.936 -0.65 . . . . 28.280000000000001 113.012 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 80.9 m95 -133.75 132.72 40.87 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.125 0.488 . . . . 99.989999999999995 110.704 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 48' ' ' MET . 94.7 mt -120.08 166.6 13.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.272 -0.876 . . . . 24.600000000000001 110.087 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' HB2' HD22 ' A' ' 32' ' ' LEU . 14.0 tp10 -125.97 120.61 30.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.55 -0.296 . . . . 43.399999999999999 110.636 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.16 163.36 31.43 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.729 -0.748 . . . . 24.600000000000001 113.118 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 27' ' ' ARG . 1.9 tm-20 -95.05 103.79 15.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.037 0.446 . . . . 32.100000000000001 110.462 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.479 HD23 HG21 ' A' ' 20' ' ' ILE . 45.8 tp -129.82 140.71 50.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.535 -0.757 . . . . 24.600000000000001 110.113 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 65.0 18.26 11.43 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.032 -0.531 . . . . 30.739999999999998 111.192 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.2 14.36 66.74 Favored Glycine 0 C--N 1.341 0.815 0 C-N-CA 120.992 -0.623 . . . . 33.009999999999998 113.331 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -140.94 149.29 41.65 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.826 0.346 . . . . 99.989999999999995 110.8 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -94.8 115.26 27.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.928 -0.767 . . . . 99.989999999999995 108.928 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.9 -176.54 14.69 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.259 -0.972 . . . . 24.600000000000001 113.613 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.579 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 54.8 mtt -111.62 133.77 53.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.491 -0.355 . . . . 33.810000000000002 110.162 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.486 ' CE1' HG21 ' A' ' 26' ' ' ILE . 4.8 p90 -136.51 156.92 76.13 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.273 -0.422 . . . . 99.989999999999995 111.473 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.6 ' HG2' ' HB2' ' A' ' 53' ' ' PHE . 19.6 Cg_endo -58.99 136.56 74.2 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.741 2.294 . . . . 24.600000000000001 112.436 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.75 -38.18 83.12 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.791 -0.641 . . . . 25.32 111.849 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -78.29 4.74 12.03 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.808 0.67 . . . . 25.559999999999999 112.808 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.6 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 5.3 m-85 -105.25 -22.33 13.08 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.494 0.188 . . . . 99.989999999999995 110.996 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 18.3 m -117.36 141.07 37.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.467 -0.333 . . . . 24.600000000000001 110.65 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -113.63 125.24 53.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 99.989999999999995 110.306 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -51.69 141.47 16.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.439 -0.346 . . . . 36.5 110.993 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.644 HD12 ' HB ' ' A' ' 5' ' ' ILE . 39.4 mm -85.97 93.32 3.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.167 -0.47 . . . . 29.5 110.458 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.099 -0.953 . . . . 99.989999999999995 110.824 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.746 0.307 . . . . 30.68 111.186 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.41 149.03 25.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.023 0.44 . . . . 27.210000000000001 111.132 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.629 ' HB2' HG21 ' A' ' 29' ' ' VAL . 6.8 m-85 -129.04 152.73 48.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.626 -0.715 . . . . 99.989999999999995 110.709 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.2 tt -114.84 136.36 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 24.600000000000001 109.703 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.522 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 36.8 t -74.29 122.06 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 24.600000000000001 110.83 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.428 ' HG3' ' CD2' ' A' ' 8' ' ' TYR . 11.9 pt-20 -103.1 -20.76 14.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.914 -0.584 . . . . 30.579999999999998 111.065 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.428 ' CD2' ' HG3' ' A' ' 7' ' ' GLU . 61.2 m-85 -134.52 141.86 46.84 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.844 0.354 . . . . 99.989999999999995 110.653 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -79.22 127.57 32.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.038 -0.528 . . . . 24.600000000000001 110.441 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.491 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 34.8 t80 -125.47 137.12 53.97 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.381 -0.372 . . . . 99.989999999999995 111.019 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -94.82 119.12 32.87 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.063 -0.517 . . . . 26.050000000000001 110.38 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.504 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -66.46 103.38 1.03 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.273 -0.421 . . . . 26.149999999999999 111.469 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.07 -33.78 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.887 -0.597 . . . . 31.710000000000001 110.265 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 53.0 m80 -90.52 178.2 6.16 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.93 -0.577 . . . . 99.989999999999995 109.968 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.58 -46.05 20.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.665 -0.243 . . . . 45.18 110.693 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.13 -22.26 52.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.25 -0.432 . . . . 35.420000000000002 110.84 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.504 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 16.0 tp10 -52.71 125.53 16.99 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.898 0.38 . . . . 26.239999999999998 110.908 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.423 HD21 ' HB3' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -90.39 127.61 36.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.934 -0.575 . . . . 24.600000000000001 110.61 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.8 m -80.92 86.28 6.09 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.005 -0.739 . . . . 99.989999999999995 109.005 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.563 HD11 ' HB3' ' A' ' 53' ' ' PHE . 23.8 pt -91.6 137.3 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.002 0.429 . . . . 24.600000000000001 111.794 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -118.38 139.18 51.77 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.862 -0.608 . . . . 99.989999999999995 109.966 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.6 t -47.57 124.76 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 111.994 0.368 . . . . 24.600000000000001 111.994 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.77 -18.24 37.7 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.848 -0.614 . . . . 24.600000000000001 113.527 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.594 ' HB3' HD12 ' A' ' 42' ' ' LEU . 41.7 mt-10 -78.14 153.59 31.95 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 117.263 0.531 . . . . 24.600000000000001 111.821 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.0 pt -112.65 125.93 69.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.665 -0.698 . . . . 24.600000000000001 110.245 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.638 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 3.9 mp -97.49 124.87 50.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.47 . . . . 24.600000000000001 110.405 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.5 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 40.2 ttm180 -78.46 127.58 32.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.265 -0.425 . . . . 99.989999999999995 112.032 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 61.5 t30 57.37 67.33 0.99 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.671 -0.695 . . . . 24.600000000000001 112.09 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.638 ' CG2' ' HB ' ' A' ' 26' ' ' ILE . 76.1 t -91.12 108.39 19.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 26.149999999999999 110.864 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -110.89 167.1 10.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.896 -0.593 . . . . 99.989999999999995 110.929 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -92.67 135.64 33.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.945 -0.571 . . . . 99.989999999999995 110.333 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 39' ' ' GLU . 95.1 mt -96.16 -177.42 3.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 37.710000000000001 110.987 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -81.41 -0.19 40.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.267 -0.424 . . . . 40.380000000000003 111.349 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.415 ' HB3' ' HD1' ' A' ' 37' ' ' TRP . 38.6 mt-10 -105.57 121.6 44.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.84 -0.43 . . . . 38.539999999999999 109.84 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.0 117.83 5.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.039 -0.528 . . . . 33.270000000000003 110.767 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.44 11.23 57.38 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.003 -0.618 . . . . 28.280000000000001 113.123 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.482 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 69.6 m95 -130.29 129.0 42.69 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.168 0.509 . . . . 99.989999999999995 111.103 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 48' ' ' MET . 8.0 mp -121.45 168.64 11.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.316 -0.856 . . . . 24.600000000000001 109.982 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HB2' HD21 ' A' ' 32' ' ' LEU . 10.8 tp10 -127.05 123.04 36.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.487 -0.324 . . . . 43.399999999999999 110.877 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.439 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -155.49 163.41 31.6 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.622 -0.799 . . . . 24.600000000000001 113.42 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 27' ' ' ARG . 22.9 mt-10 -97.5 104.36 16.38 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.843 0.354 . . . . 32.100000000000001 110.921 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.594 HD12 ' HB3' ' A' ' 24' ' ' GLU . 43.1 tp -128.24 138.29 52.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 24.600000000000001 110.387 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.8 m120 63.37 21.95 13.04 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.893 -0.594 . . . . 30.739999999999998 111.21 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.7 12.79 76.98 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 121.007 -0.616 . . . . 33.009999999999998 113.476 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -135.32 144.53 46.76 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.819 0.342 . . . . 99.989999999999995 110.502 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -92.23 114.3 26.8 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.246 -1.02 . . . . 99.989999999999995 108.246 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.56 154.4 25.15 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.807 -1.187 . . . . 24.600000000000001 114.316 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.568 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 37.7 ttm -81.44 137.72 35.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.857 -0.671 . . . . 33.810000000000002 110.134 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.55 ' CE2' HG23 ' A' ' 26' ' ' ILE . 3.0 p90 -140.69 159.81 61.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.437 -0.347 . . . . 99.989999999999995 111.213 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.534 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 34.1 Cg_exo -61.03 145.9 98.46 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.688 2.259 . . . . 24.600000000000001 112.839 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.45 -38.4 84.44 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.734 -0.666 . . . . 25.32 111.997 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -85.67 9.32 16.58 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.37 0.507 . . . . 25.559999999999999 112.37 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.563 ' HB3' HD11 ' A' ' 20' ' ' ILE . 9.1 m-85 -105.11 -24.42 12.77 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.553 0.216 . . . . 99.989999999999995 110.432 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 20.2 m -115.45 137.8 47.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.21 -0.45 . . . . 24.600000000000001 109.927 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -115.64 124.2 50.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.4 -0.364 . . . . 99.989999999999995 110.591 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 38.0 tt0 -55.68 132.08 48.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.322 -0.399 . . . . 36.5 110.671 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.8 mt -93.5 75.64 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.205 0.526 . . . . 29.5 110.386 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.56 -0.734 . . . . 99.989999999999995 110.881 -179.893 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.724 0.297 . . . . 33.030000000000001 111.344 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.71 157.26 19.68 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.155 -0.475 . . . . 30.379999999999999 111.093 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.604 ' HB2' HG22 ' A' ' 29' ' ' VAL . 8.1 m-85 -133.2 151.51 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.864 -0.607 . . . . 30.379999999999999 110.88 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.4 tt -109.56 137.03 43.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.339 -0.615 . . . . 30.57 109.339 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.507 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 37.4 t -79.94 119.03 28.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.879 0.371 . . . . 31.149999999999999 110.798 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -102.58 -20.04 14.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.993 -0.549 . . . . 37.960000000000001 110.976 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -130.62 138.01 49.9 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.565 -0.289 . . . . 30.379999999999999 110.634 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -75.02 127.64 33.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 32.049999999999997 110.594 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.447 ' HB3' HG12 ' A' ' 20' ' ' ILE . 68.1 t80 -117.82 132.78 56.4 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.185 -0.461 . . . . 33.979999999999997 110.317 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -93.68 154.71 17.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 36.689999999999998 110.759 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.46 116.02 6.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 30.620000000000001 110.51 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.55 -27.91 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.92 -0.582 . . . . 30.559999999999999 110.445 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.622 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 52.0 m80 -148.54 -179.22 6.8 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.123 -0.49 . . . . 30.379999999999999 110.177 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -76.32 -29.32 57.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 35.799999999999997 110.841 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -94.09 6.78 47.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.371 -0.377 . . . . 32.579999999999998 111.524 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.622 ' HG2' ' HB2' ' A' ' 14' ' ' HIS . 45.0 mm-40 -95.95 131.66 42.08 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 110.238 -0.282 . . . . 36.109999999999999 110.238 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.502 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -88.69 123.83 33.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 30.739999999999998 111.129 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 37.0 m -81.62 84.91 6.64 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.081 -0.711 . . . . 30.809999999999999 109.081 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.524 HD12 ' HB3' ' A' ' 53' ' ' PHE . 35.1 pt -90.06 142.64 12.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.746 -0.661 . . . . 30.390000000000001 111.743 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.427 ' HD3' ' N ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -121.2 142.5 49.84 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.126 -0.488 . . . . 30.379999999999999 110.107 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -49.5 124.78 2.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 112.014 0.376 . . . . 31.460000000000001 112.014 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.1 -16.67 45.74 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.864 -0.607 . . . . 30.600000000000001 113.686 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.0 156.68 25.79 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 117.468 0.634 . . . . 35.799999999999997 112.018 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.9 mm -113.82 127.9 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.364 -0.834 . . . . 30.379999999999999 110.124 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.574 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 36.6 mt -98.46 125.75 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 32.07 110.834 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.542 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 75.8 mtm180 -71.77 124.5 24.94 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.833 -0.621 . . . . 30.379999999999999 112.553 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 49.37 72.68 0.29 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.65 -0.705 . . . . 30.379999999999999 112.491 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.604 HG22 ' HB2' ' A' ' 4' ' ' TYR . 71.6 t -86.59 109.0 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 30.379999999999999 110.325 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -105.42 158.96 16.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.81 -0.632 . . . . 38.770000000000003 110.688 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -90.18 134.17 34.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.701 -0.481 . . . . 32.939999999999998 109.701 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.425 HD13 ' HG2' ' A' ' 48' ' ' MET . 91.1 mt -97.16 -177.55 3.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.401 -0.363 . . . . 33.130000000000003 111.19 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.9 2.57 33.77 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.257 -0.428 . . . . 42.18 111.214 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 4.8 mp0 -105.73 116.31 31.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.318 -0.623 . . . . 38.109999999999999 109.318 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.78 118.02 5.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.263 -0.426 . . . . 30.43 110.651 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.17 9.14 57.28 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.899 -0.667 . . . . 30.379999999999999 113.408 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.432 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 73.4 m95 -130.98 130.54 43.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.245 0.545 . . . . 30.379999999999999 111.087 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 48' ' ' MET . 6.6 mp -120.74 168.79 11.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.121 -0.945 . . . . 30.379999999999999 109.663 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -128.21 123.96 35.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.647 0.26 . . . . 38.590000000000003 110.732 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.446 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -151.26 160.18 28.56 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.754 -0.736 . . . . 30.379999999999999 112.829 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 3.3 mp0 -97.2 102.93 14.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.068 0.461 . . . . 37.880000000000003 110.946 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.514 ' CD2' HG23 ' A' ' 20' ' ' ILE . 54.9 tp -125.81 138.12 53.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.65 -0.704 . . . . 30.379999999999999 109.989 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 62.5 21.15 12.43 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.091 -0.504 . . . . 40.090000000000003 111.471 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.93 9.46 80.72 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 120.937 -0.649 . . . . 31.289999999999999 113.6 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -132.18 141.39 49.08 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.687 0.28 . . . . 44.740000000000002 110.407 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -91.86 114.69 27.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.617 -0.882 . . . . 33.119999999999997 108.617 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.26 179.91 16.94 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.267 -0.968 . . . . 30.379999999999999 113.509 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.568 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 77.3 mtp -111.2 134.89 52.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.441 -0.379 . . . . 35.170000000000002 110.227 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.412 ' CE1' HG22 ' A' ' 54' ' ' VAL . 2.0 p90 -135.36 159.09 73.04 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.151 -0.477 . . . . 30.379999999999999 110.999 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 33.6 Cg_exo -61.06 148.74 91.95 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.708 2.272 . . . . 30.379999999999999 112.815 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.43 -39.06 85.44 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.761 -0.654 . . . . 32.210000000000001 111.794 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -87.35 15.3 6.6 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.307 0.484 . . . . 34.539999999999999 112.307 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.524 ' HB3' HD12 ' A' ' 20' ' ' ILE . 4.9 m-85 -106.71 -24.98 11.94 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 120.527 0.203 . . . . 34.039999999999999 110.603 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 28.2 m -124.31 144.81 32.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.178 -0.464 . . . . 31.539999999999999 110.54 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -122.03 128.74 51.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 30.59 110.108 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -52.83 136.28 34.34 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.62 0.248 . . . . 32.189999999999998 110.788 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.447 HG21 HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -84.1 103.75 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.371 0.605 . . . . 30.539999999999999 110.375 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.135 -0.936 . . . . 40.630000000000003 110.745 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.73 0.3 . . . . 33.030000000000001 111.156 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -79.95 150.78 30.38 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.989 0.423 . . . . 30.379999999999999 111.497 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.644 ' HB2' HG21 ' A' ' 29' ' ' VAL . 10.4 m-85 -130.37 151.79 50.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.613 -0.721 . . . . 30.379999999999999 110.72 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.4 tt -120.07 124.35 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 30.57 109.89 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 25.3 t -63.82 129.65 27.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 31.149999999999999 111.319 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -109.92 -25.31 10.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.656 -0.702 . . . . 37.960000000000001 110.428 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -132.79 139.19 47.41 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.288 -0.415 . . . . 30.379999999999999 110.283 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -69.0 141.96 54.76 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.331 -0.395 . . . . 32.049999999999997 111.029 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -135.95 126.07 26.22 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.232 -0.44 . . . . 33.979999999999997 110.855 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -82.59 117.38 22.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 36.689999999999998 111.321 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.94 104.89 3.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.939 -0.573 . . . . 30.620000000000001 110.945 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.6 t -85.95 -37.26 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.797 -0.638 . . . . 30.559999999999999 110.169 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 55.3 m-70 -89.59 174.11 7.94 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.96 -0.564 . . . . 30.379999999999999 110.795 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -81.19 -31.34 34.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.117 -0.492 . . . . 35.799999999999997 110.965 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -100.0 16.74 22.96 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.493 -0.321 . . . . 32.579999999999998 110.724 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 14' ' ' HIS . 22.6 tt0 -96.93 125.94 41.71 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.906 -0.405 . . . . 36.109999999999999 109.906 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.503 ' HG ' ' HA3' ' A' ' 47' ' ' GLY . 35.3 mt -79.94 133.5 36.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.863 0.363 . . . . 30.739999999999998 111.064 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 m -87.17 55.16 3.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.848 -0.614 . . . . 30.809999999999999 110.527 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 6' ' ' VAL . 22.1 pt -48.81 120.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 112.546 0.573 . . . . 30.390000000000001 112.546 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -113.43 136.46 52.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.394 -0.821 . . . . 30.379999999999999 109.292 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -43.09 122.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.733 0.301 . . . . 31.460000000000001 111.715 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.42 -18.41 38.57 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.075 -0.583 . . . . 30.600000000000001 113.813 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.412 ' HB3' HD13 ' A' ' 42' ' ' LEU . 41.8 mt-10 -80.03 147.28 31.57 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 117.554 0.677 . . . . 35.799999999999997 111.534 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.417 ' N ' HD11 ' A' ' 25' ' ' ILE . 4.4 mp -111.79 127.79 68.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.805 -0.634 . . . . 30.379999999999999 110.311 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.509 HG22 ' CE1' ' A' ' 49' ' ' PHE . 3.9 mp -96.07 122.28 47.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.28 -0.418 . . . . 32.07 110.287 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 22.0 mmm180 -74.31 127.74 33.76 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.083 -0.508 . . . . 30.379999999999999 112.073 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 52.39 73.42 0.34 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.816 -0.629 . . . . 30.379999999999999 112.176 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.644 HG21 ' HB2' ' A' ' 4' ' ' TYR . 55.9 t -88.77 110.57 21.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.973 -0.558 . . . . 30.379999999999999 111.507 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -102.48 154.97 18.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.699 -0.682 . . . . 38.770000000000003 109.923 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.41 ' HA ' HD23 ' A' ' 38' ' ' LEU . 86.1 tttt -80.48 123.35 28.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.953 0.406 . . . . 32.939999999999998 110.988 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.1 tp -77.83 162.77 26.64 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.774 -0.648 . . . . 33.130000000000003 110.068 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -61.75 -28.81 69.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.487 -0.324 . . . . 42.18 110.79 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -83.95 129.87 34.91 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.805 0.336 . . . . 38.109999999999999 110.761 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.61 122.42 16.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.864 -0.607 . . . . 30.43 109.675 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.06 18.04 38.36 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 30.379999999999999 112.342 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -134.46 135.18 42.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.105 0.479 . . . . 30.379999999999999 110.484 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 48' ' ' MET . 81.0 mt -124.73 161.71 25.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.345 -0.843 . . . . 30.379999999999999 110.022 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.635 ' HG2' ' HD2' ' A' ' 46' ' ' ARG . 31.2 tt0 -125.43 119.45 28.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.103 -0.332 . . . . 38.590000000000003 110.103 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.486 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -157.23 165.67 33.38 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.417 -0.897 . . . . 30.379999999999999 113.405 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 2.0 tm-20 -86.79 109.38 19.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.942 0.401 . . . . 37.880000000000003 110.079 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.486 HD22 HG23 ' A' ' 20' ' ' ILE . 57.8 tp -132.03 134.09 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.665 -0.698 . . . . 30.379999999999999 110.371 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 64.18 21.39 12.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.922 -0.581 . . . . 40.090000000000003 111.398 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.61 18.66 59.73 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 120.97 -0.633 . . . . 31.289999999999999 113.553 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -144.45 150.91 38.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.777 0.322 . . . . 44.740000000000002 110.645 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.635 ' HD2' ' HG2' ' A' ' 39' ' ' GLU . 6.8 tpp180 -94.19 115.98 28.33 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.989 -0.745 . . . . 33.119999999999997 108.989 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.503 ' HA3' ' HG ' ' A' ' 18' ' ' LEU . . . -141.07 -170.83 12.32 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.322 -0.942 . . . . 30.379999999999999 113.442 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.573 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 45.8 mtt -119.07 138.05 53.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.547 -0.326 . . . . 35.170000000000002 110.158 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.509 ' CE1' HG22 ' A' ' 26' ' ' ILE . 4.5 p90 -143.23 158.92 57.26 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 30.379999999999999 111.475 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 37.6 Cg_exo -57.35 141.46 94.79 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.817 2.344 . . . . 30.379999999999999 112.941 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -75.45 -39.04 59.3 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.563 -0.744 . . . . 32.210000000000001 111.453 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -76.35 -3.98 39.74 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.741 0.645 . . . . 34.539999999999999 112.741 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.482 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 6.9 m-85 -93.7 -34.15 13.36 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 110.336 -0.246 . . . . 34.039999999999999 110.336 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 24.7 m -102.72 143.55 14.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.198 -0.456 . . . . 31.539999999999999 110.214 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -109.99 130.44 55.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.355 -0.384 . . . . 30.59 110.808 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -52.0 132.21 32.3 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.127 -0.488 . . . . 32.189999999999998 110.582 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.9 mt -92.51 81.68 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.044 0.45 . . . . 30.539999999999999 110.437 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.037 -0.982 . . . . 40.630000000000003 111.217 -179.926 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.729 0.3 . . . . 33.030000000000001 111.364 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -80.65 149.82 29.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.152 -0.476 . . . . 30.379999999999999 110.734 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.62 ' HB2' HG22 ' A' ' 29' ' ' VAL . 9.0 m-85 -128.87 151.37 49.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.81 -0.632 . . . . 30.379999999999999 110.891 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.3 tt -116.9 126.46 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 30.57 109.75 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.541 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 34.8 t -68.19 128.52 31.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.963 0.411 . . . . 31.149999999999999 110.918 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -110.14 -22.82 11.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.702 -0.681 . . . . 37.960000000000001 110.77 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -133.43 140.8 47.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.413 -0.358 . . . . 30.379999999999999 110.389 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -72.28 136.5 46.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.319 -0.4 . . . . 32.049999999999997 110.71 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.501 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 63.5 t80 -137.43 128.61 27.78 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.278 -0.419 . . . . 33.979999999999997 111.093 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.431 ' HA ' HG22 ' A' ' 19' ' ' THR . 6.1 p-10 -79.97 157.15 26.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.868 -0.605 . . . . 36.689999999999998 110.463 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.08 95.59 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.372 -0.376 . . . . 30.620000000000001 111.158 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.12 -37.2 46.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.071 -0.513 . . . . 30.559999999999999 109.83 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 91.5 m-70 -93.38 165.86 12.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.721 -0.672 . . . . 30.379999999999999 110.724 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -74.6 -33.78 62.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 35.799999999999997 110.885 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.63 17.31 15.13 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.148 -0.478 . . . . 32.579999999999998 110.901 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 14' ' ' HIS . 21.3 tt0 -97.77 128.47 44.44 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.99 -0.374 . . . . 36.109999999999999 109.99 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.562 ' HG ' ' HA3' ' A' ' 47' ' ' GLY . 6.6 mt -82.75 130.34 35.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 30.739999999999998 111.181 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.431 HG22 ' HA ' ' A' ' 11' ' ' ASP . 11.4 m -86.81 64.96 8.78 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.971 -0.558 . . . . 30.809999999999999 109.703 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.541 ' HB ' ' CG2' ' A' ' 6' ' ' VAL . 30.0 pt -60.94 127.4 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 112.629 0.603 . . . . 30.390000000000001 112.629 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -115.14 138.42 50.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.625 -0.716 . . . . 30.379999999999999 109.663 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.4 125.37 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.728 0.299 . . . . 31.460000000000001 111.794 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.86 -19.72 40.51 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.053 -0.594 . . . . 30.600000000000001 113.456 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -76.3 146.6 38.79 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 117.254 0.527 . . . . 35.799999999999997 111.639 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.4 pt -109.18 125.16 66.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.852 -0.613 . . . . 30.379999999999999 110.147 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.647 HG23 ' CE1' ' A' ' 49' ' ' PHE . 6.1 mm -94.97 119.87 43.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 32.07 110.636 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.498 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 88.8 mtm180 -75.75 127.69 33.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 30.379999999999999 112.007 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.9 t30 53.07 73.37 0.36 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.798 -0.637 . . . . 30.379999999999999 112.133 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.635 ' CG2' ' HB ' ' A' ' 26' ' ' ILE . 66.4 t -91.85 110.15 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 30.379999999999999 111.189 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -107.64 162.82 13.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.868 -0.605 . . . . 38.770000000000003 110.546 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HA ' HD21 ' A' ' 38' ' ' LEU . 5.7 mmmt -90.14 128.66 36.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 32.939999999999998 110.861 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.487 HD22 ' HB2' ' A' ' 39' ' ' GLU . 92.8 mt -90.14 179.41 5.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.033 -0.53 . . . . 33.130000000000003 110.866 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.09 -3.51 45.7 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.252 -0.431 . . . . 42.18 111.179 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 35.3 mt-10 -100.93 119.08 38.19 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.798 -0.445 . . . . 38.109999999999999 109.798 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -60.93 117.65 5.72 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.303 -0.408 . . . . 30.43 110.274 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.08 17.45 34.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.024 -0.608 . . . . 30.379999999999999 112.4 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.433 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 99.3 m95 -133.55 132.3 40.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.137 0.494 . . . . 30.379999999999999 111.016 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.601 ' O ' ' HA ' ' A' ' 48' ' ' MET . 83.5 mt -119.87 160.91 21.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.317 -0.856 . . . . 30.379999999999999 109.936 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.487 ' HB2' HD22 ' A' ' 32' ' ' LEU . 9.1 tp10 -122.92 117.56 25.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.574 0.226 . . . . 38.590000000000003 110.674 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.453 ' HA3' HG22 ' A' ' 26' ' ' ILE . . . -156.13 164.64 32.45 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.499 -0.857 . . . . 30.379999999999999 113.418 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 3.5 mp0 -92.13 117.06 29.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.06 0.457 . . . . 37.880000000000003 111.104 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.528 HD23 HG21 ' A' ' 20' ' ' ILE . 55.5 tp -131.87 130.5 41.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.59 -0.732 . . . . 30.379999999999999 110.308 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 60.99 26.09 16.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.94 -0.573 . . . . 40.090000000000003 111.54 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.37 15.29 69.25 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.715 -0.755 . . . . 31.289999999999999 113.954 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -139.02 145.49 39.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.853 0.327 . . . . 44.740000000000002 110.422 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -95.46 120.0 34.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.558 -0.534 . . . . 33.119999999999997 109.558 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.562 ' HA3' ' HG ' ' A' ' 18' ' ' LEU . . . -149.34 155.42 26.3 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.293 -0.956 . . . . 30.379999999999999 113.669 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.601 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 24.8 ptt? -80.96 140.49 35.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.955 0.407 . . . . 35.170000000000002 110.9 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.647 ' CE1' HG23 ' A' ' 26' ' ' ILE . 6.1 p90 -141.63 162.68 45.48 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.933 -0.576 . . . . 30.379999999999999 111.095 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.531 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 25.9 Cg_exo -62.73 144.07 93.23 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.779 2.32 . . . . 30.379999999999999 112.971 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.6 -39.41 67.33 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.728 -0.669 . . . . 32.210000000000001 111.84 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -79.83 0.37 31.27 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.061 0.763 . . . . 34.539999999999999 113.061 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 9.6 m-85 -98.18 -31.22 12.2 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.494 0.188 . . . . 34.039999999999999 110.669 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 25.6 m -110.08 135.14 50.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.401 -0.363 . . . . 31.539999999999999 110.53 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -107.09 127.71 53.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 30.59 110.495 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 37.6 tt0 -57.61 136.31 56.78 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.446 -0.343 . . . . 32.189999999999998 110.668 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.4 mt -93.82 84.79 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 30.539999999999999 110.602 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.132 -0.937 . . . . 40.630000000000003 110.89 -179.954 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.816 0.341 . . . . 30.68 111.129 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -88.29 156.91 18.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.166 -0.47 . . . . 27.210000000000001 111.368 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.695 ' HB2' HG22 ' A' ' 29' ' ' VAL . 8.9 m-85 -133.38 152.97 51.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.505 -0.771 . . . . 99.989999999999995 110.578 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.5 tt -117.84 129.75 73.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.064 -0.516 . . . . 24.600000000000001 109.691 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.562 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 21.9 t -69.26 127.18 30.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.369 -0.378 . . . . 24.600000000000001 111.316 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.467 ' HG3' ' CD2' ' A' ' 8' ' ' TYR . 14.2 pt-20 -109.48 -19.16 13.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.885 -0.598 . . . . 30.579999999999998 110.839 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.467 ' CD2' ' HG3' ' A' ' 7' ' ' GLU . 30.8 m-85 -133.08 142.87 48.96 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.488 -0.323 . . . . 99.989999999999995 110.181 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -77.28 129.34 35.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.413 -0.358 . . . . 24.600000000000001 110.752 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.452 ' HB3' HG12 ' A' ' 20' ' ' ILE . 77.8 t80 -124.46 130.71 52.97 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.292 -0.413 . . . . 99.989999999999995 110.664 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -93.33 113.12 25.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.881 -0.6 . . . . 26.050000000000001 110.318 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.89 106.97 1.11 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.049 -0.523 . . . . 26.149999999999999 111.326 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -83.76 -36.13 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.757 -0.656 . . . . 31.710000000000001 110.177 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -94.02 176.37 6.36 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.891 -0.595 . . . . 99.989999999999995 110.596 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -81.3 -33.54 32.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 45.18 110.905 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -80.8 -28.23 36.35 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.363 -0.381 . . . . 35.420000000000002 110.552 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.42 134.46 57.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.27 -0.423 . . . . 26.239999999999998 111.114 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.552 ' HG ' ' HA3' ' A' ' 47' ' ' GLY . 28.9 mt -92.42 132.68 36.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.566 -0.743 . . . . 24.600000000000001 110.562 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.6 m -84.26 78.91 9.7 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.299 -0.63 . . . . 99.989999999999995 109.299 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.641 HG21 ' HG ' ' A' ' 42' ' ' LEU . 33.1 pt -78.42 133.41 30.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.935 0.398 . . . . 24.600000000000001 111.752 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -118.24 138.29 52.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 99.989999999999995 109.902 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.41 HG22 ' CA ' ' A' ' 8' ' ' TYR . 39.0 t -44.99 120.98 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.283 -0.417 . . . . 24.600000000000001 111.743 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.13 -21.01 25.4 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.046 -0.597 . . . . 24.600000000000001 113.633 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.541 ' HB3' HD22 ' A' ' 42' ' ' LEU . 39.1 mt-10 -76.32 154.48 35.01 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 117.343 0.572 . . . . 24.600000000000001 111.676 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.5 mt -117.29 127.72 74.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.528 -0.76 . . . . 24.600000000000001 110.16 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.613 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 4.0 mp -94.94 125.44 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 24.600000000000001 110.393 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.586 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 7.7 mpt_? -80.0 125.49 29.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.482 . . . . 99.989999999999995 111.851 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.07 65.87 0.95 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.804 -0.634 . . . . 24.600000000000001 111.779 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.695 HG22 ' HB2' ' A' ' 4' ' ' TYR . 61.8 t -87.59 105.54 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.841 -0.618 . . . . 26.149999999999999 111.238 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -107.37 161.48 14.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.792 -0.64 . . . . 99.989999999999995 110.441 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.486 ' HA ' HD23 ' A' ' 38' ' ' LEU . 39.1 ttmt -84.68 132.14 34.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 99.989999999999995 110.468 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.9 tp -91.01 171.01 9.56 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.865 -0.607 . . . . 37.710000000000001 110.331 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -77.13 -1.71 30.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.629 0.252 . . . . 40.380000000000003 110.855 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -103.67 122.49 45.15 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.646 -0.501 . . . . 38.539999999999999 109.646 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -60.86 117.9 6.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 33.270000000000003 110.461 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.05 15.39 45.24 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.99 -0.624 . . . . 28.280000000000001 112.833 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -132.54 132.47 42.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.163 0.506 . . . . 99.989999999999995 111.153 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 48' ' ' MET . 98.0 mt -118.79 162.25 18.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.262 -0.881 . . . . 24.600000000000001 110.021 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -123.09 118.36 27.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.577 -0.283 . . . . 43.399999999999999 110.439 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.408 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -162.12 170.96 37.91 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.615 -0.802 . . . . 24.600000000000001 113.523 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 34.6 mt-10 -94.09 105.86 17.85 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.918 0.39 . . . . 32.100000000000001 110.46 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.641 ' HG ' HG21 ' A' ' 20' ' ' ILE . 3.1 tm? -124.49 130.44 52.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.879 -0.601 . . . . 24.600000000000001 110.065 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.487 ' HB2' HD12 ' A' ' 42' ' ' LEU . 66.6 t30 64.14 25.1 13.62 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.025 -0.534 . . . . 30.739999999999998 110.939 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.38 13.87 79.66 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 121.003 -0.617 . . . . 33.009999999999998 113.299 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -130.86 140.22 50.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.851 0.358 . . . . 99.989999999999995 110.736 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -91.4 114.03 26.46 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.485 -0.932 . . . . 99.989999999999995 108.485 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.552 ' HA3' ' HG ' ' A' ' 18' ' ' LEU . . . -151.19 -168.97 16.34 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.031 -1.081 . . . . 24.600000000000001 114.018 -178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.597 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 50.7 mtt -111.77 138.72 47.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.499 -0.351 . . . . 33.810000000000002 110.661 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.613 ' CZ ' HG23 ' A' ' 26' ' ' ILE . 4.6 p90 -140.59 153.42 68.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 99.989999999999995 111.35 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.523 ' HG2' ' HB2' ' A' ' 53' ' ' PHE . 9.9 Cg_endo -54.05 135.76 65.0 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.87 2.38 . . . . 24.600000000000001 112.691 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -67.9 -38.08 82.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.686 -0.688 . . . . 25.32 112.104 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -81.64 5.59 17.75 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.685 0.624 . . . . 25.559999999999999 112.685 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.523 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 9.8 m-85 -102.56 -24.82 13.76 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.494 0.188 . . . . 99.989999999999995 110.601 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 31.0 m -116.5 137.19 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.307 -0.406 . . . . 24.600000000000001 110.401 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -111.24 129.16 56.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 99.989999999999995 110.344 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -50.46 141.36 12.25 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.404 -0.362 . . . . 36.5 110.996 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.7 mt -95.33 89.77 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 29.5 110.751 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.55 -0.738 . . . . 99.989999999999995 110.879 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.603 0.24 . . . . 33.030000000000001 111.034 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.1 152.04 22.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.13 0.49 . . . . 30.379999999999999 111.783 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.639 ' HB2' HG23 ' A' ' 29' ' ' VAL . 7.6 m-85 -130.91 152.6 50.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.396 -0.82 . . . . 30.379999999999999 110.702 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 tp -113.31 132.93 60.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.937 -0.574 . . . . 30.57 109.804 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.528 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 40.5 t -74.42 123.52 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.91 0.386 . . . . 31.149999999999999 110.703 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.468 ' HG3' ' CD2' ' A' ' 8' ' ' TYR . 12.5 pt-20 -104.34 -21.18 13.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 37.960000000000001 111.113 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.468 ' CD2' ' HG3' ' A' ' 7' ' ' GLU . 60.9 m-85 -133.14 142.52 48.71 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.856 0.36 . . . . 30.379999999999999 110.827 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -77.57 128.46 34.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 32.049999999999997 110.371 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.498 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 53.0 t80 -128.67 135.98 50.01 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.753 0.311 . . . . 33.979999999999997 111.13 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -96.9 119.85 36.16 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.003 -0.544 . . . . 36.689999999999998 110.562 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.18 105.17 1.32 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.275 -0.42 . . . . 30.620000000000001 111.107 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -87.05 -36.94 10.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.887 -0.597 . . . . 30.559999999999999 110.035 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.549 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 52.8 m-70 -89.21 -179.77 5.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.887 -0.597 . . . . 30.379999999999999 110.305 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -78.84 -45.82 19.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.502 -0.317 . . . . 35.799999999999997 111.029 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -77.93 -23.28 48.66 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.572 -0.286 . . . . 32.579999999999998 111.007 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.549 ' HG2' ' HB2' ' A' ' 14' ' ' HIS . 29.6 mm-40 -52.99 132.22 37.32 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.992 0.425 . . . . 36.109999999999999 111.012 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -95.5 129.01 42.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.639 -0.71 . . . . 30.739999999999998 110.589 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.8 m -82.99 86.11 7.05 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.992 -0.744 . . . . 30.809999999999999 108.992 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 53' ' ' PHE . 36.1 pt -87.71 137.59 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 120.92 0.39 . . . . 30.390000000000001 111.895 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -116.51 135.55 53.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.811 -0.631 . . . . 30.379999999999999 109.974 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -47.21 124.41 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.935 0.398 . . . . 31.460000000000001 111.634 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.25 -16.31 42.07 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.763 -0.653 . . . . 30.600000000000001 113.322 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -82.2 150.0 27.6 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 117.278 0.539 . . . . 35.799999999999997 111.643 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.1 mt -109.17 128.02 65.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.666 -0.697 . . . . 30.379999999999999 110.14 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.571 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 4.2 mp -97.03 126.46 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.444 . . . . 32.07 110.58 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.41 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 83.9 mtp180 -76.51 125.75 29.77 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.075 -0.511 . . . . 30.379999999999999 112.172 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.2 t30 55.2 69.9 0.69 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.726 -0.67 . . . . 30.379999999999999 112.241 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.639 HG23 ' HB2' ' A' ' 4' ' ' TYR . 89.0 t -88.44 106.61 16.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.984 -0.553 . . . . 30.379999999999999 110.511 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -103.96 160.22 15.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.874 -0.603 . . . . 38.770000000000003 110.88 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.407 ' HA ' ' CD2' ' A' ' 38' ' ' LEU . 63.0 mttp -90.84 132.12 36.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 32.939999999999998 110.07 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.459 HD23 ' HB2' ' A' ' 39' ' ' GLU . 93.8 mt -94.68 178.67 5.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 33.130000000000003 110.871 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.58 0.89 31.97 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.29 -0.414 . . . . 42.18 111.013 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.441 ' HB3' ' HD1' ' A' ' 37' ' ' TRP . 36.1 mt-10 -104.49 120.4 41.17 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.426 -0.583 . . . . 38.109999999999999 109.426 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -61.02 118.1 6.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 30.43 110.77 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.6 11.87 56.44 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.011 -0.614 . . . . 30.379999999999999 113.066 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.59 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 55.3 m95 -129.97 129.88 44.33 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.148 0.499 . . . . 30.379999999999999 111.208 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 48' ' ' MET . 90.1 mt -121.96 165.94 15.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.355 -0.839 . . . . 30.379999999999999 109.997 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.459 ' HB2' HD23 ' A' ' 32' ' ' LEU . 9.1 tp10 -126.08 122.07 34.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.611 -0.268 . . . . 38.590000000000003 110.612 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.463 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -154.76 162.37 30.76 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.635 -0.793 . . . . 30.379999999999999 113.283 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 3.1 mp0 -96.89 104.99 17.05 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.024 0.44 . . . . 37.880000000000003 110.945 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.5 ' CD2' HG23 ' A' ' 20' ' ' ILE . 53.0 tp -130.67 138.05 49.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.657 -0.702 . . . . 30.379999999999999 110.1 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 67.65 18.99 9.87 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.975 -0.557 . . . . 40.090000000000003 110.951 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.47 14.88 67.38 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 120.886 -0.673 . . . . 31.289999999999999 113.466 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -142.51 149.06 38.65 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.8 0.334 . . . . 44.740000000000002 110.377 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -92.82 116.3 28.91 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.704 -0.85 . . . . 33.119999999999997 108.704 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.1 151.75 22.75 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.036 -1.078 . . . . 30.379999999999999 114.011 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.59 ' SD ' ' HB3' ' A' ' 37' ' ' TRP . 62.0 ttp -81.44 135.57 35.64 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.242 -0.479 . . . . 35.170000000000002 110.312 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.546 ' CE2' HG21 ' A' ' 26' ' ' ILE . 6.0 p90 -139.49 158.53 68.33 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 30.379999999999999 111.236 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.53 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 34.8 Cg_exo -59.01 141.28 98.17 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.672 2.248 . . . . 30.379999999999999 112.721 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.31 -36.7 79.72 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.693 -0.685 . . . . 32.210000000000001 111.575 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -83.18 4.55 26.21 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.33 0.493 . . . . 34.539999999999999 112.33 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.546 ' HB3' HD13 ' A' ' 20' ' ' ILE . 9.2 m-85 -101.3 -21.69 14.81 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 120.621 0.248 . . . . 34.039999999999999 110.466 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 24.3 m -120.51 141.62 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.205 -0.452 . . . . 31.539999999999999 109.994 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -116.14 129.07 56.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.388 -0.369 . . . . 30.59 110.689 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -55.14 129.45 38.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.415 -0.357 . . . . 32.189999999999998 110.102 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.4 mt -87.65 81.0 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.02 0.438 . . . . 30.539999999999999 110.765 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.0 tttm . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.072 -0.966 . . . . 40.630000000000003 111.026 -179.763 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.711 0.291 . . . . 30.68 111.325 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -85.62 154.52 21.64 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.226 -0.443 . . . . 27.210000000000001 110.748 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 56' ' ' GLU . 8.3 m-85 -127.95 151.58 48.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 99.989999999999995 111.24 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.524 ' HB ' HD12 ' A' ' 57' ' ' ILE . 6.5 tp -112.34 133.2 58.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.667 -0.697 . . . . 24.600000000000001 109.328 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.506 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 38.3 t -77.34 124.18 35.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.806 0.336 . . . . 24.600000000000001 110.791 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.411 ' C ' HG21 ' A' ' 22' ' ' VAL . 19.4 mm-40 -108.44 -17.46 13.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.992 -0.549 . . . . 30.579999999999998 111.166 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.462 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 73.9 m-85 -133.71 141.29 47.49 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.673 0.273 . . . . 99.989999999999995 110.674 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -77.49 128.35 34.06 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.301 -0.409 . . . . 24.600000000000001 110.69 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.448 ' CD1' ' HG3' ' A' ' 50' ' ' PRO . 40.1 t80 -125.81 136.28 52.94 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.492 -0.322 . . . . 99.989999999999995 110.841 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -94.17 119.48 33.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.086 -0.506 . . . . 26.050000000000001 110.898 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.494 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -69.53 104.99 2.49 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.102 -0.499 . . . . 26.149999999999999 111.089 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.4 t -89.59 -34.87 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.748 -0.66 . . . . 31.710000000000001 110.138 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 43.7 m80 -90.91 172.06 8.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.906 -0.588 . . . . 99.989999999999995 110.514 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.68 -36.95 50.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 45.18 110.392 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -92.76 15.37 14.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.135 -0.484 . . . . 35.420000000000002 110.901 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.494 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 23.0 tp10 -92.53 127.84 38.17 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.911 -0.404 . . . . 26.239999999999998 109.911 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.461 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -86.39 124.95 33.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 24.600000000000001 111.139 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.2 m -81.18 83.75 6.73 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.274 -0.639 . . . . 99.989999999999995 109.274 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.506 ' HB ' ' CG2' ' A' ' 6' ' ' VAL . 38.0 pt -85.42 132.88 30.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.042 0.448 . . . . 24.600000000000001 111.709 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 -119.28 138.75 52.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.87 -0.604 . . . . 99.989999999999995 110.181 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.411 HG21 ' C ' ' A' ' 7' ' ' GLU . 46.2 t -44.25 120.97 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.841 0.353 . . . . 24.600000000000001 111.898 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.51 -19.52 28.79 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.87 -0.604 . . . . 24.600000000000001 113.613 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.473 ' HB3' HD12 ' A' ' 42' ' ' LEU . 35.2 mt-10 -76.19 150.43 37.11 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 117.308 0.554 . . . . 24.600000000000001 111.981 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.6 mt -111.81 124.47 68.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.475 -0.784 . . . . 24.600000000000001 109.682 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.56 HG22 ' CE2' ' A' ' 49' ' ' PHE . 30.0 mt -97.12 123.15 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 24.600000000000001 110.403 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -75.71 133.57 40.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.028 -0.533 . . . . 99.989999999999995 112.067 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.7 p30 46.42 71.44 0.3 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.53 -0.759 . . . . 24.600000000000001 112.564 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.597 ' HB ' ' CD1' ' A' ' 4' ' ' TYR . 85.3 t -88.26 110.46 21.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.785 -0.643 . . . . 26.149999999999999 110.834 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -107.0 160.9 15.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.745 -0.661 . . . . 99.989999999999995 110.482 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -88.81 132.41 34.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 99.989999999999995 110.03 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.512 HD22 ' HB2' ' A' ' 39' ' ' GLU . 95.9 mt -92.34 -179.98 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 37.710000000000001 111.166 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -81.36 -0.51 41.55 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.125 -0.489 . . . . 40.380000000000003 111.167 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -105.71 120.51 41.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.693 -0.484 . . . . 38.539999999999999 109.693 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -59.75 117.88 5.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.465 . . . . 33.270000000000003 110.638 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.26 13.02 50.25 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.939 -0.648 . . . . 28.280000000000001 112.963 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -131.38 130.13 42.23 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.139 0.495 . . . . 99.989999999999995 111.154 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 48' ' ' MET . 6.4 mp -119.71 164.39 16.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.295 -0.866 . . . . 24.600000000000001 109.525 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.512 ' HB2' HD22 ' A' ' 32' ' ' LEU . 13.4 tp10 -126.38 122.6 35.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.638 0.256 . . . . 43.399999999999999 111.069 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.08 162.47 30.94 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.832 -0.699 . . . . 24.600000000000001 112.991 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -96.34 104.87 16.86 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.113 0.482 . . . . 32.100000000000001 111.026 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.473 HD12 ' HB3' ' A' ' 24' ' ' GLU . 59.8 tp -125.53 137.61 53.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.579 -0.737 . . . . 24.600000000000001 109.933 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 63.61 21.92 12.93 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.992 -0.549 . . . . 30.739999999999998 110.913 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.98 12.93 80.41 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 120.902 -0.666 . . . . 33.009999999999998 113.233 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -133.38 142.15 48.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.796 0.332 . . . . 99.989999999999995 110.287 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -93.96 114.77 27.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.91 -0.774 . . . . 99.989999999999995 108.91 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.53 153.99 25.68 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.299 -0.953 . . . . 24.600000000000001 113.344 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.609 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 22.7 ptt? -79.23 145.66 33.47 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.683 0.278 . . . . 33.810000000000002 110.369 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.56 ' CE2' HG22 ' A' ' 26' ' ' ILE . 3.8 p90 -143.99 155.66 58.81 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.256 -0.429 . . . . 99.989999999999995 111.22 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.581 ' HG2' ' HB2' ' A' ' 53' ' ' PHE . 14.5 Cg_endo -57.55 148.96 69.91 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.755 2.303 . . . . 24.600000000000001 112.99 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -73.36 -41.3 63.59 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.443 -0.799 . . . . 25.32 112.791 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -82.53 11.26 5.89 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.991 0.738 . . . . 25.559999999999999 112.991 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.581 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 16.3 m-85 -107.38 -27.2 10.61 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.57 0.224 . . . . 99.989999999999995 110.778 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 27.5 m -116.88 139.86 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 116.323 -0.398 . . . . 24.600000000000001 110.39 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -118.37 127.44 53.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.371 -0.377 . . . . 99.989999999999995 110.528 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . 12.8 pt-20 -60.92 131.97 52.37 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.542 -0.299 . . . . 36.5 110.411 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.524 HD12 ' HB ' ' A' ' 5' ' ' ILE . 22.4 mt -87.73 85.59 2.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.114 0.483 . . . . 29.5 110.762 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.445 -0.788 . . . . 99.989999999999995 110.856 -179.917 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.749 0.309 . . . . 30.68 111.021 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -84.64 154.57 22.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.275 -0.42 . . . . 27.210000000000001 111.306 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.622 ' HB2' HG22 ' A' ' 29' ' ' VAL . 6.4 m-85 -130.76 151.4 51.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.772 -0.649 . . . . 99.989999999999995 110.917 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 tp -113.69 128.09 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.689 -0.687 . . . . 24.600000000000001 109.63 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.515 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 29.8 t -73.89 124.37 31.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.422 -0.354 . . . . 24.600000000000001 110.794 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.79 -18.95 13.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.028 -0.533 . . . . 30.579999999999998 110.929 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -130.49 140.54 50.52 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.706 0.288 . . . . 99.989999999999995 110.672 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 21' ' ' ARG . 34.6 m-20 -76.33 131.5 39.23 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.266 -0.424 . . . . 24.600000000000001 110.564 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.402 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 44.5 t80 -132.08 131.56 42.5 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.501 -0.318 . . . . 99.989999999999995 110.834 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -95.02 119.84 34.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.94 -0.573 . . . . 26.050000000000001 110.604 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.454 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -65.08 107.25 1.47 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.013 -0.54 . . . . 26.149999999999999 111.56 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.1 p -87.8 -36.47 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.779 -0.646 . . . . 31.710000000000001 109.95 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -90.37 172.84 8.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.837 -0.62 . . . . 99.989999999999995 110.422 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.81 -35.61 43.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.323 -0.399 . . . . 45.18 110.303 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -92.28 9.39 34.11 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.08 -0.509 . . . . 35.420000000000002 110.986 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.454 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 22.7 tp10 -87.28 126.78 35.05 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.906 -0.405 . . . . 26.239999999999998 109.906 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 42' ' ' LEU . 11.0 tp -84.92 126.53 33.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 24.600000000000001 110.753 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.5 m -83.12 88.44 6.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.887 -0.597 . . . . 99.989999999999995 109.394 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.515 ' HB ' ' CG2' ' A' ' 6' ' ' VAL . 33.0 pt -89.07 131.06 37.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.813 0.34 . . . . 24.600000000000001 111.237 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 9' ' ' ASP . 25.2 mmm180 -117.12 138.78 51.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.154 -0.475 . . . . 99.989999999999995 110.105 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t -45.42 122.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.391 -0.368 . . . . 24.600000000000001 111.791 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.82 -18.97 39.5 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.052 -0.594 . . . . 24.600000000000001 113.575 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.44 ' HB3' HD12 ' A' ' 42' ' ' LEU . 18.2 mm-40 -77.16 147.46 36.49 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.286 0.543 . . . . 24.600000000000001 112.264 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.6 mm -107.7 123.02 62.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.462 -0.79 . . . . 24.600000000000001 109.894 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.538 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 41.0 mt -95.18 124.18 47.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.389 -0.369 . . . . 24.600000000000001 110.535 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.462 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -74.53 128.37 35.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.901 -0.59 . . . . 99.989999999999995 112.245 -178.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 50.64 70.92 0.46 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.698 -0.683 . . . . 24.600000000000001 112.401 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.622 HG22 ' HB2' ' A' ' 4' ' ' TYR . 73.0 t -87.52 107.5 17.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.981 -0.554 . . . . 26.149999999999999 110.741 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -103.74 157.08 17.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.719 -0.673 . . . . 99.989999999999995 110.475 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -89.27 129.9 35.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.414 . . . . 99.989999999999995 109.966 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.498 HD21 ' HB2' ' A' ' 39' ' ' GLU . 87.9 mt -91.17 178.33 6.01 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.345 -0.389 . . . . 37.710000000000001 111.031 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -79.92 0.96 29.14 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.216 -0.447 . . . . 40.380000000000003 111.082 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 3.8 mp0 -105.65 122.0 45.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.463 -0.569 . . . . 38.539999999999999 109.463 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -61.55 116.93 5.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.174 -0.466 . . . . 33.270000000000003 110.435 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.41 12.54 51.04 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.907 -0.663 . . . . 28.280000000000001 113.006 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 44.7 m95 -130.26 129.59 43.49 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.168 0.509 . . . . 99.989999999999995 111.088 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 48' ' ' MET . 85.1 mt -120.07 165.49 14.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.277 -0.874 . . . . 24.600000000000001 109.781 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HB2' HD21 ' A' ' 32' ' ' LEU . 38.7 tt0 -126.68 121.63 32.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.694 -0.23 . . . . 43.399999999999999 110.783 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.93 164.89 32.96 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.527 -0.844 . . . . 24.600000000000001 113.433 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.668 ' HG3' ' HG2' ' A' ' 46' ' ' ARG . 2.9 mp0 -94.1 106.08 18.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.769 0.318 . . . . 32.100000000000001 110.59 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.509 HD23 HG21 ' A' ' 20' ' ' ILE . 40.1 tp -130.61 137.18 49.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 24.600000000000001 110.251 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 64.55 19.73 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 30.739999999999998 111.218 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.74 13.5 72.38 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 121.021 -0.609 . . . . 33.009999999999998 113.453 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.1 mmt180 -136.3 145.31 45.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.909 0.385 . . . . 99.989999999999995 110.739 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.668 ' HG2' ' HG3' ' A' ' 41' ' ' GLU . 31.9 mtp180 -92.69 116.4 28.98 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.914 -0.772 . . . . 99.989999999999995 108.914 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.19 -175.14 15.99 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.116 -1.04 . . . . 24.600000000000001 113.31 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.592 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.2 ptp -112.7 139.68 48.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.943 -0.392 . . . . 33.810000000000002 109.943 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CE1' HG22 ' A' ' 26' ' ' ILE . 3.3 p90 -138.57 159.05 69.17 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.172 -0.467 . . . . 99.989999999999995 111.315 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 36.4 Cg_exo -60.98 136.62 66.75 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.625 2.217 . . . . 24.600000000000001 112.355 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -67.68 -36.2 80.26 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.924 -0.58 . . . . 25.32 111.48 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -79.24 2.11 22.38 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.725 0.639 . . . . 25.559999999999999 112.725 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 9.7 m-85 -102.81 -23.49 13.78 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.554 0.216 . . . . 99.989999999999995 110.852 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 30.9 m -120.63 139.43 47.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.274 -0.421 . . . . 24.600000000000001 110.364 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -112.97 133.29 55.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.345 -0.389 . . . . 99.989999999999995 110.503 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -54.74 137.76 43.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.334 -0.394 . . . . 36.5 110.436 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt -91.27 86.0 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.002 0.43 . . . . 29.5 110.764 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.412 ' HD3' ' C ' ' A' ' 58' ' ' LYS . 7.6 tmtm? . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.02 -0.991 . . . . 99.989999999999995 110.583 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.753 0.311 . . . . 33.030000000000001 111.029 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.03 159.02 16.35 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.103 0.478 . . . . 30.379999999999999 111.49 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.672 ' HB2' HG21 ' A' ' 29' ' ' VAL . 7.8 m-85 -131.34 153.36 49.69 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.528 -0.76 . . . . 30.379999999999999 111.079 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.531 ' HB ' HD11 ' A' ' 57' ' ' ILE . 17.2 tt -111.45 138.06 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.573 . . . . 30.57 109.607 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.456 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 25.1 t -80.78 121.02 33.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.431 -0.35 . . . . 31.149999999999999 110.744 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -104.77 -19.35 13.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.086 -0.506 . . . . 37.960000000000001 111.148 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -132.84 140.42 47.94 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.53 -0.305 . . . . 30.379999999999999 110.363 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.56 130.13 36.53 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.26 -0.427 . . . . 32.049999999999997 110.87 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.463 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 47.6 t80 -129.98 136.48 49.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.943 -0.571 . . . . 33.979999999999997 110.371 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.87 120.61 40.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.139 -0.482 . . . . 36.689999999999998 110.537 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.453 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -64.3 109.07 1.77 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.076 -0.511 . . . . 30.620000000000001 111.695 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.1 t -89.02 -36.35 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.63 -0.714 . . . . 30.559999999999999 109.747 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -92.19 175.02 7.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.767 -0.651 . . . . 30.379999999999999 110.621 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.2 -36.54 47.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.193 -0.458 . . . . 35.799999999999997 110.567 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -93.0 12.96 22.17 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.035 -0.53 . . . . 32.579999999999998 111.038 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 17.5 tp10 -91.54 129.98 37.43 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.801 -0.444 . . . . 36.109999999999999 109.801 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.658 HD12 ' HB3' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -89.31 124.88 34.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.753 0.311 . . . . 30.739999999999998 111.328 -179.521 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.447 ' N ' HD13 ' A' ' 18' ' ' LEU . 32.9 m -81.49 86.13 6.38 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.107 -0.701 . . . . 30.809999999999999 109.107 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.537 HG21 HD21 ' A' ' 42' ' ' LEU . 29.8 pt -87.28 135.31 25.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.396 -0.365 . . . . 30.390000000000001 111.51 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.3 mtp85 -119.06 138.19 53.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.136 -0.484 . . . . 30.379999999999999 110.165 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.3 t -45.32 122.72 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.894 0.378 . . . . 31.460000000000001 111.904 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.63 -18.77 34.59 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.824 -0.625 . . . . 30.600000000000001 113.567 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HB3' HD11 ' A' ' 42' ' ' LEU . 32.6 mt-10 -76.09 155.19 34.97 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.365 0.582 . . . . 35.799999999999997 111.931 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.3 mt -115.53 125.75 72.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.45 -0.795 . . . . 30.379999999999999 109.749 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.707 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 5.5 mm -91.27 120.44 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 32.07 110.756 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.38 122.21 23.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.285 -0.416 . . . . 30.379999999999999 112.107 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 57.97 70.76 0.63 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.753 -0.658 . . . . 30.379999999999999 112.61 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.707 ' CG2' ' HB ' ' A' ' 26' ' ' ILE . 59.8 t -86.39 108.6 17.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.297 -0.41 . . . . 30.379999999999999 111.088 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -105.16 155.97 18.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.802 -0.635 . . . . 38.770000000000003 110.358 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -82.06 127.75 33.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 32.939999999999998 110.264 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 tp -88.42 170.89 10.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 33.130000000000003 110.308 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -78.91 0.85 25.7 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.67 -0.241 . . . . 42.18 110.867 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.487 ' HB3' ' HD1' ' A' ' 37' ' ' TRP . 2.9 mp0 -104.55 116.17 31.61 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.565 -0.532 . . . . 38.109999999999999 109.565 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.92 121.82 10.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 30.43 110.991 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.42 14.78 56.67 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.862 -0.685 . . . . 30.379999999999999 113.031 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.487 ' HD1' ' HB3' ' A' ' 34' ' ' GLU . 92.5 m95 -134.01 132.28 39.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.156 0.503 . . . . 30.379999999999999 110.951 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 48' ' ' MET . 3.7 mm? -117.33 163.43 16.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.295 -0.866 . . . . 30.379999999999999 109.735 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -123.48 119.81 31.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.774 -0.194 . . . . 38.590000000000003 110.482 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.45 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -153.09 161.51 29.67 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.468 -0.872 . . . . 30.379999999999999 113.514 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -95.15 106.61 18.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.084 0.468 . . . . 37.880000000000003 110.825 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.658 ' HB3' HD12 ' A' ' 18' ' ' LEU . 30.3 tp -132.93 142.13 48.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.668 -0.696 . . . . 30.379999999999999 110.073 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.422 ' ND2' ' HG ' ' A' ' 42' ' ' LEU . 54.8 m-80 65.46 17.49 10.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.726 -0.67 . . . . 40.090000000000003 111.181 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.28 15.51 62.21 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 121.005 -0.617 . . . . 31.289999999999999 113.492 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -145.24 151.95 39.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.745 0.307 . . . . 44.740000000000002 110.44 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -95.31 119.04 33.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.11 -0.7 . . . . 33.119999999999997 109.11 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -145.73 150.01 22.19 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.554 -0.832 . . . . 30.379999999999999 113.079 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.594 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 22.8 ptp -78.62 145.46 34.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.718 0.294 . . . . 35.170000000000002 110.373 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.625 ' CZ ' HG23 ' A' ' 26' ' ' ILE . 3.4 p90 -143.2 157.64 59.81 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.024 -0.535 . . . . 30.379999999999999 111.179 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.513 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 27.2 Cg_exo -61.8 145.58 97.11 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.678 2.252 . . . . 30.379999999999999 112.821 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.95 -37.39 78.82 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.617 -0.719 . . . . 32.210000000000001 112.077 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -78.74 4.71 13.05 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.9 0.704 . . . . 34.539999999999999 112.9 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 13.2 m-85 -107.81 -24.23 11.76 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.491 0.186 . . . . 34.039999999999999 111.307 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.5 HG23 ' CE1' ' A' ' 49' ' ' PHE . 29.1 m -121.03 139.95 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 110.113 -0.329 . . . . 31.539999999999999 110.113 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -122.24 131.93 54.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.446 -0.343 . . . . 30.59 110.41 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -54.65 131.26 42.92 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.425 -0.352 . . . . 32.189999999999998 110.64 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.531 HD11 ' HB ' ' A' ' 5' ' ' ILE . 44.2 mt -87.41 84.54 2.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.071 0.462 . . . . 30.539999999999999 110.763 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 96.1 mttt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.084 -0.96 . . . . 40.630000000000003 110.882 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.754 0.311 . . . . 30.68 111.104 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -83.61 157.51 22.24 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.242 -0.435 . . . . 27.210000000000001 111.196 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.632 ' HB2' HG21 ' A' ' 29' ' ' VAL . 7.4 m-85 -134.16 151.92 51.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.829 -0.623 . . . . 99.989999999999995 110.81 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.644 ' HB ' HD12 ' A' ' 57' ' ' ILE . 13.8 tt -113.81 134.03 57.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.402 -0.592 . . . . 24.600000000000001 109.402 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.529 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 37.0 t -76.67 123.63 33.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.917 0.389 . . . . 24.600000000000001 110.828 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -106.49 -21.18 13.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.931 -0.577 . . . . 30.579999999999998 111.002 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.92 141.26 48.27 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.521 -0.308 . . . . 99.989999999999995 110.436 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -74.75 129.3 37.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 24.600000000000001 110.984 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.545 ' HB3' HG12 ' A' ' 20' ' ' ILE . 54.2 t80 -127.11 132.94 50.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.928 -0.578 . . . . 99.989999999999995 110.183 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -100.02 116.65 32.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.009 -0.541 . . . . 26.050000000000001 110.638 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.83 107.33 0.96 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.016 -0.538 . . . . 26.149999999999999 111.143 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.7 t -77.66 -39.35 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.925 -0.58 . . . . 31.710000000000001 109.83 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.689 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 46.5 m-70 -98.31 178.15 5.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.753 -0.658 . . . . 99.989999999999995 110.712 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -81.71 -27.13 34.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.033 -0.531 . . . . 45.18 111.092 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -92.09 5.87 48.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.511 -0.313 . . . . 35.420000000000002 111.098 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.689 ' HG2' ' HB2' ' A' ' 14' ' ' HIS . 40.3 mm-40 -94.42 135.35 35.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 110.013 -0.366 . . . . 26.239999999999998 110.013 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.432 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -89.6 125.7 35.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.94 -0.573 . . . . 24.600000000000001 110.835 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.3 m -83.08 86.18 7.05 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.32 -0.622 . . . . 99.989999999999995 109.32 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.545 HG12 ' HB3' ' A' ' 10' ' ' TYR . 43.4 pt -84.7 136.82 21.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.161 -0.472 . . . . 24.600000000000001 111.906 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -119.8 137.78 53.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.862 -0.608 . . . . 99.989999999999995 110.187 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.5 t -45.72 122.51 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.078 0.399 . . . . 24.600000000000001 112.078 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.14 -18.22 36.63 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.846 -0.616 . . . . 24.600000000000001 113.69 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.448 ' HB3' HD12 ' A' ' 42' ' ' LEU . 32.8 mt-10 -78.31 152.76 32.24 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.395 0.598 . . . . 24.600000000000001 112.107 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.5 mm -112.38 125.23 69.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.493 -0.776 . . . . 24.600000000000001 109.743 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.586 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 40.4 mt -96.98 125.03 50.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 24.600000000000001 110.782 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 78.2 ttt180 -75.55 125.88 29.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.775 -0.648 . . . . 99.989999999999995 112.422 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 54.41 68.74 0.81 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.697 -0.683 . . . . 24.600000000000001 112.413 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.632 HG21 ' HB2' ' A' ' 4' ' ' TYR . 91.6 t -88.43 107.94 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 26.149999999999999 110.839 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -108.4 164.6 12.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.844 -0.616 . . . . 99.989999999999995 110.623 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -90.59 133.46 35.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.289 -0.414 . . . . 99.989999999999995 110.517 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.444 HD13 ' HG2' ' A' ' 48' ' ' MET . 94.5 mt -96.17 -177.77 4.1 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.976 -0.556 . . . . 37.710000000000001 110.955 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -81.83 -0.2 42.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.309 -0.405 . . . . 40.380000000000003 111.226 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 31.6 mt-10 -103.38 115.88 31.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.745 -0.465 . . . . 38.539999999999999 109.745 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -58.12 118.46 5.47 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.258 -0.428 . . . . 33.270000000000003 110.575 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.85 14.15 53.12 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.936 -0.65 . . . . 28.280000000000001 113.012 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 80.9 m95 -133.75 132.72 40.87 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.125 0.488 . . . . 99.989999999999995 110.704 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 48' ' ' MET . 94.7 mt -120.08 166.6 13.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.272 -0.876 . . . . 24.600000000000001 110.087 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' HB2' HD22 ' A' ' 32' ' ' LEU . 14.0 tp10 -125.97 120.61 30.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.55 -0.296 . . . . 43.399999999999999 110.636 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.16 163.36 31.43 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.729 -0.748 . . . . 24.600000000000001 113.118 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 27' ' ' ARG . 1.9 tm-20 -95.05 103.79 15.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.037 0.446 . . . . 32.100000000000001 110.462 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.479 HD23 HG21 ' A' ' 20' ' ' ILE . 45.8 tp -129.82 140.71 50.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.535 -0.757 . . . . 24.600000000000001 110.113 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 65.0 18.26 11.43 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.032 -0.531 . . . . 30.739999999999998 111.192 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.2 14.36 66.74 Favored Glycine 0 C--N 1.341 0.815 0 C-N-CA 120.992 -0.623 . . . . 33.009999999999998 113.331 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -140.94 149.29 41.65 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.826 0.346 . . . . 99.989999999999995 110.8 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -94.8 115.26 27.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.928 -0.767 . . . . 99.989999999999995 108.928 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.9 -176.54 14.69 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.259 -0.972 . . . . 24.600000000000001 113.613 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.579 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 54.8 mtt -111.62 133.77 53.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.491 -0.355 . . . . 33.810000000000002 110.162 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.486 ' CE1' HG21 ' A' ' 26' ' ' ILE . 4.8 p90 -136.51 156.92 76.13 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.273 -0.422 . . . . 99.989999999999995 111.473 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.6 ' HG2' ' HB2' ' A' ' 53' ' ' PHE . 19.6 Cg_endo -58.99 136.56 74.2 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.741 2.294 . . . . 24.600000000000001 112.436 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.75 -38.18 83.12 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.791 -0.641 . . . . 25.32 111.849 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -78.29 4.74 12.03 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.808 0.67 . . . . 25.559999999999999 112.808 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.6 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 5.3 m-85 -105.25 -22.33 13.08 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.494 0.188 . . . . 99.989999999999995 110.996 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 18.3 m -117.36 141.07 37.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.467 -0.333 . . . . 24.600000000000001 110.65 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -113.63 125.24 53.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 99.989999999999995 110.306 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -51.69 141.47 16.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.439 -0.346 . . . . 36.5 110.993 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.644 HD12 ' HB ' ' A' ' 5' ' ' ILE . 39.4 mm -85.97 93.32 3.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.167 -0.47 . . . . 29.5 110.458 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.099 -0.953 . . . . 99.989999999999995 110.824 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.746 0.307 . . . . 30.68 111.186 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.41 149.03 25.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.023 0.44 . . . . 27.210000000000001 111.132 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.629 ' HB2' HG21 ' A' ' 29' ' ' VAL . 6.8 m-85 -129.04 152.73 48.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.626 -0.715 . . . . 99.989999999999995 110.709 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.2 tt -114.84 136.36 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 24.600000000000001 109.703 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.522 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 36.8 t -74.29 122.06 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 24.600000000000001 110.83 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.428 ' HG3' ' CD2' ' A' ' 8' ' ' TYR . 11.9 pt-20 -103.1 -20.76 14.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.914 -0.584 . . . . 30.579999999999998 111.065 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.428 ' CD2' ' HG3' ' A' ' 7' ' ' GLU . 61.2 m-85 -134.52 141.86 46.84 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.844 0.354 . . . . 99.989999999999995 110.653 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -79.22 127.57 32.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.038 -0.528 . . . . 24.600000000000001 110.441 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.491 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 34.8 t80 -125.47 137.12 53.97 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.381 -0.372 . . . . 99.989999999999995 111.019 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -94.82 119.12 32.87 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.063 -0.517 . . . . 26.050000000000001 110.38 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.504 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -66.46 103.38 1.03 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.273 -0.421 . . . . 26.149999999999999 111.469 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.07 -33.78 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.887 -0.597 . . . . 31.710000000000001 110.265 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 53.0 m80 -90.52 178.2 6.16 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.93 -0.577 . . . . 99.989999999999995 109.968 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.58 -46.05 20.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.665 -0.243 . . . . 45.18 110.693 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.13 -22.26 52.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.25 -0.432 . . . . 35.420000000000002 110.84 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.504 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 16.0 tp10 -52.71 125.53 16.99 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.898 0.38 . . . . 26.239999999999998 110.908 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.423 HD21 ' HB3' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -90.39 127.61 36.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.934 -0.575 . . . . 24.600000000000001 110.61 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.8 m -80.92 86.28 6.09 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.005 -0.739 . . . . 99.989999999999995 109.005 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.563 HD11 ' HB3' ' A' ' 53' ' ' PHE . 23.8 pt -91.6 137.3 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.002 0.429 . . . . 24.600000000000001 111.794 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -118.38 139.18 51.77 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.862 -0.608 . . . . 99.989999999999995 109.966 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.6 t -47.57 124.76 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 111.994 0.368 . . . . 24.600000000000001 111.994 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.77 -18.24 37.7 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.848 -0.614 . . . . 24.600000000000001 113.527 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.594 ' HB3' HD12 ' A' ' 42' ' ' LEU . 41.7 mt-10 -78.14 153.59 31.95 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 117.263 0.531 . . . . 24.600000000000001 111.821 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.0 pt -112.65 125.93 69.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.665 -0.698 . . . . 24.600000000000001 110.245 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.638 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 3.9 mp -97.49 124.87 50.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.47 . . . . 24.600000000000001 110.405 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.5 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 40.2 ttm180 -78.46 127.58 32.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.265 -0.425 . . . . 99.989999999999995 112.032 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 61.5 t30 57.37 67.33 0.99 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.671 -0.695 . . . . 24.600000000000001 112.09 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.638 ' CG2' ' HB ' ' A' ' 26' ' ' ILE . 76.1 t -91.12 108.39 19.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 26.149999999999999 110.864 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -110.89 167.1 10.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.896 -0.593 . . . . 99.989999999999995 110.929 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -92.67 135.64 33.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.945 -0.571 . . . . 99.989999999999995 110.333 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 39' ' ' GLU . 95.1 mt -96.16 -177.42 3.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 37.710000000000001 110.987 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -81.41 -0.19 40.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.267 -0.424 . . . . 40.380000000000003 111.349 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.415 ' HB3' ' HD1' ' A' ' 37' ' ' TRP . 38.6 mt-10 -105.57 121.6 44.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.84 -0.43 . . . . 38.539999999999999 109.84 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.0 117.83 5.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.039 -0.528 . . . . 33.270000000000003 110.767 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.44 11.23 57.38 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.003 -0.618 . . . . 28.280000000000001 113.123 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.482 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 69.6 m95 -130.29 129.0 42.69 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.168 0.509 . . . . 99.989999999999995 111.103 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 48' ' ' MET . 8.0 mp -121.45 168.64 11.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.316 -0.856 . . . . 24.600000000000001 109.982 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HB2' HD21 ' A' ' 32' ' ' LEU . 10.8 tp10 -127.05 123.04 36.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.487 -0.324 . . . . 43.399999999999999 110.877 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.439 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -155.49 163.41 31.6 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.622 -0.799 . . . . 24.600000000000001 113.42 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 27' ' ' ARG . 22.9 mt-10 -97.5 104.36 16.38 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.843 0.354 . . . . 32.100000000000001 110.921 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.594 HD12 ' HB3' ' A' ' 24' ' ' GLU . 43.1 tp -128.24 138.29 52.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 24.600000000000001 110.387 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.8 m120 63.37 21.95 13.04 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.893 -0.594 . . . . 30.739999999999998 111.21 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.7 12.79 76.98 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 121.007 -0.616 . . . . 33.009999999999998 113.476 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -135.32 144.53 46.76 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.819 0.342 . . . . 99.989999999999995 110.502 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -92.23 114.3 26.8 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.246 -1.02 . . . . 99.989999999999995 108.246 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.56 154.4 25.15 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.807 -1.187 . . . . 24.600000000000001 114.316 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.568 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 37.7 ttm -81.44 137.72 35.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.857 -0.671 . . . . 33.810000000000002 110.134 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.55 ' CE2' HG23 ' A' ' 26' ' ' ILE . 3.0 p90 -140.69 159.81 61.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.437 -0.347 . . . . 99.989999999999995 111.213 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.534 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 34.1 Cg_exo -61.03 145.9 98.46 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.688 2.259 . . . . 24.600000000000001 112.839 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.45 -38.4 84.44 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.734 -0.666 . . . . 25.32 111.997 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -85.67 9.32 16.58 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.37 0.507 . . . . 25.559999999999999 112.37 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.563 ' HB3' HD11 ' A' ' 20' ' ' ILE . 9.1 m-85 -105.11 -24.42 12.77 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.553 0.216 . . . . 99.989999999999995 110.432 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 20.2 m -115.45 137.8 47.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.21 -0.45 . . . . 24.600000000000001 109.927 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -115.64 124.2 50.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.4 -0.364 . . . . 99.989999999999995 110.591 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 38.0 tt0 -55.68 132.08 48.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.322 -0.399 . . . . 36.5 110.671 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.8 mt -93.5 75.64 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.205 0.526 . . . . 29.5 110.386 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.56 -0.734 . . . . 99.989999999999995 110.881 -179.893 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.724 0.297 . . . . 33.030000000000001 111.344 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.71 157.26 19.68 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.155 -0.475 . . . . 30.379999999999999 111.093 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.604 ' HB2' HG22 ' A' ' 29' ' ' VAL . 8.1 m-85 -133.2 151.51 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.864 -0.607 . . . . 30.379999999999999 110.88 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.4 tt -109.56 137.03 43.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.339 -0.615 . . . . 30.57 109.339 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.507 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 37.4 t -79.94 119.03 28.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.879 0.371 . . . . 31.149999999999999 110.798 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -102.58 -20.04 14.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.993 -0.549 . . . . 37.960000000000001 110.976 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -130.62 138.01 49.9 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.565 -0.289 . . . . 30.379999999999999 110.634 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -75.02 127.64 33.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 32.049999999999997 110.594 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.447 ' HB3' HG12 ' A' ' 20' ' ' ILE . 68.1 t80 -117.82 132.78 56.4 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.185 -0.461 . . . . 33.979999999999997 110.317 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -93.68 154.71 17.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 36.689999999999998 110.759 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.46 116.02 6.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 30.620000000000001 110.51 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.55 -27.91 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.92 -0.582 . . . . 30.559999999999999 110.445 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.622 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 52.0 m80 -148.54 -179.22 6.8 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.123 -0.49 . . . . 30.379999999999999 110.177 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -76.32 -29.32 57.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 35.799999999999997 110.841 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -94.09 6.78 47.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.371 -0.377 . . . . 32.579999999999998 111.524 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.622 ' HG2' ' HB2' ' A' ' 14' ' ' HIS . 45.0 mm-40 -95.95 131.66 42.08 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 110.238 -0.282 . . . . 36.109999999999999 110.238 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.502 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -88.69 123.83 33.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 30.739999999999998 111.129 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 37.0 m -81.62 84.91 6.64 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.081 -0.711 . . . . 30.809999999999999 109.081 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.524 HD12 ' HB3' ' A' ' 53' ' ' PHE . 35.1 pt -90.06 142.64 12.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.746 -0.661 . . . . 30.390000000000001 111.743 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.427 ' HD3' ' N ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -121.2 142.5 49.84 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.126 -0.488 . . . . 30.379999999999999 110.107 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -49.5 124.78 2.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 112.014 0.376 . . . . 31.460000000000001 112.014 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.1 -16.67 45.74 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.864 -0.607 . . . . 30.600000000000001 113.686 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.0 156.68 25.79 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 117.468 0.634 . . . . 35.799999999999997 112.018 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.9 mm -113.82 127.9 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.364 -0.834 . . . . 30.379999999999999 110.124 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.574 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 36.6 mt -98.46 125.75 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 32.07 110.834 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.542 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 75.8 mtm180 -71.77 124.5 24.94 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.833 -0.621 . . . . 30.379999999999999 112.553 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 49.37 72.68 0.29 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.65 -0.705 . . . . 30.379999999999999 112.491 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.604 HG22 ' HB2' ' A' ' 4' ' ' TYR . 71.6 t -86.59 109.0 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 30.379999999999999 110.325 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -105.42 158.96 16.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.81 -0.632 . . . . 38.770000000000003 110.688 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -90.18 134.17 34.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.701 -0.481 . . . . 32.939999999999998 109.701 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.425 HD13 ' HG2' ' A' ' 48' ' ' MET . 91.1 mt -97.16 -177.55 3.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.401 -0.363 . . . . 33.130000000000003 111.19 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.9 2.57 33.77 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.257 -0.428 . . . . 42.18 111.214 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 4.8 mp0 -105.73 116.31 31.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.318 -0.623 . . . . 38.109999999999999 109.318 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.78 118.02 5.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.263 -0.426 . . . . 30.43 110.651 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.17 9.14 57.28 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.899 -0.667 . . . . 30.379999999999999 113.408 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.432 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 73.4 m95 -130.98 130.54 43.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.245 0.545 . . . . 30.379999999999999 111.087 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 48' ' ' MET . 6.6 mp -120.74 168.79 11.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.121 -0.945 . . . . 30.379999999999999 109.663 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -128.21 123.96 35.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.647 0.26 . . . . 38.590000000000003 110.732 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.446 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -151.26 160.18 28.56 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.754 -0.736 . . . . 30.379999999999999 112.829 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 3.3 mp0 -97.2 102.93 14.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.068 0.461 . . . . 37.880000000000003 110.946 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.514 ' CD2' HG23 ' A' ' 20' ' ' ILE . 54.9 tp -125.81 138.12 53.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.65 -0.704 . . . . 30.379999999999999 109.989 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 62.5 21.15 12.43 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.091 -0.504 . . . . 40.090000000000003 111.471 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.93 9.46 80.72 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 120.937 -0.649 . . . . 31.289999999999999 113.6 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -132.18 141.39 49.08 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.687 0.28 . . . . 44.740000000000002 110.407 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -91.86 114.69 27.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.617 -0.882 . . . . 33.119999999999997 108.617 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.26 179.91 16.94 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.267 -0.968 . . . . 30.379999999999999 113.509 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.568 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 77.3 mtp -111.2 134.89 52.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.441 -0.379 . . . . 35.170000000000002 110.227 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.412 ' CE1' HG22 ' A' ' 54' ' ' VAL . 2.0 p90 -135.36 159.09 73.04 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.151 -0.477 . . . . 30.379999999999999 110.999 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 33.6 Cg_exo -61.06 148.74 91.95 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.708 2.272 . . . . 30.379999999999999 112.815 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.43 -39.06 85.44 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.761 -0.654 . . . . 32.210000000000001 111.794 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -87.35 15.3 6.6 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.307 0.484 . . . . 34.539999999999999 112.307 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.524 ' HB3' HD12 ' A' ' 20' ' ' ILE . 4.9 m-85 -106.71 -24.98 11.94 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 120.527 0.203 . . . . 34.039999999999999 110.603 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 28.2 m -124.31 144.81 32.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.178 -0.464 . . . . 31.539999999999999 110.54 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -122.03 128.74 51.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 30.59 110.108 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -52.83 136.28 34.34 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.62 0.248 . . . . 32.189999999999998 110.788 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.447 HG21 HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -84.1 103.75 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.371 0.605 . . . . 30.539999999999999 110.375 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.135 -0.936 . . . . 40.630000000000003 110.745 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.73 0.3 . . . . 33.030000000000001 111.156 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -79.95 150.78 30.38 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.989 0.423 . . . . 30.379999999999999 111.497 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.644 ' HB2' HG21 ' A' ' 29' ' ' VAL . 10.4 m-85 -130.37 151.79 50.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.613 -0.721 . . . . 30.379999999999999 110.72 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.4 tt -120.07 124.35 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 30.57 109.89 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 25.3 t -63.82 129.65 27.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 31.149999999999999 111.319 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -109.92 -25.31 10.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.656 -0.702 . . . . 37.960000000000001 110.428 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -132.79 139.19 47.41 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.288 -0.415 . . . . 30.379999999999999 110.283 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -69.0 141.96 54.76 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.331 -0.395 . . . . 32.049999999999997 111.029 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -135.95 126.07 26.22 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.232 -0.44 . . . . 33.979999999999997 110.855 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -82.59 117.38 22.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 36.689999999999998 111.321 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.94 104.89 3.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.939 -0.573 . . . . 30.620000000000001 110.945 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.6 t -85.95 -37.26 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.797 -0.638 . . . . 30.559999999999999 110.169 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 55.3 m-70 -89.59 174.11 7.94 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.96 -0.564 . . . . 30.379999999999999 110.795 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -81.19 -31.34 34.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.117 -0.492 . . . . 35.799999999999997 110.965 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -100.0 16.74 22.96 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.493 -0.321 . . . . 32.579999999999998 110.724 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 14' ' ' HIS . 22.6 tt0 -96.93 125.94 41.71 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.906 -0.405 . . . . 36.109999999999999 109.906 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.503 ' HG ' ' HA3' ' A' ' 47' ' ' GLY . 35.3 mt -79.94 133.5 36.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.863 0.363 . . . . 30.739999999999998 111.064 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 m -87.17 55.16 3.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.848 -0.614 . . . . 30.809999999999999 110.527 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 6' ' ' VAL . 22.1 pt -48.81 120.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 112.546 0.573 . . . . 30.390000000000001 112.546 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -113.43 136.46 52.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.394 -0.821 . . . . 30.379999999999999 109.292 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -43.09 122.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.733 0.301 . . . . 31.460000000000001 111.715 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.42 -18.41 38.57 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.075 -0.583 . . . . 30.600000000000001 113.813 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' HB3' HD13 ' A' ' 42' ' ' LEU . 41.8 mt-10 -80.03 147.28 31.57 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 117.554 0.677 . . . . 35.799999999999997 111.534 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.417 ' N ' HD11 ' A' ' 25' ' ' ILE . 4.4 mp -111.79 127.79 68.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.805 -0.634 . . . . 30.379999999999999 110.311 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.509 HG22 ' CE1' ' A' ' 49' ' ' PHE . 3.9 mp -96.07 122.28 47.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.28 -0.418 . . . . 32.07 110.287 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 22.0 mmm180 -74.31 127.74 33.76 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.083 -0.508 . . . . 30.379999999999999 112.073 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 52.39 73.42 0.34 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.816 -0.629 . . . . 30.379999999999999 112.176 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.644 HG21 ' HB2' ' A' ' 4' ' ' TYR . 55.9 t -88.77 110.57 21.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.973 -0.558 . . . . 30.379999999999999 111.507 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -102.48 154.97 18.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.699 -0.682 . . . . 38.770000000000003 109.923 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.41 ' HA ' HD23 ' A' ' 38' ' ' LEU . 86.1 tttt -80.48 123.35 28.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.953 0.406 . . . . 32.939999999999998 110.988 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.1 tp -77.83 162.77 26.64 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.774 -0.648 . . . . 33.130000000000003 110.068 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -61.75 -28.81 69.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.487 -0.324 . . . . 42.18 110.79 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -83.95 129.87 34.91 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.805 0.336 . . . . 38.109999999999999 110.761 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.61 122.42 16.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.864 -0.607 . . . . 30.43 109.675 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.06 18.04 38.36 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 30.379999999999999 112.342 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -134.46 135.18 42.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.105 0.479 . . . . 30.379999999999999 110.484 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 48' ' ' MET . 81.0 mt -124.73 161.71 25.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.345 -0.843 . . . . 30.379999999999999 110.022 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.635 ' HG2' ' HD2' ' A' ' 46' ' ' ARG . 31.2 tt0 -125.43 119.45 28.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.103 -0.332 . . . . 38.590000000000003 110.103 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.486 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -157.23 165.67 33.38 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.417 -0.897 . . . . 30.379999999999999 113.405 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 2.0 tm-20 -86.79 109.38 19.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.942 0.401 . . . . 37.880000000000003 110.079 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.486 HD22 HG23 ' A' ' 20' ' ' ILE . 57.8 tp -132.03 134.09 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.665 -0.698 . . . . 30.379999999999999 110.371 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 64.18 21.39 12.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.922 -0.581 . . . . 40.090000000000003 111.398 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.61 18.66 59.73 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 120.97 -0.633 . . . . 31.289999999999999 113.553 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -144.45 150.91 38.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.777 0.322 . . . . 44.740000000000002 110.645 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.635 ' HD2' ' HG2' ' A' ' 39' ' ' GLU . 6.8 tpp180 -94.19 115.98 28.33 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.989 -0.745 . . . . 33.119999999999997 108.989 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.503 ' HA3' ' HG ' ' A' ' 18' ' ' LEU . . . -141.07 -170.83 12.32 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.322 -0.942 . . . . 30.379999999999999 113.442 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.573 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 45.8 mtt -119.07 138.05 53.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.547 -0.326 . . . . 35.170000000000002 110.158 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.509 ' CE1' HG22 ' A' ' 26' ' ' ILE . 4.5 p90 -143.23 158.92 57.26 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 30.379999999999999 111.475 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 37.6 Cg_exo -57.35 141.46 94.79 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.817 2.344 . . . . 30.379999999999999 112.941 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -75.45 -39.04 59.3 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.563 -0.744 . . . . 32.210000000000001 111.453 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -76.35 -3.98 39.74 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.741 0.645 . . . . 34.539999999999999 112.741 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.482 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 6.9 m-85 -93.7 -34.15 13.36 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 110.336 -0.246 . . . . 34.039999999999999 110.336 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 24.7 m -102.72 143.55 14.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.198 -0.456 . . . . 31.539999999999999 110.214 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -109.99 130.44 55.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.355 -0.384 . . . . 30.59 110.808 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -52.0 132.21 32.3 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.127 -0.488 . . . . 32.189999999999998 110.582 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.9 mt -92.51 81.68 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.044 0.45 . . . . 30.539999999999999 110.437 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.037 -0.982 . . . . 40.630000000000003 111.217 -179.926 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.729 0.3 . . . . 33.030000000000001 111.364 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -80.65 149.82 29.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.152 -0.476 . . . . 30.379999999999999 110.734 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.62 ' HB2' HG22 ' A' ' 29' ' ' VAL . 9.0 m-85 -128.87 151.37 49.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.81 -0.632 . . . . 30.379999999999999 110.891 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.3 tt -116.9 126.46 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 30.57 109.75 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.541 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 34.8 t -68.19 128.52 31.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.963 0.411 . . . . 31.149999999999999 110.918 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -110.14 -22.82 11.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.702 -0.681 . . . . 37.960000000000001 110.77 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -133.43 140.8 47.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.413 -0.358 . . . . 30.379999999999999 110.389 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -72.28 136.5 46.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.319 -0.4 . . . . 32.049999999999997 110.71 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.501 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 63.5 t80 -137.43 128.61 27.78 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.278 -0.419 . . . . 33.979999999999997 111.093 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.431 ' HA ' HG22 ' A' ' 19' ' ' THR . 6.1 p-10 -79.97 157.15 26.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.868 -0.605 . . . . 36.689999999999998 110.463 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.08 95.59 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.372 -0.376 . . . . 30.620000000000001 111.158 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.12 -37.2 46.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.071 -0.513 . . . . 30.559999999999999 109.83 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 91.5 m-70 -93.38 165.86 12.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.721 -0.672 . . . . 30.379999999999999 110.724 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -74.6 -33.78 62.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 35.799999999999997 110.885 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.63 17.31 15.13 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.148 -0.478 . . . . 32.579999999999998 110.901 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 14' ' ' HIS . 21.3 tt0 -97.77 128.47 44.44 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.99 -0.374 . . . . 36.109999999999999 109.99 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.562 ' HG ' ' HA3' ' A' ' 47' ' ' GLY . 6.6 mt -82.75 130.34 35.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 30.739999999999998 111.181 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.431 HG22 ' HA ' ' A' ' 11' ' ' ASP . 11.4 m -86.81 64.96 8.78 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.971 -0.558 . . . . 30.809999999999999 109.703 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.541 ' HB ' ' CG2' ' A' ' 6' ' ' VAL . 30.0 pt -60.94 127.4 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 112.629 0.603 . . . . 30.390000000000001 112.629 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -115.14 138.42 50.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.625 -0.716 . . . . 30.379999999999999 109.663 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.4 125.37 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.728 0.299 . . . . 31.460000000000001 111.794 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.86 -19.72 40.51 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.053 -0.594 . . . . 30.600000000000001 113.456 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -76.3 146.6 38.79 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 117.254 0.527 . . . . 35.799999999999997 111.639 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.4 pt -109.18 125.16 66.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.852 -0.613 . . . . 30.379999999999999 110.147 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.647 HG23 ' CE1' ' A' ' 49' ' ' PHE . 6.1 mm -94.97 119.87 43.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 32.07 110.636 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.498 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 88.8 mtm180 -75.75 127.69 33.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 30.379999999999999 112.007 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.9 t30 53.07 73.37 0.36 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.798 -0.637 . . . . 30.379999999999999 112.133 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.635 ' CG2' ' HB ' ' A' ' 26' ' ' ILE . 66.4 t -91.85 110.15 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 30.379999999999999 111.189 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -107.64 162.82 13.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.868 -0.605 . . . . 38.770000000000003 110.546 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HA ' HD21 ' A' ' 38' ' ' LEU . 5.7 mmmt -90.14 128.66 36.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 32.939999999999998 110.861 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.487 HD22 ' HB2' ' A' ' 39' ' ' GLU . 92.8 mt -90.14 179.41 5.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.033 -0.53 . . . . 33.130000000000003 110.866 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.09 -3.51 45.7 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.252 -0.431 . . . . 42.18 111.179 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 35.3 mt-10 -100.93 119.08 38.19 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.798 -0.445 . . . . 38.109999999999999 109.798 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -60.93 117.65 5.72 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.303 -0.408 . . . . 30.43 110.274 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.08 17.45 34.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.024 -0.608 . . . . 30.379999999999999 112.4 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.433 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 99.3 m95 -133.55 132.3 40.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.137 0.494 . . . . 30.379999999999999 111.016 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.601 ' O ' ' HA ' ' A' ' 48' ' ' MET . 83.5 mt -119.87 160.91 21.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.317 -0.856 . . . . 30.379999999999999 109.936 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.487 ' HB2' HD22 ' A' ' 32' ' ' LEU . 9.1 tp10 -122.92 117.56 25.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.574 0.226 . . . . 38.590000000000003 110.674 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.453 ' HA3' HG22 ' A' ' 26' ' ' ILE . . . -156.13 164.64 32.45 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.499 -0.857 . . . . 30.379999999999999 113.418 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 3.5 mp0 -92.13 117.06 29.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.06 0.457 . . . . 37.880000000000003 111.104 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.528 HD23 HG21 ' A' ' 20' ' ' ILE . 55.5 tp -131.87 130.5 41.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.59 -0.732 . . . . 30.379999999999999 110.308 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 60.99 26.09 16.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.94 -0.573 . . . . 40.090000000000003 111.54 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.37 15.29 69.25 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.715 -0.755 . . . . 31.289999999999999 113.954 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -139.02 145.49 39.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.853 0.327 . . . . 44.740000000000002 110.422 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -95.46 120.0 34.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.558 -0.534 . . . . 33.119999999999997 109.558 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.562 ' HA3' ' HG ' ' A' ' 18' ' ' LEU . . . -149.34 155.42 26.3 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.293 -0.956 . . . . 30.379999999999999 113.669 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.601 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 24.8 ptt? -80.96 140.49 35.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.955 0.407 . . . . 35.170000000000002 110.9 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.647 ' CE1' HG23 ' A' ' 26' ' ' ILE . 6.1 p90 -141.63 162.68 45.48 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.933 -0.576 . . . . 30.379999999999999 111.095 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.531 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 25.9 Cg_exo -62.73 144.07 93.23 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.779 2.32 . . . . 30.379999999999999 112.971 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.6 -39.41 67.33 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.728 -0.669 . . . . 32.210000000000001 111.84 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -79.83 0.37 31.27 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.061 0.763 . . . . 34.539999999999999 113.061 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 9.6 m-85 -98.18 -31.22 12.2 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.494 0.188 . . . . 34.039999999999999 110.669 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 25.6 m -110.08 135.14 50.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.401 -0.363 . . . . 31.539999999999999 110.53 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -107.09 127.71 53.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 30.59 110.495 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 37.6 tt0 -57.61 136.31 56.78 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.446 -0.343 . . . . 32.189999999999998 110.668 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.4 mt -93.82 84.79 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 30.539999999999999 110.602 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.132 -0.937 . . . . 40.630000000000003 110.89 -179.954 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.816 0.341 . . . . 30.68 111.129 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -88.29 156.91 18.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.166 -0.47 . . . . 27.210000000000001 111.368 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.695 ' HB2' HG22 ' A' ' 29' ' ' VAL . 8.9 m-85 -133.38 152.97 51.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.505 -0.771 . . . . 99.989999999999995 110.578 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.5 tt -117.84 129.75 73.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.064 -0.516 . . . . 24.600000000000001 109.691 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.562 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 21.9 t -69.26 127.18 30.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.369 -0.378 . . . . 24.600000000000001 111.316 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.467 ' HG3' ' CD2' ' A' ' 8' ' ' TYR . 14.2 pt-20 -109.48 -19.16 13.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.885 -0.598 . . . . 30.579999999999998 110.839 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.467 ' CD2' ' HG3' ' A' ' 7' ' ' GLU . 30.8 m-85 -133.08 142.87 48.96 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.488 -0.323 . . . . 99.989999999999995 110.181 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -77.28 129.34 35.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.413 -0.358 . . . . 24.600000000000001 110.752 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.452 ' HB3' HG12 ' A' ' 20' ' ' ILE . 77.8 t80 -124.46 130.71 52.97 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.292 -0.413 . . . . 99.989999999999995 110.664 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -93.33 113.12 25.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.881 -0.6 . . . . 26.050000000000001 110.318 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.89 106.97 1.11 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.049 -0.523 . . . . 26.149999999999999 111.326 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -83.76 -36.13 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.757 -0.656 . . . . 31.710000000000001 110.177 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -94.02 176.37 6.36 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.891 -0.595 . . . . 99.989999999999995 110.596 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -81.3 -33.54 32.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 45.18 110.905 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -80.8 -28.23 36.35 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.363 -0.381 . . . . 35.420000000000002 110.552 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.42 134.46 57.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.27 -0.423 . . . . 26.239999999999998 111.114 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.552 ' HG ' ' HA3' ' A' ' 47' ' ' GLY . 28.9 mt -92.42 132.68 36.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.566 -0.743 . . . . 24.600000000000001 110.562 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.6 m -84.26 78.91 9.7 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.299 -0.63 . . . . 99.989999999999995 109.299 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.641 HG21 ' HG ' ' A' ' 42' ' ' LEU . 33.1 pt -78.42 133.41 30.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.935 0.398 . . . . 24.600000000000001 111.752 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -118.24 138.29 52.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 99.989999999999995 109.902 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.41 HG22 ' CA ' ' A' ' 8' ' ' TYR . 39.0 t -44.99 120.98 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.283 -0.417 . . . . 24.600000000000001 111.743 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.13 -21.01 25.4 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.046 -0.597 . . . . 24.600000000000001 113.633 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.541 ' HB3' HD22 ' A' ' 42' ' ' LEU . 39.1 mt-10 -76.32 154.48 35.01 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 117.343 0.572 . . . . 24.600000000000001 111.676 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.5 mt -117.29 127.72 74.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.528 -0.76 . . . . 24.600000000000001 110.16 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.613 HG23 ' CZ ' ' A' ' 49' ' ' PHE . 4.0 mp -94.94 125.44 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 24.600000000000001 110.393 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.586 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 7.7 mpt_? -80.0 125.49 29.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.482 . . . . 99.989999999999995 111.851 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.07 65.87 0.95 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.804 -0.634 . . . . 24.600000000000001 111.779 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.695 HG22 ' HB2' ' A' ' 4' ' ' TYR . 61.8 t -87.59 105.54 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.841 -0.618 . . . . 26.149999999999999 111.238 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -107.37 161.48 14.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.792 -0.64 . . . . 99.989999999999995 110.441 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.486 ' HA ' HD23 ' A' ' 38' ' ' LEU . 39.1 ttmt -84.68 132.14 34.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 99.989999999999995 110.468 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.9 tp -91.01 171.01 9.56 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.865 -0.607 . . . . 37.710000000000001 110.331 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -77.13 -1.71 30.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.629 0.252 . . . . 40.380000000000003 110.855 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -103.67 122.49 45.15 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.646 -0.501 . . . . 38.539999999999999 109.646 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -60.86 117.9 6.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 33.270000000000003 110.461 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.05 15.39 45.24 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.99 -0.624 . . . . 28.280000000000001 112.833 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -132.54 132.47 42.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.163 0.506 . . . . 99.989999999999995 111.153 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 48' ' ' MET . 98.0 mt -118.79 162.25 18.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.262 -0.881 . . . . 24.600000000000001 110.021 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -123.09 118.36 27.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.577 -0.283 . . . . 43.399999999999999 110.439 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.408 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -162.12 170.96 37.91 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.615 -0.802 . . . . 24.600000000000001 113.523 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 34.6 mt-10 -94.09 105.86 17.85 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.918 0.39 . . . . 32.100000000000001 110.46 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.641 ' HG ' HG21 ' A' ' 20' ' ' ILE . 3.1 tm? -124.49 130.44 52.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.879 -0.601 . . . . 24.600000000000001 110.065 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.487 ' HB2' HD12 ' A' ' 42' ' ' LEU . 66.6 t30 64.14 25.1 13.62 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.025 -0.534 . . . . 30.739999999999998 110.939 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.38 13.87 79.66 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 121.003 -0.617 . . . . 33.009999999999998 113.299 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -130.86 140.22 50.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.851 0.358 . . . . 99.989999999999995 110.736 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -91.4 114.03 26.46 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.485 -0.932 . . . . 99.989999999999995 108.485 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.552 ' HA3' ' HG ' ' A' ' 18' ' ' LEU . . . -151.19 -168.97 16.34 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.031 -1.081 . . . . 24.600000000000001 114.018 -178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.597 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 50.7 mtt -111.77 138.72 47.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.499 -0.351 . . . . 33.810000000000002 110.661 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.613 ' CZ ' HG23 ' A' ' 26' ' ' ILE . 4.6 p90 -140.59 153.42 68.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 99.989999999999995 111.35 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.523 ' HG2' ' HB2' ' A' ' 53' ' ' PHE . 9.9 Cg_endo -54.05 135.76 65.0 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.87 2.38 . . . . 24.600000000000001 112.691 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -67.9 -38.08 82.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.686 -0.688 . . . . 25.32 112.104 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -81.64 5.59 17.75 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.685 0.624 . . . . 25.559999999999999 112.685 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.523 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 9.8 m-85 -102.56 -24.82 13.76 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.494 0.188 . . . . 99.989999999999995 110.601 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 31.0 m -116.5 137.19 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.307 -0.406 . . . . 24.600000000000001 110.401 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -111.24 129.16 56.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 99.989999999999995 110.344 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -50.46 141.36 12.25 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.404 -0.362 . . . . 36.5 110.996 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.7 mt -95.33 89.77 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 29.5 110.751 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.55 -0.738 . . . . 99.989999999999995 110.879 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.603 0.24 . . . . 33.030000000000001 111.034 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.1 152.04 22.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.13 0.49 . . . . 30.379999999999999 111.783 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.639 ' HB2' HG23 ' A' ' 29' ' ' VAL . 7.6 m-85 -130.91 152.6 50.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.396 -0.82 . . . . 30.379999999999999 110.702 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 tp -113.31 132.93 60.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.937 -0.574 . . . . 30.57 109.804 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.528 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 40.5 t -74.42 123.52 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.91 0.386 . . . . 31.149999999999999 110.703 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.468 ' HG3' ' CD2' ' A' ' 8' ' ' TYR . 12.5 pt-20 -104.34 -21.18 13.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 37.960000000000001 111.113 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.468 ' CD2' ' HG3' ' A' ' 7' ' ' GLU . 60.9 m-85 -133.14 142.52 48.71 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.856 0.36 . . . . 30.379999999999999 110.827 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -77.57 128.46 34.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 32.049999999999997 110.371 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.498 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 53.0 t80 -128.67 135.98 50.01 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.753 0.311 . . . . 33.979999999999997 111.13 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -96.9 119.85 36.16 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.003 -0.544 . . . . 36.689999999999998 110.562 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.18 105.17 1.32 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.275 -0.42 . . . . 30.620000000000001 111.107 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -87.05 -36.94 10.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.887 -0.597 . . . . 30.559999999999999 110.035 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.549 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 52.8 m-70 -89.21 -179.77 5.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.887 -0.597 . . . . 30.379999999999999 110.305 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -78.84 -45.82 19.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.502 -0.317 . . . . 35.799999999999997 111.029 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -77.93 -23.28 48.66 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.572 -0.286 . . . . 32.579999999999998 111.007 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.549 ' HG2' ' HB2' ' A' ' 14' ' ' HIS . 29.6 mm-40 -52.99 132.22 37.32 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.992 0.425 . . . . 36.109999999999999 111.012 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -95.5 129.01 42.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.639 -0.71 . . . . 30.739999999999998 110.589 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.8 m -82.99 86.11 7.05 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.992 -0.744 . . . . 30.809999999999999 108.992 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 53' ' ' PHE . 36.1 pt -87.71 137.59 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 120.92 0.39 . . . . 30.390000000000001 111.895 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -116.51 135.55 53.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.811 -0.631 . . . . 30.379999999999999 109.974 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -47.21 124.41 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.935 0.398 . . . . 31.460000000000001 111.634 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.25 -16.31 42.07 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.763 -0.653 . . . . 30.600000000000001 113.322 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -82.2 150.0 27.6 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 117.278 0.539 . . . . 35.799999999999997 111.643 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.1 mt -109.17 128.02 65.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.666 -0.697 . . . . 30.379999999999999 110.14 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.571 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 4.2 mp -97.03 126.46 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.444 . . . . 32.07 110.58 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.41 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 83.9 mtp180 -76.51 125.75 29.77 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.075 -0.511 . . . . 30.379999999999999 112.172 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.2 t30 55.2 69.9 0.69 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.726 -0.67 . . . . 30.379999999999999 112.241 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.639 HG23 ' HB2' ' A' ' 4' ' ' TYR . 89.0 t -88.44 106.61 16.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.984 -0.553 . . . . 30.379999999999999 110.511 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -103.96 160.22 15.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.874 -0.603 . . . . 38.770000000000003 110.88 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.407 ' HA ' ' CD2' ' A' ' 38' ' ' LEU . 63.0 mttp -90.84 132.12 36.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 32.939999999999998 110.07 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.459 HD23 ' HB2' ' A' ' 39' ' ' GLU . 93.8 mt -94.68 178.67 5.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 33.130000000000003 110.871 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.58 0.89 31.97 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.29 -0.414 . . . . 42.18 111.013 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.441 ' HB3' ' HD1' ' A' ' 37' ' ' TRP . 36.1 mt-10 -104.49 120.4 41.17 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.426 -0.583 . . . . 38.109999999999999 109.426 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -61.02 118.1 6.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 30.43 110.77 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.6 11.87 56.44 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.011 -0.614 . . . . 30.379999999999999 113.066 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.59 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 55.3 m95 -129.97 129.88 44.33 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.148 0.499 . . . . 30.379999999999999 111.208 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 48' ' ' MET . 90.1 mt -121.96 165.94 15.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.355 -0.839 . . . . 30.379999999999999 109.997 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.459 ' HB2' HD23 ' A' ' 32' ' ' LEU . 9.1 tp10 -126.08 122.07 34.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.611 -0.268 . . . . 38.590000000000003 110.612 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.463 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -154.76 162.37 30.76 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.635 -0.793 . . . . 30.379999999999999 113.283 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 3.1 mp0 -96.89 104.99 17.05 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.024 0.44 . . . . 37.880000000000003 110.945 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.5 ' CD2' HG23 ' A' ' 20' ' ' ILE . 53.0 tp -130.67 138.05 49.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.657 -0.702 . . . . 30.379999999999999 110.1 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 67.65 18.99 9.87 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.975 -0.557 . . . . 40.090000000000003 110.951 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.47 14.88 67.38 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 120.886 -0.673 . . . . 31.289999999999999 113.466 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -142.51 149.06 38.65 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.8 0.334 . . . . 44.740000000000002 110.377 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -92.82 116.3 28.91 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.704 -0.85 . . . . 33.119999999999997 108.704 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.1 151.75 22.75 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.036 -1.078 . . . . 30.379999999999999 114.011 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.59 ' SD ' ' HB3' ' A' ' 37' ' ' TRP . 62.0 ttp -81.44 135.57 35.64 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.242 -0.479 . . . . 35.170000000000002 110.312 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.546 ' CE2' HG21 ' A' ' 26' ' ' ILE . 6.0 p90 -139.49 158.53 68.33 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 30.379999999999999 111.236 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.53 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 34.8 Cg_exo -59.01 141.28 98.17 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.672 2.248 . . . . 30.379999999999999 112.721 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.31 -36.7 79.72 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.693 -0.685 . . . . 32.210000000000001 111.575 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -83.18 4.55 26.21 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.33 0.493 . . . . 34.539999999999999 112.33 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.546 ' HB3' HD13 ' A' ' 20' ' ' ILE . 9.2 m-85 -101.3 -21.69 14.81 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 120.621 0.248 . . . . 34.039999999999999 110.466 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 24.3 m -120.51 141.62 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.205 -0.452 . . . . 31.539999999999999 109.994 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -116.14 129.07 56.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.388 -0.369 . . . . 30.59 110.689 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -55.14 129.45 38.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.415 -0.357 . . . . 32.189999999999998 110.102 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.4 mt -87.65 81.0 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.02 0.438 . . . . 30.539999999999999 110.765 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.0 tttm . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.072 -0.966 . . . . 40.630000000000003 111.026 -179.763 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.711 0.291 . . . . 30.68 111.325 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -85.62 154.52 21.64 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.226 -0.443 . . . . 27.210000000000001 110.748 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 56' ' ' GLU . 8.3 m-85 -127.95 151.58 48.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 99.989999999999995 111.24 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.524 ' HB ' HD12 ' A' ' 57' ' ' ILE . 6.5 tp -112.34 133.2 58.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.667 -0.697 . . . . 24.600000000000001 109.328 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.506 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 38.3 t -77.34 124.18 35.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.806 0.336 . . . . 24.600000000000001 110.791 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.411 ' C ' HG21 ' A' ' 22' ' ' VAL . 19.4 mm-40 -108.44 -17.46 13.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.992 -0.549 . . . . 30.579999999999998 111.166 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.462 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 73.9 m-85 -133.71 141.29 47.49 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.673 0.273 . . . . 99.989999999999995 110.674 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -77.49 128.35 34.06 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.301 -0.409 . . . . 24.600000000000001 110.69 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.448 ' CD1' ' HG3' ' A' ' 50' ' ' PRO . 40.1 t80 -125.81 136.28 52.94 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.492 -0.322 . . . . 99.989999999999995 110.841 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -94.17 119.48 33.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.086 -0.506 . . . . 26.050000000000001 110.898 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.494 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -69.53 104.99 2.49 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.102 -0.499 . . . . 26.149999999999999 111.089 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.4 t -89.59 -34.87 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.748 -0.66 . . . . 31.710000000000001 110.138 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 43.7 m80 -90.91 172.06 8.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.906 -0.588 . . . . 99.989999999999995 110.514 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.68 -36.95 50.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 45.18 110.392 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -92.76 15.37 14.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.135 -0.484 . . . . 35.420000000000002 110.901 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.494 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 23.0 tp10 -92.53 127.84 38.17 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.911 -0.404 . . . . 26.239999999999998 109.911 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.461 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -86.39 124.95 33.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 24.600000000000001 111.139 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.2 m -81.18 83.75 6.73 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.274 -0.639 . . . . 99.989999999999995 109.274 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.506 ' HB ' ' CG2' ' A' ' 6' ' ' VAL . 38.0 pt -85.42 132.88 30.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.042 0.448 . . . . 24.600000000000001 111.709 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 -119.28 138.75 52.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.87 -0.604 . . . . 99.989999999999995 110.181 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.411 HG21 ' C ' ' A' ' 7' ' ' GLU . 46.2 t -44.25 120.97 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.841 0.353 . . . . 24.600000000000001 111.898 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.51 -19.52 28.79 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.87 -0.604 . . . . 24.600000000000001 113.613 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.473 ' HB3' HD12 ' A' ' 42' ' ' LEU . 35.2 mt-10 -76.19 150.43 37.11 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 117.308 0.554 . . . . 24.600000000000001 111.981 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.6 mt -111.81 124.47 68.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.475 -0.784 . . . . 24.600000000000001 109.682 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.56 HG22 ' CE2' ' A' ' 49' ' ' PHE . 30.0 mt -97.12 123.15 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 24.600000000000001 110.403 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -75.71 133.57 40.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.028 -0.533 . . . . 99.989999999999995 112.067 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.7 p30 46.42 71.44 0.3 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.53 -0.759 . . . . 24.600000000000001 112.564 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.597 ' HB ' ' CD1' ' A' ' 4' ' ' TYR . 85.3 t -88.26 110.46 21.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.785 -0.643 . . . . 26.149999999999999 110.834 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -107.0 160.9 15.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.745 -0.661 . . . . 99.989999999999995 110.482 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -88.81 132.41 34.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 99.989999999999995 110.03 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.512 HD22 ' HB2' ' A' ' 39' ' ' GLU . 95.9 mt -92.34 -179.98 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 37.710000000000001 111.166 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -81.36 -0.51 41.55 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.125 -0.489 . . . . 40.380000000000003 111.167 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -105.71 120.51 41.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.693 -0.484 . . . . 38.539999999999999 109.693 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -59.75 117.88 5.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.465 . . . . 33.270000000000003 110.638 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.26 13.02 50.25 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.939 -0.648 . . . . 28.280000000000001 112.963 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -131.38 130.13 42.23 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.139 0.495 . . . . 99.989999999999995 111.154 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 48' ' ' MET . 6.4 mp -119.71 164.39 16.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.295 -0.866 . . . . 24.600000000000001 109.525 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.512 ' HB2' HD22 ' A' ' 32' ' ' LEU . 13.4 tp10 -126.38 122.6 35.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.638 0.256 . . . . 43.399999999999999 111.069 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.08 162.47 30.94 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.832 -0.699 . . . . 24.600000000000001 112.991 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -96.34 104.87 16.86 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.113 0.482 . . . . 32.100000000000001 111.026 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.473 HD12 ' HB3' ' A' ' 24' ' ' GLU . 59.8 tp -125.53 137.61 53.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.579 -0.737 . . . . 24.600000000000001 109.933 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 63.61 21.92 12.93 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.992 -0.549 . . . . 30.739999999999998 110.913 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.98 12.93 80.41 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 120.902 -0.666 . . . . 33.009999999999998 113.233 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -133.38 142.15 48.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.796 0.332 . . . . 99.989999999999995 110.287 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -93.96 114.77 27.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.91 -0.774 . . . . 99.989999999999995 108.91 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.53 153.99 25.68 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.299 -0.953 . . . . 24.600000000000001 113.344 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.609 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 22.7 ptt? -79.23 145.66 33.47 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.683 0.278 . . . . 33.810000000000002 110.369 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.56 ' CE2' HG22 ' A' ' 26' ' ' ILE . 3.8 p90 -143.99 155.66 58.81 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.256 -0.429 . . . . 99.989999999999995 111.22 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.581 ' HG2' ' HB2' ' A' ' 53' ' ' PHE . 14.5 Cg_endo -57.55 148.96 69.91 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.755 2.303 . . . . 24.600000000000001 112.99 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -73.36 -41.3 63.59 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.443 -0.799 . . . . 25.32 112.791 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -82.53 11.26 5.89 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.991 0.738 . . . . 25.559999999999999 112.991 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.581 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 16.3 m-85 -107.38 -27.2 10.61 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.57 0.224 . . . . 99.989999999999995 110.778 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 27.5 m -116.88 139.86 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 116.323 -0.398 . . . . 24.600000000000001 110.39 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -118.37 127.44 53.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.371 -0.377 . . . . 99.989999999999995 110.528 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . 12.8 pt-20 -60.92 131.97 52.37 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.542 -0.299 . . . . 36.5 110.411 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.524 HD12 ' HB ' ' A' ' 5' ' ' ILE . 22.4 mt -87.73 85.59 2.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.114 0.483 . . . . 29.5 110.762 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.445 -0.788 . . . . 99.989999999999995 110.856 -179.917 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.749 0.309 . . . . 30.68 111.021 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -84.64 154.57 22.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.275 -0.42 . . . . 27.210000000000001 111.306 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.622 ' HB2' HG22 ' A' ' 29' ' ' VAL . 6.4 m-85 -130.76 151.4 51.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.772 -0.649 . . . . 99.989999999999995 110.917 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 tp -113.69 128.09 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.689 -0.687 . . . . 24.600000000000001 109.63 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.515 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 29.8 t -73.89 124.37 31.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.422 -0.354 . . . . 24.600000000000001 110.794 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.79 -18.95 13.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.028 -0.533 . . . . 30.579999999999998 110.929 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -130.49 140.54 50.52 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.706 0.288 . . . . 99.989999999999995 110.672 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 21' ' ' ARG . 34.6 m-20 -76.33 131.5 39.23 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.266 -0.424 . . . . 24.600000000000001 110.564 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.402 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 44.5 t80 -132.08 131.56 42.5 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.501 -0.318 . . . . 99.989999999999995 110.834 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -95.02 119.84 34.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.94 -0.573 . . . . 26.050000000000001 110.604 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.454 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -65.08 107.25 1.47 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.013 -0.54 . . . . 26.149999999999999 111.56 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.1 p -87.8 -36.47 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.779 -0.646 . . . . 31.710000000000001 109.95 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -90.37 172.84 8.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.837 -0.62 . . . . 99.989999999999995 110.422 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.81 -35.61 43.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.323 -0.399 . . . . 45.18 110.303 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -92.28 9.39 34.11 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.08 -0.509 . . . . 35.420000000000002 110.986 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.454 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 22.7 tp10 -87.28 126.78 35.05 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.906 -0.405 . . . . 26.239999999999998 109.906 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 42' ' ' LEU . 11.0 tp -84.92 126.53 33.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 24.600000000000001 110.753 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.5 m -83.12 88.44 6.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.887 -0.597 . . . . 99.989999999999995 109.394 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.515 ' HB ' ' CG2' ' A' ' 6' ' ' VAL . 33.0 pt -89.07 131.06 37.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.813 0.34 . . . . 24.600000000000001 111.237 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 9' ' ' ASP . 25.2 mmm180 -117.12 138.78 51.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.154 -0.475 . . . . 99.989999999999995 110.105 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.3 t -45.42 122.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.391 -0.368 . . . . 24.600000000000001 111.791 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.82 -18.97 39.5 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.052 -0.594 . . . . 24.600000000000001 113.575 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.44 ' HB3' HD12 ' A' ' 42' ' ' LEU . 18.2 mm-40 -77.16 147.46 36.49 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.286 0.543 . . . . 24.600000000000001 112.264 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.6 mm -107.7 123.02 62.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.462 -0.79 . . . . 24.600000000000001 109.894 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.538 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 41.0 mt -95.18 124.18 47.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.389 -0.369 . . . . 24.600000000000001 110.535 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.462 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -74.53 128.37 35.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.901 -0.59 . . . . 99.989999999999995 112.245 -178.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 50.64 70.92 0.46 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.698 -0.683 . . . . 24.600000000000001 112.401 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.622 HG22 ' HB2' ' A' ' 4' ' ' TYR . 73.0 t -87.52 107.5 17.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.981 -0.554 . . . . 26.149999999999999 110.741 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -103.74 157.08 17.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.719 -0.673 . . . . 99.989999999999995 110.475 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -89.27 129.9 35.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.414 . . . . 99.989999999999995 109.966 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.498 HD21 ' HB2' ' A' ' 39' ' ' GLU . 87.9 mt -91.17 178.33 6.01 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.345 -0.389 . . . . 37.710000000000001 111.031 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -79.92 0.96 29.14 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.216 -0.447 . . . . 40.380000000000003 111.082 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 3.8 mp0 -105.65 122.0 45.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.463 -0.569 . . . . 38.539999999999999 109.463 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -61.55 116.93 5.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.174 -0.466 . . . . 33.270000000000003 110.435 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.41 12.54 51.04 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.907 -0.663 . . . . 28.280000000000001 113.006 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 44.7 m95 -130.26 129.59 43.49 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.168 0.509 . . . . 99.989999999999995 111.088 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 48' ' ' MET . 85.1 mt -120.07 165.49 14.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.277 -0.874 . . . . 24.600000000000001 109.781 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HB2' HD21 ' A' ' 32' ' ' LEU . 38.7 tt0 -126.68 121.63 32.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.694 -0.23 . . . . 43.399999999999999 110.783 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.93 164.89 32.96 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.527 -0.844 . . . . 24.600000000000001 113.433 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.668 ' HG3' ' HG2' ' A' ' 46' ' ' ARG . 2.9 mp0 -94.1 106.08 18.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.769 0.318 . . . . 32.100000000000001 110.59 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.509 HD23 HG21 ' A' ' 20' ' ' ILE . 40.1 tp -130.61 137.18 49.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 24.600000000000001 110.251 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 64.55 19.73 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 30.739999999999998 111.218 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.74 13.5 72.38 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 121.021 -0.609 . . . . 33.009999999999998 113.453 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.1 mmt180 -136.3 145.31 45.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.909 0.385 . . . . 99.989999999999995 110.739 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.668 ' HG2' ' HG3' ' A' ' 41' ' ' GLU . 31.9 mtp180 -92.69 116.4 28.98 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.914 -0.772 . . . . 99.989999999999995 108.914 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.19 -175.14 15.99 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.116 -1.04 . . . . 24.600000000000001 113.31 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.592 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.2 ptp -112.7 139.68 48.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.943 -0.392 . . . . 33.810000000000002 109.943 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CE1' HG22 ' A' ' 26' ' ' ILE . 3.3 p90 -138.57 159.05 69.17 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.172 -0.467 . . . . 99.989999999999995 111.315 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 36.4 Cg_exo -60.98 136.62 66.75 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.625 2.217 . . . . 24.600000000000001 112.355 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -67.68 -36.2 80.26 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.924 -0.58 . . . . 25.32 111.48 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -79.24 2.11 22.38 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.725 0.639 . . . . 25.559999999999999 112.725 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 9.7 m-85 -102.81 -23.49 13.78 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.554 0.216 . . . . 99.989999999999995 110.852 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 30.9 m -120.63 139.43 47.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.274 -0.421 . . . . 24.600000000000001 110.364 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -112.97 133.29 55.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.345 -0.389 . . . . 99.989999999999995 110.503 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -54.74 137.76 43.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.334 -0.394 . . . . 36.5 110.436 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt -91.27 86.0 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.002 0.43 . . . . 29.5 110.764 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.412 ' HD3' ' C ' ' A' ' 58' ' ' LYS . 7.6 tmtm? . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.02 -0.991 . . . . 99.989999999999995 110.583 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.753 0.311 . . . . 33.030000000000001 111.029 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.03 159.02 16.35 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.103 0.478 . . . . 30.379999999999999 111.49 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.672 ' HB2' HG21 ' A' ' 29' ' ' VAL . 7.8 m-85 -131.34 153.36 49.69 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.528 -0.76 . . . . 30.379999999999999 111.079 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.531 ' HB ' HD11 ' A' ' 57' ' ' ILE . 17.2 tt -111.45 138.06 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.573 . . . . 30.57 109.607 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.456 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 25.1 t -80.78 121.02 33.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.431 -0.35 . . . . 31.149999999999999 110.744 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -104.77 -19.35 13.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.086 -0.506 . . . . 37.960000000000001 111.148 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -132.84 140.42 47.94 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.53 -0.305 . . . . 30.379999999999999 110.363 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.56 130.13 36.53 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.26 -0.427 . . . . 32.049999999999997 110.87 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.463 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 47.6 t80 -129.98 136.48 49.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.943 -0.571 . . . . 33.979999999999997 110.371 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.87 120.61 40.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.139 -0.482 . . . . 36.689999999999998 110.537 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.453 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -64.3 109.07 1.77 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.076 -0.511 . . . . 30.620000000000001 111.695 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.1 t -89.02 -36.35 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.63 -0.714 . . . . 30.559999999999999 109.747 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -92.19 175.02 7.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.767 -0.651 . . . . 30.379999999999999 110.621 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.2 -36.54 47.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.193 -0.458 . . . . 35.799999999999997 110.567 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -93.0 12.96 22.17 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.035 -0.53 . . . . 32.579999999999998 111.038 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 17.5 tp10 -91.54 129.98 37.43 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.801 -0.444 . . . . 36.109999999999999 109.801 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.658 HD12 ' HB3' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -89.31 124.88 34.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.753 0.311 . . . . 30.739999999999998 111.328 -179.521 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.447 ' N ' HD13 ' A' ' 18' ' ' LEU . 32.9 m -81.49 86.13 6.38 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.107 -0.701 . . . . 30.809999999999999 109.107 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.537 HG21 HD21 ' A' ' 42' ' ' LEU . 29.8 pt -87.28 135.31 25.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.396 -0.365 . . . . 30.390000000000001 111.51 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.3 mtp85 -119.06 138.19 53.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.136 -0.484 . . . . 30.379999999999999 110.165 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.3 t -45.32 122.72 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.894 0.378 . . . . 31.460000000000001 111.904 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.63 -18.77 34.59 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.824 -0.625 . . . . 30.600000000000001 113.567 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HB3' HD11 ' A' ' 42' ' ' LEU . 32.6 mt-10 -76.09 155.19 34.97 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.365 0.582 . . . . 35.799999999999997 111.931 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.3 mt -115.53 125.75 72.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.45 -0.795 . . . . 30.379999999999999 109.749 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.707 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 5.5 mm -91.27 120.44 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 32.07 110.756 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.38 122.21 23.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.285 -0.416 . . . . 30.379999999999999 112.107 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 57.97 70.76 0.63 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.753 -0.658 . . . . 30.379999999999999 112.61 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.707 ' CG2' ' HB ' ' A' ' 26' ' ' ILE . 59.8 t -86.39 108.6 17.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.297 -0.41 . . . . 30.379999999999999 111.088 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -105.16 155.97 18.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.802 -0.635 . . . . 38.770000000000003 110.358 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -82.06 127.75 33.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 32.939999999999998 110.264 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 tp -88.42 170.89 10.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 33.130000000000003 110.308 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -78.91 0.85 25.7 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.67 -0.241 . . . . 42.18 110.867 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.487 ' HB3' ' HD1' ' A' ' 37' ' ' TRP . 2.9 mp0 -104.55 116.17 31.61 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.565 -0.532 . . . . 38.109999999999999 109.565 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.92 121.82 10.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 30.43 110.991 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.42 14.78 56.67 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.862 -0.685 . . . . 30.379999999999999 113.031 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.487 ' HD1' ' HB3' ' A' ' 34' ' ' GLU . 92.5 m95 -134.01 132.28 39.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.156 0.503 . . . . 30.379999999999999 110.951 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 48' ' ' MET . 3.7 mm? -117.33 163.43 16.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.295 -0.866 . . . . 30.379999999999999 109.735 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -123.48 119.81 31.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.774 -0.194 . . . . 38.590000000000003 110.482 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.45 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -153.09 161.51 29.67 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.468 -0.872 . . . . 30.379999999999999 113.514 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -95.15 106.61 18.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.084 0.468 . . . . 37.880000000000003 110.825 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.658 ' HB3' HD12 ' A' ' 18' ' ' LEU . 30.3 tp -132.93 142.13 48.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.668 -0.696 . . . . 30.379999999999999 110.073 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.422 ' ND2' ' HG ' ' A' ' 42' ' ' LEU . 54.8 m-80 65.46 17.49 10.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.726 -0.67 . . . . 40.090000000000003 111.181 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.28 15.51 62.21 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 121.005 -0.617 . . . . 31.289999999999999 113.492 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -145.24 151.95 39.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.745 0.307 . . . . 44.740000000000002 110.44 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -95.31 119.04 33.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.11 -0.7 . . . . 33.119999999999997 109.11 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -145.73 150.01 22.19 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.554 -0.832 . . . . 30.379999999999999 113.079 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.594 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 22.8 ptp -78.62 145.46 34.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.718 0.294 . . . . 35.170000000000002 110.373 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.625 ' CZ ' HG23 ' A' ' 26' ' ' ILE . 3.4 p90 -143.2 157.64 59.81 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.024 -0.535 . . . . 30.379999999999999 111.179 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.513 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 27.2 Cg_exo -61.8 145.58 97.11 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.678 2.252 . . . . 30.379999999999999 112.821 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.95 -37.39 78.82 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.617 -0.719 . . . . 32.210000000000001 112.077 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -78.74 4.71 13.05 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.9 0.704 . . . . 34.539999999999999 112.9 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 13.2 m-85 -107.81 -24.23 11.76 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.491 0.186 . . . . 34.039999999999999 111.307 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.5 HG23 ' CE1' ' A' ' 49' ' ' PHE . 29.1 m -121.03 139.95 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 110.113 -0.329 . . . . 31.539999999999999 110.113 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -122.24 131.93 54.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.446 -0.343 . . . . 30.59 110.41 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -54.65 131.26 42.92 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.425 -0.352 . . . . 32.189999999999998 110.64 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.531 HD11 ' HB ' ' A' ' 5' ' ' ILE . 44.2 mt -87.41 84.54 2.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.071 0.462 . . . . 30.539999999999999 110.763 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 96.1 mttt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.084 -0.96 . . . . 40.630000000000003 110.882 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.754 0.311 . . . . 30.68 111.104 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -83.61 157.51 22.24 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.242 -0.435 . . . . 27.21 111.196 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.851 ' HB2' HG21 ' A' ' 29' ' ' VAL . 7.4 m-85 -134.16 151.92 51.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.829 -0.623 . . . . 24.84 110.81 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.664 ' HB ' HD11 ' A' ' 57' ' ' ILE . 13.8 tt -113.81 134.03 57.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.402 -0.592 . . . . 24.6 109.402 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 37.0 t -76.67 123.63 33.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.917 0.389 . . . . 16.73 110.828 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -106.49 -21.18 13.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.931 -0.577 . . . . 30.58 111.002 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.92 141.26 48.27 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.521 -0.308 . . . . 22.64 110.436 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -74.75 129.3 37.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 22.7 110.984 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.574 ' HB3' HG12 ' A' ' 20' ' ' ILE . 54.2 t80 -127.11 132.94 50.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.928 -0.578 . . . . 19.88 110.183 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -100.02 116.65 32.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.009 -0.541 . . . . 26.05 110.638 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.83 107.33 0.96 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.016 -0.538 . . . . 26.15 111.143 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.7 t -77.66 -39.35 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.925 -0.58 . . . . 31.71 109.83 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.722 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 46.5 m-70 -98.31 178.15 5.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.753 -0.658 . . . . 37.29 110.712 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -81.71 -27.13 34.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.033 -0.531 . . . . 45.18 111.092 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -92.09 5.87 48.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.511 -0.313 . . . . 35.42 111.098 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.722 ' HG2' ' HB2' ' A' ' 14' ' ' HIS . 40.3 mm-40 -94.42 135.35 35.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 110.013 -0.366 . . . . 26.24 110.013 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.44 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -89.6 125.7 35.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.94 -0.573 . . . . 23.56 110.835 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.3 m -83.08 86.18 7.05 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.32 -0.622 . . . . 22.84 109.32 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.574 HG12 ' HB3' ' A' ' 10' ' ' TYR . 43.4 pt -84.7 136.82 21.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.161 -0.472 . . . . 24.6 111.906 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -119.8 137.78 53.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.862 -0.608 . . . . 18.72 110.187 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.5 t -45.72 122.51 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.078 0.399 . . . . 17.47 112.078 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.14 -18.22 36.63 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.846 -0.616 . . . . 18.82 113.69 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.49 ' HB3' HD11 ' A' ' 42' ' ' LEU . 32.8 mt-10 -78.31 152.76 32.24 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.395 0.598 . . . . 16.59 112.107 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.5 mm -112.38 125.23 69.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.493 -0.776 . . . . 24.6 109.743 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.592 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 40.4 mt -96.98 125.03 50.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 24.6 110.782 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.531 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 78.2 ttt180 -75.55 125.88 29.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.775 -0.648 . . . . 21.55 112.422 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 54.41 68.74 0.81 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.697 -0.683 . . . . 24.05 112.413 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.851 HG21 ' HB2' ' A' ' 4' ' ' TYR . 91.6 t -88.43 107.94 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 26.15 110.839 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -108.4 164.6 12.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.844 -0.616 . . . . 42.51 110.623 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HA ' HD23 ' A' ' 38' ' ' LEU . 40.4 ttmt -90.59 133.46 35.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.289 -0.414 . . . . 33.31 110.517 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.463 HD21 ' HB2' ' A' ' 39' ' ' GLU . 94.5 mt -96.17 -177.77 4.1 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.976 -0.556 . . . . 37.71 110.955 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -81.83 -0.2 42.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.309 -0.405 . . . . 40.38 111.226 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 31.6 mt-10 -103.38 115.88 31.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.745 -0.465 . . . . 38.54 109.745 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -58.12 118.46 5.47 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.258 -0.428 . . . . 33.27 110.575 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 93.85 14.15 53.12 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.936 -0.65 . . . . 28.28 113.012 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.481 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 80.9 m95 -133.75 132.72 40.87 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.125 0.488 . . . . 23.14 110.704 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.598 ' O ' ' HA ' ' A' ' 48' ' ' MET . 94.7 mt -120.08 166.6 13.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.272 -0.876 . . . . 23.91 110.087 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.463 ' HB2' HD21 ' A' ' 32' ' ' LEU . 14.0 tp10 -125.97 120.61 30.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.55 -0.296 . . . . 43.4 110.636 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.16 163.36 31.43 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.729 -0.748 . . . . 20.08 113.118 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 27' ' ' ARG . 1.9 tm-20 -95.05 103.79 15.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.037 0.446 . . . . 32.1 110.462 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.501 ' CD2' HG22 ' A' ' 20' ' ' ILE . 45.8 tp -129.82 140.71 50.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.535 -0.757 . . . . 22.89 110.113 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 65.0 18.26 11.43 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.032 -0.531 . . . . 30.74 111.192 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.2 14.36 66.74 Favored Glycine 0 C--N 1.341 0.815 0 C-N-CA 120.992 -0.623 . . . . 33.01 113.331 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -140.94 149.29 41.65 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.826 0.346 . . . . 45.68 110.8 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -94.8 115.26 27.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.928 -0.767 . . . . 38.71 108.928 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.9 -176.54 14.69 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.259 -0.972 . . . . 23.54 113.613 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.598 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 54.8 mtt -111.62 133.77 53.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.491 -0.355 . . . . 33.81 110.162 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.514 ' HZ ' HG22 ' A' ' 29' ' ' VAL . 4.8 p90 -136.51 156.92 76.13 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.273 -0.422 . . . . 21.48 111.473 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.591 ' HG2' ' HB2' ' A' ' 53' ' ' PHE . 19.6 Cg_endo -58.99 136.56 74.2 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.741 2.294 . . . . 18.64 112.436 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.75 -38.18 83.12 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.791 -0.641 . . . . 25.32 111.849 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -78.29 4.74 12.03 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.808 0.67 . . . . 25.56 112.808 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.591 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 5.3 m-85 -105.25 -22.33 13.08 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.494 0.188 . . . . 21.91 110.996 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 18.3 m -117.36 141.07 37.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.467 -0.333 . . . . 20.47 110.65 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.4 ' O ' HG22 ' A' ' 5' ' ' ILE . 17.5 tppt? -113.63 125.24 53.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 24.52 110.306 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -51.69 141.47 16.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.439 -0.346 . . . . 36.5 110.993 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.664 HD11 ' HB ' ' A' ' 5' ' ' ILE . 39.4 mm -85.97 93.32 3.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.167 -0.47 . . . . 29.5 110.458 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.099 -0.953 . . . . 44.29 110.824 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.746 0.307 . . . . 30.68 111.186 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.41 149.03 25.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.023 0.44 . . . . 27.21 111.132 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.86 ' HB2' HG21 ' A' ' 29' ' ' VAL . 6.8 m-85 -129.04 152.73 48.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.626 -0.715 . . . . 24.84 110.709 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.406 ' HB ' HD11 ' A' ' 57' ' ' ILE . 18.2 tt -114.84 136.36 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 24.6 109.703 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.561 ' CG2' HD11 ' A' ' 26' ' ' ILE . 36.8 t -74.29 122.06 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 16.73 110.83 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.43 ' HG3' ' CD2' ' A' ' 8' ' ' TYR . 11.9 pt-20 -103.1 -20.76 14.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.914 -0.584 . . . . 30.58 111.065 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.43 ' CD2' ' HG3' ' A' ' 7' ' ' GLU . 61.2 m-85 -134.52 141.86 46.84 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.844 0.354 . . . . 22.64 110.653 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -79.22 127.57 32.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.038 -0.528 . . . . 22.7 110.441 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.498 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 34.8 t80 -125.47 137.12 53.97 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.381 -0.372 . . . . 19.88 111.019 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -94.82 119.12 32.87 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.063 -0.517 . . . . 26.05 110.38 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.512 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -66.46 103.38 1.03 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.273 -0.421 . . . . 26.15 111.469 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.07 -33.78 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.887 -0.597 . . . . 31.71 110.265 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.514 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 53.0 m80 -90.52 178.2 6.16 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.93 -0.577 . . . . 37.29 109.968 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.58 -46.05 20.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.665 -0.243 . . . . 45.18 110.693 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.13 -22.26 52.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.25 -0.432 . . . . 35.42 110.84 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 14' ' ' HIS . 16.0 tp10 -52.71 125.53 16.99 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.898 0.38 . . . . 26.24 110.908 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.39 127.61 36.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.934 -0.575 . . . . 23.56 110.61 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.8 m -80.92 86.28 6.09 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.005 -0.739 . . . . 22.84 109.005 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.684 HD11 ' HB3' ' A' ' 53' ' ' PHE . 23.8 pt -91.6 137.3 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.002 0.429 . . . . 24.6 111.794 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -118.38 139.18 51.77 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.862 -0.608 . . . . 18.72 109.966 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.403 HG22 ' CA ' ' A' ' 8' ' ' TYR . 40.6 t -47.57 124.76 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 111.994 0.368 . . . . 17.47 111.994 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.77 -18.24 37.7 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.848 -0.614 . . . . 18.82 113.527 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.742 ' HB3' HD11 ' A' ' 42' ' ' LEU . 41.7 mt-10 -78.14 153.59 31.95 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 117.263 0.531 . . . . 16.59 111.821 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.0 pt -112.65 125.93 69.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.665 -0.698 . . . . 24.6 110.245 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.634 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 3.9 mp -97.49 124.87 50.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.47 . . . . 24.6 110.405 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.521 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 40.2 ttm180 -78.46 127.58 32.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.265 -0.425 . . . . 21.55 112.032 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 61.5 t30 57.37 67.33 0.99 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.671 -0.695 . . . . 24.05 112.09 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.86 HG21 ' HB2' ' A' ' 4' ' ' TYR . 76.1 t -91.12 108.39 19.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 26.15 110.864 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -110.89 167.1 10.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.896 -0.593 . . . . 42.51 110.929 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -92.67 135.64 33.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.945 -0.571 . . . . 33.31 110.333 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.553 HD21 ' HB2' ' A' ' 39' ' ' GLU . 95.1 mt -96.16 -177.42 3.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 37.71 110.987 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -81.41 -0.19 40.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.267 -0.424 . . . . 40.38 111.349 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HB3' ' HD1' ' A' ' 37' ' ' TRP . 38.6 mt-10 -105.57 121.6 44.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.84 -0.43 . . . . 38.54 109.84 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.0 117.83 5.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.039 -0.528 . . . . 33.27 110.767 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 94.44 11.23 57.38 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.003 -0.618 . . . . 28.28 113.123 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.505 ' C ' HD12 ' A' ' 38' ' ' LEU . 69.6 m95 -130.29 129.0 42.69 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.168 0.509 . . . . 23.14 111.103 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 48' ' ' MET . 8.0 mp -121.45 168.64 11.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.316 -0.856 . . . . 23.91 109.982 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.553 ' HB2' HD21 ' A' ' 32' ' ' LEU . 10.8 tp10 -127.05 123.04 36.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.487 -0.324 . . . . 43.4 110.877 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.438 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -155.49 163.41 31.6 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.622 -0.799 . . . . 20.08 113.42 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 27' ' ' ARG . 22.9 mt-10 -97.5 104.36 16.38 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.843 0.354 . . . . 32.1 110.921 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.742 HD11 ' HB3' ' A' ' 24' ' ' GLU . 43.1 tp -128.24 138.29 52.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 22.89 110.387 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.405 ' OD1' ' HG ' ' A' ' 42' ' ' LEU . 19.8 m120 63.37 21.95 13.04 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.893 -0.594 . . . . 30.74 111.21 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.7 12.79 76.98 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 121.007 -0.616 . . . . 33.01 113.476 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -135.32 144.53 46.76 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.819 0.342 . . . . 45.68 110.502 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -92.23 114.3 26.8 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.246 -1.02 . . . . 38.71 108.246 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.56 154.4 25.15 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.807 -1.187 . . . . 23.54 114.316 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.592 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 37.7 ttm -81.44 137.72 35.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.857 -0.671 . . . . 33.81 110.134 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' A' ' 26' ' ' ILE . 3.0 p90 -140.69 159.81 61.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.437 -0.347 . . . . 21.48 111.213 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.564 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 34.1 Cg_exo -61.03 145.9 98.46 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.688 2.259 . . . . 18.64 112.839 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.484 ' HA ' HD13 ' A' ' 38' ' ' LEU . 24.3 t70 -67.45 -38.4 84.44 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.734 -0.666 . . . . 25.32 111.997 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -85.67 9.32 16.58 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.37 0.507 . . . . 25.56 112.37 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.684 ' HB3' HD11 ' A' ' 20' ' ' ILE . 9.1 m-85 -105.11 -24.42 12.77 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.553 0.216 . . . . 21.91 110.432 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 20.2 m -115.45 137.8 47.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.21 -0.45 . . . . 20.47 109.927 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -115.64 124.2 50.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.4 -0.364 . . . . 24.52 110.591 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 38.0 tt0 -55.68 132.08 48.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.322 -0.399 . . . . 36.5 110.671 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.406 HD11 ' HB ' ' A' ' 5' ' ' ILE . 45.8 mt -93.5 75.64 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.205 0.526 . . . . 29.5 110.386 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.56 -0.734 . . . . 44.29 110.881 -179.893 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.724 0.297 . . . . 33.03 111.344 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.71 157.26 19.68 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.155 -0.475 . . . . 30.12 111.093 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.835 ' HB2' HG21 ' A' ' 29' ' ' VAL . 8.1 m-85 -133.2 151.51 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.864 -0.607 . . . . 30.11 110.88 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 55' ' ' LYS . 15.4 tt -109.56 137.03 43.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.339 -0.615 . . . . 30.57 109.339 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.584 HG21 ' HB ' ' A' ' 20' ' ' ILE . 37.4 t -79.94 119.03 28.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.879 0.371 . . . . 31.15 110.798 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -102.58 -20.04 14.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.993 -0.549 . . . . 37.96 110.976 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -130.62 138.01 49.9 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.565 -0.289 . . . . 29.97 110.634 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -75.02 127.64 33.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 32.05 110.594 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.489 ' HB3' HG12 ' A' ' 20' ' ' ILE . 68.1 t80 -117.82 132.78 56.4 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.185 -0.461 . . . . 33.98 110.317 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -93.68 154.71 17.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 36.69 110.759 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.46 116.02 6.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 30.62 110.51 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.55 -27.91 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.92 -0.582 . . . . 30.56 110.445 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.65 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 52.0 m80 -148.54 -179.22 6.8 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.123 -0.49 . . . . 29.61 110.177 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -76.32 -29.32 57.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 35.8 110.841 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -94.09 6.78 47.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.371 -0.377 . . . . 32.58 111.524 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.65 ' HG2' ' HB2' ' A' ' 14' ' ' HIS . 45.0 mm-40 -95.95 131.66 42.08 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 110.238 -0.282 . . . . 36.11 110.238 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -88.69 123.83 33.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 30.74 111.129 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 37.0 m -81.62 84.91 6.64 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.081 -0.711 . . . . 30.81 109.081 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 53' ' ' PHE . 35.1 pt -90.06 142.64 12.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.746 -0.661 . . . . 30.39 111.743 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.417 ' N ' ' HD3' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -121.2 142.5 49.84 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.126 -0.488 . . . . 29.61 110.107 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -49.5 124.78 2.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 112.014 0.376 . . . . 31.46 112.014 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.1 -16.67 45.74 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.864 -0.607 . . . . 30.6 113.686 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.0 156.68 25.79 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 117.468 0.634 . . . . 35.8 112.018 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.9 mm -113.82 127.9 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.364 -0.834 . . . . 30.38 110.124 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.59 HD12 HG11 ' A' ' 54' ' ' VAL . 36.6 mt -98.46 125.75 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 32.07 110.834 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.573 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 75.8 mtm180 -71.77 124.5 24.94 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.833 -0.621 . . . . 29.72 112.553 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 49.37 72.68 0.29 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.65 -0.705 . . . . 29.65 112.491 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.835 HG21 ' HB2' ' A' ' 4' ' ' TYR . 71.6 t -86.59 109.0 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 30.31 110.325 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -105.42 158.96 16.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.81 -0.632 . . . . 38.77 110.688 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -90.18 134.17 34.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.701 -0.481 . . . . 32.94 109.701 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.444 HD11 ' HG2' ' A' ' 48' ' ' MET . 91.1 mt -97.16 -177.55 3.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.401 -0.363 . . . . 33.13 111.19 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.9 2.57 33.77 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.257 -0.428 . . . . 42.18 111.214 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 4.8 mp0 -105.73 116.31 31.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.318 -0.623 . . . . 38.11 109.318 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.78 118.02 5.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.263 -0.426 . . . . 30.43 110.651 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 96.17 9.14 57.28 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.899 -0.667 . . . . 30.13 113.408 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 73.4 m95 -130.98 130.54 43.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.245 0.545 . . . . 30.29 111.087 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 48' ' ' MET . 6.6 mp -120.74 168.79 11.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.121 -0.945 . . . . 30.33 109.663 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.426 ' HB2' HD21 ' A' ' 32' ' ' LEU . 40.1 tt0 -128.21 123.96 35.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.647 0.26 . . . . 38.59 110.732 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.448 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -151.26 160.18 28.56 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.754 -0.736 . . . . 29.85 112.829 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 3.3 mp0 -97.2 102.93 14.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.068 0.461 . . . . 37.88 110.946 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.553 ' CD2' HG22 ' A' ' 20' ' ' ILE . 54.9 tp -125.81 138.12 53.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.65 -0.704 . . . . 30.38 109.989 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 62.5 21.15 12.43 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.091 -0.504 . . . . 40.09 111.471 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.93 9.46 80.72 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 120.937 -0.649 . . . . 31.29 113.6 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -132.18 141.39 49.08 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.687 0.28 . . . . 44.74 110.407 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -91.86 114.69 27.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.617 -0.882 . . . . 33.12 108.617 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.26 179.91 16.94 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.267 -0.968 . . . . 29.77 113.509 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.585 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 77.3 mtp -111.2 134.89 52.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.441 -0.379 . . . . 35.17 110.227 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.513 ' CE2' HD13 ' A' ' 26' ' ' ILE . 2.0 p90 -135.36 159.09 73.04 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.151 -0.477 . . . . 30.17 110.999 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 33.6 Cg_exo -61.06 148.74 91.95 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.708 2.272 . . . . 30.28 112.815 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.43 -39.06 85.44 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.761 -0.654 . . . . 32.21 111.794 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -87.35 15.3 6.6 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.307 0.484 . . . . 34.54 112.307 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.586 ' HB3' HD11 ' A' ' 20' ' ' ILE . 4.9 m-85 -106.71 -24.98 11.94 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 120.527 0.203 . . . . 34.04 110.603 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.59 HG11 HD12 ' A' ' 26' ' ' ILE . 28.2 m -124.31 144.81 32.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.178 -0.464 . . . . 31.54 110.54 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.458 ' O ' HG22 ' A' ' 5' ' ' ILE . 63.6 tttm -122.03 128.74 51.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 30.59 110.108 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -52.83 136.28 34.34 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.62 0.248 . . . . 32.19 110.788 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.578 HG23 ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -84.1 103.75 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.371 0.605 . . . . 30.54 110.375 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.135 -0.936 . . . . 40.63 110.745 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.73 0.3 . . . . 33.03 111.156 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -79.95 150.78 30.38 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.989 0.423 . . . . 30.12 111.497 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.858 ' HB2' HG21 ' A' ' 29' ' ' VAL . 10.4 m-85 -130.37 151.79 50.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.613 -0.721 . . . . 30.11 110.72 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.4 tt -120.07 124.35 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 30.57 109.89 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 25.3 t -63.82 129.65 27.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 31.15 111.319 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -109.92 -25.31 10.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.656 -0.702 . . . . 37.96 110.428 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -132.79 139.19 47.41 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.288 -0.415 . . . . 29.97 110.283 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -69.0 141.96 54.76 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.331 -0.395 . . . . 32.05 111.029 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -135.95 126.07 26.22 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.232 -0.44 . . . . 33.98 110.855 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -82.59 117.38 22.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 36.69 111.321 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.94 104.89 3.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.939 -0.573 . . . . 30.62 110.945 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.6 t -85.95 -37.26 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.797 -0.638 . . . . 30.56 110.169 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.602 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 55.3 m-70 -89.59 174.11 7.94 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.96 -0.564 . . . . 29.61 110.795 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -81.19 -31.34 34.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.117 -0.492 . . . . 35.8 110.965 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -100.0 16.74 22.96 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.493 -0.321 . . . . 32.58 110.724 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 14' ' ' HIS . 22.6 tt0 -96.93 125.94 41.71 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.906 -0.405 . . . . 36.11 109.906 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.687 HD12 ' CD1' ' A' ' 49' ' ' PHE . 35.3 mt -79.94 133.5 36.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.863 0.363 . . . . 30.74 111.064 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 m -87.17 55.16 3.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.848 -0.614 . . . . 30.81 110.527 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.553 HG22 HD22 ' A' ' 42' ' ' LEU . 22.1 pt -48.81 120.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 112.546 0.573 . . . . 30.39 112.546 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -113.43 136.46 52.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.394 -0.821 . . . . 29.61 109.292 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -43.09 122.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.733 0.301 . . . . 31.46 111.715 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.42 -18.41 38.57 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.075 -0.583 . . . . 30.6 113.813 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.428 ' HB3' HD11 ' A' ' 42' ' ' LEU . 41.8 mt-10 -80.03 147.28 31.57 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 117.554 0.677 . . . . 35.8 111.534 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 25' ' ' ILE . 4.4 mp -111.79 127.79 68.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.805 -0.634 . . . . 30.38 110.311 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.53 HG21 ' CE1' ' A' ' 49' ' ' PHE . 3.9 mp -96.07 122.28 47.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.28 -0.418 . . . . 32.07 110.287 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.569 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 22.0 mmm180 -74.31 127.74 33.76 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.083 -0.508 . . . . 29.72 112.073 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 52.39 73.42 0.34 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.816 -0.629 . . . . 29.65 112.176 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.858 HG21 ' HB2' ' A' ' 4' ' ' TYR . 55.9 t -88.77 110.57 21.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.973 -0.558 . . . . 30.31 111.507 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -102.48 154.97 18.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.699 -0.682 . . . . 38.77 109.923 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.455 ' HA ' HD23 ' A' ' 38' ' ' LEU . 86.1 tttt -80.48 123.35 28.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.953 0.406 . . . . 32.94 110.988 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.1 tp -77.83 162.77 26.64 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.774 -0.648 . . . . 33.13 110.068 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -61.75 -28.81 69.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.487 -0.324 . . . . 42.18 110.79 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -83.95 129.87 34.91 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.805 0.336 . . . . 38.11 110.761 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.61 122.42 16.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.864 -0.607 . . . . 30.43 109.675 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 94.06 18.04 38.36 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 30.13 112.342 -178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -134.46 135.18 42.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.105 0.479 . . . . 30.29 110.484 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 48' ' ' MET . 81.0 mt -124.73 161.71 25.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.345 -0.843 . . . . 30.33 110.022 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.43 119.45 28.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.103 -0.332 . . . . 38.59 110.103 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.504 ' O ' HD11 ' A' ' 18' ' ' LEU . . . -157.23 165.67 33.38 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.417 -0.897 . . . . 29.85 113.405 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.569 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 2.0 tm-20 -86.79 109.38 19.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.942 0.401 . . . . 37.88 110.079 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.591 ' HB3' HD13 ' A' ' 18' ' ' LEU . 57.8 tp -132.03 134.09 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.665 -0.698 . . . . 30.38 110.371 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 64.18 21.39 12.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.922 -0.581 . . . . 40.09 111.398 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.61 18.66 59.73 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 120.97 -0.633 . . . . 31.29 113.553 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -144.45 150.91 38.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.777 0.322 . . . . 44.74 110.645 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.8 tpp180 -94.19 115.98 28.33 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.989 -0.745 . . . . 33.12 108.989 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.499 ' HA3' ' HG ' ' A' ' 18' ' ' LEU . . . -141.07 -170.83 12.32 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.322 -0.942 . . . . 29.77 113.442 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.594 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 45.8 mtt -119.07 138.05 53.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.547 -0.326 . . . . 35.17 110.158 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.687 ' CD1' HD12 ' A' ' 18' ' ' LEU . 4.5 p90 -143.23 158.92 57.26 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 30.17 111.475 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.515 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 37.6 Cg_exo -57.35 141.46 94.79 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.817 2.344 . . . . 30.28 112.941 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -75.45 -39.04 59.3 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.563 -0.744 . . . . 32.21 111.453 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -76.35 -3.98 39.74 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.741 0.645 . . . . 34.54 112.741 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 6.9 m-85 -93.7 -34.15 13.36 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 110.336 -0.246 . . . . 34.04 110.336 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.655 HG21 ' HE2' ' A' ' 49' ' ' PHE . 24.7 m -102.72 143.55 14.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.198 -0.456 . . . . 31.54 110.214 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -109.99 130.44 55.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.355 -0.384 . . . . 30.59 110.808 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -52.0 132.21 32.3 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.127 -0.488 . . . . 32.19 110.582 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.9 mt -92.51 81.68 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.044 0.45 . . . . 30.54 110.437 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.037 -0.982 . . . . 40.63 111.217 -179.926 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.422 HG23 ' HE1' ' A' ' 4' ' ' TYR . 7.8 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.729 0.3 . . . . 33.03 111.364 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -80.65 149.82 29.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.152 -0.476 . . . . 30.12 110.734 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.865 ' HB2' HG21 ' A' ' 29' ' ' VAL . 9.0 m-85 -128.87 151.37 49.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.81 -0.632 . . . . 30.11 110.891 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.3 tt -116.9 126.46 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 30.57 109.75 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.541 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 34.8 t -68.19 128.52 31.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.963 0.411 . . . . 31.15 110.918 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -110.14 -22.82 11.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.702 -0.681 . . . . 37.96 110.77 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -133.43 140.8 47.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.413 -0.358 . . . . 29.97 110.389 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -72.28 136.5 46.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.319 -0.4 . . . . 32.05 110.71 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.51 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 63.5 t80 -137.43 128.61 27.78 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.278 -0.419 . . . . 33.98 111.093 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.45 ' HA ' HG23 ' A' ' 19' ' ' THR . 6.1 p-10 -79.97 157.15 26.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.868 -0.605 . . . . 36.69 110.463 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.08 95.59 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.372 -0.376 . . . . 30.62 111.158 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.12 -37.2 46.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.071 -0.513 . . . . 30.56 109.83 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.594 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 91.5 m-70 -93.38 165.86 12.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.721 -0.672 . . . . 29.61 110.724 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -74.6 -33.78 62.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 35.8 110.885 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.63 17.31 15.13 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.148 -0.478 . . . . 32.58 110.901 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.594 ' HB2' ' HB2' ' A' ' 14' ' ' HIS . 21.3 tt0 -97.77 128.47 44.44 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.99 -0.374 . . . . 36.11 109.99 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.567 ' HG ' ' HA3' ' A' ' 47' ' ' GLY . 6.6 mt -82.75 130.34 35.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 30.74 111.181 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 11' ' ' ASP . 11.4 m -86.81 64.96 8.78 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.971 -0.558 . . . . 30.81 109.703 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.576 HG22 HD22 ' A' ' 42' ' ' LEU . 30.0 pt -60.94 127.4 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 112.629 0.603 . . . . 30.39 112.629 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -115.14 138.42 50.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.625 -0.716 . . . . 29.61 109.663 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.4 125.37 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.728 0.299 . . . . 31.46 111.794 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.86 -19.72 40.51 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.053 -0.594 . . . . 30.6 113.456 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -76.3 146.6 38.79 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 117.254 0.527 . . . . 35.8 111.639 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.4 pt -109.18 125.16 66.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.852 -0.613 . . . . 30.38 110.147 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.647 HG21 ' CE1' ' A' ' 49' ' ' PHE . 6.1 mm -94.97 119.87 43.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 32.07 110.636 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 88.8 mtm180 -75.75 127.69 33.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 29.72 112.007 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.9 t30 53.07 73.37 0.36 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.798 -0.637 . . . . 29.65 112.133 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.865 HG21 ' HB2' ' A' ' 4' ' ' TYR . 66.4 t -91.85 110.15 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 30.31 111.189 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -107.64 162.82 13.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.868 -0.605 . . . . 38.77 110.546 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.515 ' HA ' HD23 ' A' ' 38' ' ' LEU . 5.7 mmmt -90.14 128.66 36.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 32.94 110.861 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 39' ' ' GLU . 92.8 mt -90.14 179.41 5.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.033 -0.53 . . . . 33.13 110.866 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.09 -3.51 45.7 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.252 -0.431 . . . . 42.18 111.179 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 35.3 mt-10 -100.93 119.08 38.19 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.798 -0.445 . . . . 38.11 109.798 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -60.93 117.65 5.72 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.303 -0.408 . . . . 30.43 110.274 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.08 17.45 34.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.024 -0.608 . . . . 30.13 112.4 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 99.3 m95 -133.55 132.3 40.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.137 0.494 . . . . 30.29 111.016 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 48' ' ' MET . 83.5 mt -119.87 160.91 21.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.317 -0.856 . . . . 30.33 109.936 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.541 ' HB2' HD21 ' A' ' 32' ' ' LEU . 9.1 tp10 -122.92 117.56 25.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.574 0.226 . . . . 38.59 110.674 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.13 164.64 32.45 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.499 -0.857 . . . . 29.85 113.418 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 3.5 mp0 -92.13 117.06 29.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.06 0.457 . . . . 37.88 111.104 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.576 HD22 HG22 ' A' ' 20' ' ' ILE . 55.5 tp -131.87 130.5 41.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.59 -0.732 . . . . 30.38 110.308 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 60.99 26.09 16.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.94 -0.573 . . . . 40.09 111.54 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.37 15.29 69.25 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.715 -0.755 . . . . 31.29 113.954 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -139.02 145.49 39.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.853 0.327 . . . . 44.74 110.422 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -95.46 120.0 34.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.558 -0.534 . . . . 33.12 109.558 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.567 ' HA3' ' HG ' ' A' ' 18' ' ' LEU . . . -149.34 155.42 26.3 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.293 -0.956 . . . . 29.77 113.669 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.618 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 24.8 ptt? -80.96 140.49 35.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.955 0.407 . . . . 35.17 110.9 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.647 ' CE1' HG21 ' A' ' 26' ' ' ILE . 6.1 p90 -141.63 162.68 45.48 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.933 -0.576 . . . . 30.17 111.095 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.564 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 25.9 Cg_exo -62.73 144.07 93.23 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.779 2.32 . . . . 30.28 112.971 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.6 -39.41 67.33 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.728 -0.669 . . . . 32.21 111.84 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -79.83 0.37 31.27 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.061 0.763 . . . . 34.54 113.061 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 9.6 m-85 -98.18 -31.22 12.2 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.494 0.188 . . . . 34.04 110.669 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 25.6 m -110.08 135.14 50.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.401 -0.363 . . . . 31.54 110.53 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -107.09 127.71 53.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 30.59 110.495 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 37.6 tt0 -57.61 136.31 56.78 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.446 -0.343 . . . . 32.19 110.668 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.4 mt -93.82 84.79 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 30.54 110.602 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.132 -0.937 . . . . 40.63 110.89 -179.954 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.816 0.341 . . . . 30.68 111.129 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -88.29 156.91 18.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.166 -0.47 . . . . 27.21 111.368 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.829 ' HB2' HG21 ' A' ' 29' ' ' VAL . 8.9 m-85 -133.38 152.97 51.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.505 -0.771 . . . . 24.84 110.578 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.5 tt -117.84 129.75 73.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.064 -0.516 . . . . 24.6 109.691 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.566 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 21.9 t -69.26 127.18 30.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.369 -0.378 . . . . 16.73 111.316 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.482 ' HG3' ' CD2' ' A' ' 8' ' ' TYR . 14.2 pt-20 -109.48 -19.16 13.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.885 -0.598 . . . . 30.58 110.839 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.482 ' CD2' ' HG3' ' A' ' 7' ' ' GLU . 30.8 m-85 -133.08 142.87 48.96 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.488 -0.323 . . . . 22.64 110.181 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -77.28 129.34 35.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.413 -0.358 . . . . 22.7 110.752 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.486 ' HB3' HG12 ' A' ' 20' ' ' ILE . 77.8 t80 -124.46 130.71 52.97 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.292 -0.413 . . . . 19.88 110.664 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -93.33 113.12 25.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.881 -0.6 . . . . 26.05 110.318 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.89 106.97 1.11 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.049 -0.523 . . . . 26.15 111.326 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -83.76 -36.13 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.757 -0.656 . . . . 31.71 110.177 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -94.02 176.37 6.36 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.891 -0.595 . . . . 37.29 110.596 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -81.3 -33.54 32.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 45.18 110.905 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -80.8 -28.23 36.35 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.363 -0.381 . . . . 35.42 110.552 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.42 134.46 57.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.27 -0.423 . . . . 26.24 111.114 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.634 HD12 ' CD1' ' A' ' 49' ' ' PHE . 28.9 mt -92.42 132.68 36.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.566 -0.743 . . . . 23.56 110.562 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.6 m -84.26 78.91 9.7 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.299 -0.63 . . . . 22.84 109.299 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.668 HG22 ' HG ' ' A' ' 42' ' ' LEU . 33.1 pt -78.42 133.41 30.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.935 0.398 . . . . 24.6 111.752 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -118.24 138.29 52.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 18.72 109.902 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.405 HG22 ' CA ' ' A' ' 8' ' ' TYR . 39.0 t -44.99 120.98 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.283 -0.417 . . . . 17.47 111.743 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.13 -21.01 25.4 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.046 -0.597 . . . . 18.82 113.633 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.618 ' HB3' HD21 ' A' ' 42' ' ' LEU . 39.1 mt-10 -76.32 154.48 35.01 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 117.343 0.572 . . . . 16.59 111.676 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.5 mt -117.29 127.72 74.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.528 -0.76 . . . . 24.6 110.16 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.626 HG21 ' CZ ' ' A' ' 49' ' ' PHE . 4.0 mp -94.94 125.44 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 24.6 110.393 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.607 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 7.7 mpt_? -80.0 125.49 29.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.482 . . . . 21.55 111.851 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.07 65.87 0.95 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.804 -0.634 . . . . 24.05 111.779 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.829 HG21 ' HB2' ' A' ' 4' ' ' TYR . 61.8 t -87.59 105.54 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.841 -0.618 . . . . 26.15 111.238 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -107.37 161.48 14.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.792 -0.64 . . . . 42.51 110.441 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HA ' HD23 ' A' ' 38' ' ' LEU . 39.1 ttmt -84.68 132.14 34.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 33.31 110.468 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.9 tp -91.01 171.01 9.56 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.865 -0.607 . . . . 37.71 110.331 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -77.13 -1.71 30.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.629 0.252 . . . . 40.38 110.855 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 42.3 mt-10 -103.67 122.49 45.15 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.646 -0.501 . . . . 38.54 109.646 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -60.86 117.9 6.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 33.27 110.461 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.05 15.39 45.24 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.99 -0.624 . . . . 28.28 112.833 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 85.6 m95 -132.54 132.47 42.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.163 0.506 . . . . 23.14 111.153 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 48' ' ' MET . 98.0 mt -118.79 162.25 18.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.262 -0.881 . . . . 23.91 110.021 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -123.09 118.36 27.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.577 -0.283 . . . . 43.4 110.439 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.466 ' O ' HD11 ' A' ' 18' ' ' LEU . . . -162.12 170.96 37.91 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.615 -0.802 . . . . 20.08 113.523 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 34.6 mt-10 -94.09 105.86 17.85 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.918 0.39 . . . . 32.1 110.46 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.668 ' HG ' HG22 ' A' ' 20' ' ' ILE . 3.1 tm? -124.49 130.44 52.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.879 -0.601 . . . . 22.89 110.065 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.516 ' HB2' HD13 ' A' ' 42' ' ' LEU . 66.6 t30 64.14 25.1 13.62 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.025 -0.534 . . . . 30.74 110.939 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.38 13.87 79.66 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 121.003 -0.617 . . . . 33.01 113.299 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -130.86 140.22 50.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.851 0.358 . . . . 45.68 110.736 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -91.4 114.03 26.46 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.485 -0.932 . . . . 38.71 108.485 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.541 ' HA3' ' HG ' ' A' ' 18' ' ' LEU . . . -151.19 -168.97 16.34 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.031 -1.081 . . . . 23.54 114.018 -178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.617 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 50.7 mtt -111.77 138.72 47.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.499 -0.351 . . . . 33.81 110.661 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.634 ' CD1' HD12 ' A' ' 18' ' ' LEU . 4.6 p90 -140.59 153.42 68.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 21.48 111.35 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HG2' ' HB2' ' A' ' 53' ' ' PHE . 9.9 Cg_endo -54.05 135.76 65.0 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.87 2.38 . . . . 18.64 112.691 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -67.9 -38.08 82.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.686 -0.688 . . . . 25.32 112.104 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -81.64 5.59 17.75 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.685 0.624 . . . . 25.56 112.685 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.519 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 9.8 m-85 -102.56 -24.82 13.76 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.494 0.188 . . . . 21.91 110.601 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 31.0 m -116.5 137.19 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.307 -0.406 . . . . 20.47 110.401 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -111.24 129.16 56.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 24.52 110.344 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -50.46 141.36 12.25 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.404 -0.362 . . . . 36.5 110.996 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.7 mt -95.33 89.77 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 29.5 110.751 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.55 -0.738 . . . . 44.29 110.879 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.603 0.24 . . . . 33.03 111.034 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.1 152.04 22.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.13 0.49 . . . . 30.12 111.783 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.917 ' HB2' HG21 ' A' ' 29' ' ' VAL . 7.6 m-85 -130.91 152.6 50.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.396 -0.82 . . . . 30.11 110.702 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 55' ' ' LYS . 6.5 tp -113.31 132.93 60.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.937 -0.574 . . . . 30.57 109.804 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.591 ' CG2' HD11 ' A' ' 26' ' ' ILE . 40.5 t -74.42 123.52 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.91 0.386 . . . . 31.15 110.703 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.475 ' HG3' ' CD2' ' A' ' 8' ' ' TYR . 12.5 pt-20 -104.34 -21.18 13.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 37.96 111.113 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.475 ' CD2' ' HG3' ' A' ' 7' ' ' GLU . 60.9 m-85 -133.14 142.52 48.71 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.856 0.36 . . . . 29.97 110.827 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -77.57 128.46 34.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 32.05 110.371 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.505 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 53.0 t80 -128.67 135.98 50.01 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.753 0.311 . . . . 33.98 111.13 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -96.9 119.85 36.16 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.003 -0.544 . . . . 36.69 110.562 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.18 105.17 1.32 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.275 -0.42 . . . . 30.62 111.107 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -87.05 -36.94 10.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.887 -0.597 . . . . 30.56 110.035 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.574 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 52.8 m-70 -89.21 -179.77 5.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.887 -0.597 . . . . 29.61 110.305 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -78.84 -45.82 19.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.502 -0.317 . . . . 35.8 111.029 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -77.93 -23.28 48.66 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.572 -0.286 . . . . 32.58 111.007 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.574 ' HG2' ' HB2' ' A' ' 14' ' ' HIS . 29.6 mm-40 -52.99 132.22 37.32 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.992 0.425 . . . . 36.11 111.012 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.517 HD11 ' HB3' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -95.5 129.01 42.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.639 -0.71 . . . . 30.74 110.589 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.8 m -82.99 86.11 7.05 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.992 -0.744 . . . . 30.81 108.992 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.651 HD11 ' HB3' ' A' ' 53' ' ' PHE . 36.1 pt -87.71 137.59 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 120.92 0.39 . . . . 30.39 111.895 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -116.51 135.55 53.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.811 -0.631 . . . . 29.61 109.974 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -47.21 124.41 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.935 0.398 . . . . 31.46 111.634 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.25 -16.31 42.07 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.763 -0.653 . . . . 30.6 113.322 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.418 ' HB3' HD11 ' A' ' 42' ' ' LEU . 15.6 mm-40 -82.2 150.0 27.6 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 117.278 0.539 . . . . 35.8 111.643 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.1 mt -109.17 128.02 65.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.666 -0.697 . . . . 30.38 110.14 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.591 HD11 ' CG2' ' A' ' 6' ' ' VAL . 4.2 mp -97.03 126.46 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.444 . . . . 32.07 110.58 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.442 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 83.9 mtp180 -76.51 125.75 29.77 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.075 -0.511 . . . . 29.72 112.172 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.2 t30 55.2 69.9 0.69 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.726 -0.67 . . . . 29.65 112.241 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.917 HG21 ' HB2' ' A' ' 4' ' ' TYR . 89.0 t -88.44 106.61 16.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.984 -0.553 . . . . 30.31 110.511 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -103.96 160.22 15.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.874 -0.603 . . . . 38.77 110.88 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.42 ' HA ' ' CD2' ' A' ' 38' ' ' LEU . 63.0 mttp -90.84 132.12 36.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 32.94 110.07 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 39' ' ' GLU . 93.8 mt -94.68 178.67 5.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 33.13 110.871 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.58 0.89 31.97 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.29 -0.414 . . . . 42.18 111.013 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.465 ' HB3' ' HD1' ' A' ' 37' ' ' TRP . 36.1 mt-10 -104.49 120.4 41.17 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.426 -0.583 . . . . 38.11 109.426 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -61.02 118.1 6.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 30.43 110.77 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 94.6 11.87 56.44 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.011 -0.614 . . . . 30.13 113.066 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.596 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 55.3 m95 -129.97 129.88 44.33 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.148 0.499 . . . . 30.29 111.208 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 48' ' ' MET . 90.1 mt -121.96 165.94 15.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.355 -0.839 . . . . 30.33 109.997 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.499 ' HB2' HD21 ' A' ' 32' ' ' LEU . 9.1 tp10 -126.08 122.07 34.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.611 -0.268 . . . . 38.59 110.612 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.465 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -154.76 162.37 30.76 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.635 -0.793 . . . . 29.85 113.283 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.442 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 3.1 mp0 -96.89 104.99 17.05 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.024 0.44 . . . . 37.88 110.945 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.517 ' HB3' HD11 ' A' ' 18' ' ' LEU . 53.0 tp -130.67 138.05 49.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.657 -0.702 . . . . 30.38 110.1 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 67.65 18.99 9.87 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.975 -0.557 . . . . 40.09 110.951 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.47 14.88 67.38 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 120.886 -0.673 . . . . 31.29 113.466 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -142.51 149.06 38.65 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.8 0.334 . . . . 44.74 110.377 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -92.82 116.3 28.91 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.704 -0.85 . . . . 33.12 108.704 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.1 151.75 22.75 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.036 -1.078 . . . . 29.77 114.011 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 62.0 ttp -81.44 135.57 35.64 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.242 -0.479 . . . . 35.17 110.312 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.565 ' CE2' HG21 ' A' ' 26' ' ' ILE . 6.0 p90 -139.49 158.53 68.33 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 30.17 111.236 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.562 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 34.8 Cg_exo -59.01 141.28 98.17 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.672 2.248 . . . . 30.28 112.721 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.31 -36.7 79.72 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.693 -0.685 . . . . 32.21 111.575 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -83.18 4.55 26.21 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.33 0.493 . . . . 34.54 112.33 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.651 ' HB3' HD11 ' A' ' 20' ' ' ILE . 9.2 m-85 -101.3 -21.69 14.81 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 120.621 0.248 . . . . 34.04 110.466 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 24.3 m -120.51 141.62 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.205 -0.452 . . . . 31.54 109.994 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.403 ' O ' HG22 ' A' ' 5' ' ' ILE . 88.4 tttt -116.14 129.07 56.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.388 -0.369 . . . . 30.59 110.689 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -55.14 129.45 38.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.415 -0.357 . . . . 32.19 110.102 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.4 mt -87.65 81.0 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.02 0.438 . . . . 30.54 110.765 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.0 tttm . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.072 -0.966 . . . . 40.63 111.026 -179.763 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.711 0.291 . . . . 30.68 111.325 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -85.62 154.52 21.64 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.226 -0.443 . . . . 27.21 110.748 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.81 ' HB2' HG21 ' A' ' 29' ' ' VAL . 8.3 m-85 -127.95 151.58 48.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 24.84 111.24 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.65 ' HB ' HD11 ' A' ' 57' ' ' ILE . 6.5 tp -112.34 133.2 58.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.667 -0.697 . . . . 24.6 109.328 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 38.3 t -77.34 124.18 35.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.806 0.336 . . . . 16.73 110.791 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.474 ' C ' HG22 ' A' ' 22' ' ' VAL . 19.4 mm-40 -108.44 -17.46 13.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.992 -0.549 . . . . 30.58 111.166 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.492 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 73.9 m-85 -133.71 141.29 47.49 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.673 0.273 . . . . 22.64 110.674 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -77.49 128.35 34.06 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.301 -0.409 . . . . 22.7 110.69 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.463 ' CD1' ' HG3' ' A' ' 50' ' ' PRO . 40.1 t80 -125.81 136.28 52.94 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.492 -0.322 . . . . 19.88 110.841 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -94.17 119.48 33.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.086 -0.506 . . . . 26.05 110.898 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -69.53 104.99 2.49 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.102 -0.499 . . . . 26.15 111.089 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.4 t -89.59 -34.87 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.748 -0.66 . . . . 31.71 110.138 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 43.7 m80 -90.91 172.06 8.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.906 -0.588 . . . . 37.29 110.514 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.68 -36.95 50.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 45.18 110.392 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -92.76 15.37 14.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.135 -0.484 . . . . 35.42 110.901 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.501 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 23.0 tp10 -92.53 127.84 38.17 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.911 -0.404 . . . . 26.24 109.911 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -86.39 124.95 33.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 23.56 111.139 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.2 m -81.18 83.75 6.73 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.274 -0.639 . . . . 22.84 109.274 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.508 ' HB ' ' CG2' ' A' ' 6' ' ' VAL . 38.0 pt -85.42 132.88 30.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.042 0.448 . . . . 24.6 111.709 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 -119.28 138.75 52.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.87 -0.604 . . . . 18.72 110.181 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.474 HG22 ' C ' ' A' ' 7' ' ' GLU . 46.2 t -44.25 120.97 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.841 0.353 . . . . 17.47 111.898 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.51 -19.52 28.79 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.87 -0.604 . . . . 18.82 113.613 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HB3' HD11 ' A' ' 42' ' ' LEU . 35.2 mt-10 -76.19 150.43 37.11 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 117.308 0.554 . . . . 16.59 111.981 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.6 mt -111.81 124.47 68.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.475 -0.784 . . . . 24.6 109.682 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.587 HG21 ' CE2' ' A' ' 49' ' ' PHE . 30.0 mt -97.12 123.15 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 24.6 110.403 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -75.71 133.57 40.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.028 -0.533 . . . . 21.55 112.067 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.7 p30 46.42 71.44 0.3 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.53 -0.759 . . . . 24.05 112.564 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.81 HG21 ' HB2' ' A' ' 4' ' ' TYR . 85.3 t -88.26 110.46 21.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.785 -0.643 . . . . 26.15 110.834 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HG2' ' N ' ' A' ' 31' ' ' LYS . 25.9 ttpp -107.0 160.9 15.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.745 -0.661 . . . . 42.51 110.482 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.404 ' N ' ' HG2' ' A' ' 30' ' ' LYS . 98.3 mttt -88.81 132.41 34.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 33.31 110.03 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 39' ' ' GLU . 95.9 mt -92.34 -179.98 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 37.71 111.166 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -81.36 -0.51 41.55 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.125 -0.489 . . . . 40.38 111.167 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -105.71 120.51 41.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.693 -0.484 . . . . 38.54 109.693 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -59.75 117.88 5.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.465 . . . . 33.27 110.638 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.26 13.02 50.25 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.939 -0.648 . . . . 28.28 112.963 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -131.38 130.13 42.23 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.139 0.495 . . . . 23.14 111.154 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.629 ' O ' ' HA ' ' A' ' 48' ' ' MET . 6.4 mp -119.71 164.39 16.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.295 -0.866 . . . . 23.91 109.525 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HB2' HD21 ' A' ' 32' ' ' LEU . 13.4 tp10 -126.38 122.6 35.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.638 0.256 . . . . 43.4 111.069 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.08 162.47 30.94 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.832 -0.699 . . . . 20.08 112.991 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -96.34 104.87 16.86 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.113 0.482 . . . . 32.1 111.026 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' A' ' 24' ' ' GLU . 59.8 tp -125.53 137.61 53.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.579 -0.737 . . . . 22.89 109.933 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 63.61 21.92 12.93 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.992 -0.549 . . . . 30.74 110.913 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.98 12.93 80.41 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 120.902 -0.666 . . . . 33.01 113.233 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -133.38 142.15 48.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.796 0.332 . . . . 45.68 110.287 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -93.96 114.77 27.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.91 -0.774 . . . . 38.71 108.91 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.53 153.99 25.68 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.299 -0.953 . . . . 23.54 113.344 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.629 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 22.7 ptt? -79.23 145.66 33.47 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.683 0.278 . . . . 33.81 110.369 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.587 ' CE2' HG21 ' A' ' 26' ' ' ILE . 3.8 p90 -143.99 155.66 58.81 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.256 -0.429 . . . . 21.48 111.22 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.574 ' HG2' ' HB2' ' A' ' 53' ' ' PHE . 14.5 Cg_endo -57.55 148.96 69.91 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.755 2.303 . . . . 18.64 112.99 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -73.36 -41.3 63.59 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.443 -0.799 . . . . 25.32 112.791 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -82.53 11.26 5.89 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.991 0.738 . . . . 25.56 112.991 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.574 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 16.3 m-85 -107.38 -27.2 10.61 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.57 0.224 . . . . 21.91 110.778 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 27.5 m -116.88 139.86 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 116.323 -0.398 . . . . 20.47 110.39 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.424 ' O ' HG22 ' A' ' 5' ' ' ILE . 44.4 mmtm -118.37 127.44 53.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.371 -0.377 . . . . 24.52 110.528 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.634 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . 12.8 pt-20 -60.92 131.97 52.37 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.542 -0.299 . . . . 36.5 110.411 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.65 HD11 ' HB ' ' A' ' 5' ' ' ILE . 22.4 mt -87.73 85.59 2.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.114 0.483 . . . . 29.5 110.762 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.445 -0.788 . . . . 44.29 110.856 -179.917 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.749 0.309 . . . . 30.68 111.021 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -84.64 154.57 22.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.275 -0.42 . . . . 27.21 111.306 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.919 ' HB2' HG21 ' A' ' 29' ' ' VAL . 6.4 m-85 -130.76 151.4 51.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.772 -0.649 . . . . 24.84 110.917 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.424 HD13 ' CD1' ' A' ' 25' ' ' ILE . 3.4 tp -113.69 128.09 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.689 -0.687 . . . . 24.6 109.63 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.518 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 29.8 t -73.89 124.37 31.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.422 -0.354 . . . . 16.73 110.794 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.439 ' C ' HG22 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -107.79 -18.95 13.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.028 -0.533 . . . . 30.58 110.929 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -130.49 140.54 50.52 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.706 0.288 . . . . 22.64 110.672 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 21' ' ' ARG . 34.6 m-20 -76.33 131.5 39.23 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.266 -0.424 . . . . 22.7 110.564 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.432 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 44.5 t80 -132.08 131.56 42.5 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.501 -0.318 . . . . 19.88 110.834 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -95.02 119.84 34.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.94 -0.573 . . . . 26.05 110.604 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.454 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -65.08 107.25 1.47 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.013 -0.54 . . . . 26.15 111.56 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.1 p -87.8 -36.47 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.779 -0.646 . . . . 31.71 109.95 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 29.7 m80 -90.37 172.84 8.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.837 -0.62 . . . . 37.29 110.422 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.81 -35.61 43.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.323 -0.399 . . . . 45.18 110.303 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -92.28 9.39 34.11 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.08 -0.509 . . . . 35.42 110.986 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.454 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 22.7 tp10 -87.28 126.78 35.05 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.906 -0.405 . . . . 26.24 109.906 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.644 HD21 ' HB3' ' A' ' 42' ' ' LEU . 11.0 tp -84.92 126.53 33.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 23.56 110.753 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.5 m -83.12 88.44 6.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.887 -0.597 . . . . 22.84 109.394 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.555 HG22 HD22 ' A' ' 42' ' ' LEU . 33.0 pt -89.07 131.06 37.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.813 0.34 . . . . 24.6 111.237 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 9' ' ' ASP . 25.2 mmm180 -117.12 138.78 51.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.154 -0.475 . . . . 18.72 110.105 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.439 HG22 ' C ' ' A' ' 7' ' ' GLU . 48.3 t -45.42 122.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.391 -0.368 . . . . 17.47 111.791 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.82 -18.97 39.5 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.052 -0.594 . . . . 18.82 113.575 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.458 ' HB3' HD11 ' A' ' 42' ' ' LEU . 18.2 mm-40 -77.16 147.46 36.49 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.286 0.543 . . . . 16.59 112.264 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.431 HD12 HD11 ' A' ' 57' ' ' ILE . 47.6 mm -107.7 123.02 62.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.462 -0.79 . . . . 24.6 109.894 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.545 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 41.0 mt -95.18 124.18 47.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.389 -0.369 . . . . 24.6 110.535 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.491 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -74.53 128.37 35.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.901 -0.59 . . . . 21.55 112.245 -178.463 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 50.64 70.92 0.46 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.698 -0.683 . . . . 24.05 112.401 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.919 HG21 ' HB2' ' A' ' 4' ' ' TYR . 73.0 t -87.52 107.5 17.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.981 -0.554 . . . . 26.15 110.741 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -103.74 157.08 17.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.719 -0.673 . . . . 42.51 110.475 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -89.27 129.9 35.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.414 . . . . 33.31 109.966 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 39' ' ' GLU . 87.9 mt -91.17 178.33 6.01 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.345 -0.389 . . . . 37.71 111.031 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -79.92 0.96 29.14 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.216 -0.447 . . . . 40.38 111.082 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 3.8 mp0 -105.65 122.0 45.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.463 -0.569 . . . . 38.54 109.463 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -61.55 116.93 5.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.174 -0.466 . . . . 33.27 110.435 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 96.41 12.54 51.04 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.907 -0.663 . . . . 28.28 113.006 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.506 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 44.7 m95 -130.26 129.59 43.49 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.168 0.509 . . . . 23.14 111.088 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.619 ' O ' ' HA ' ' A' ' 48' ' ' MET . 85.1 mt -120.07 165.49 14.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.277 -0.874 . . . . 23.91 109.781 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.531 ' HB2' HD21 ' A' ' 32' ' ' LEU . 38.7 tt0 -126.68 121.63 32.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.694 -0.23 . . . . 43.4 110.783 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.93 164.89 32.96 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.527 -0.844 . . . . 20.08 113.433 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.688 ' HG3' ' HG2' ' A' ' 46' ' ' ARG . 2.9 mp0 -94.1 106.08 18.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.769 0.318 . . . . 32.1 110.59 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.644 ' HB3' HD21 ' A' ' 18' ' ' LEU . 40.1 tp -130.61 137.18 49.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 22.89 110.251 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 64.55 19.73 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 30.74 111.218 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.74 13.5 72.38 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 121.021 -0.609 . . . . 33.01 113.453 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.1 mmt180 -136.3 145.31 45.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.909 0.385 . . . . 45.68 110.739 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.688 ' HG2' ' HG3' ' A' ' 41' ' ' GLU . 31.9 mtp180 -92.69 116.4 28.98 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.914 -0.772 . . . . 38.71 108.914 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.19 -175.14 15.99 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.116 -1.04 . . . . 23.54 113.31 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.619 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.2 ptp -112.7 139.68 48.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.943 -0.392 . . . . 33.81 109.943 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.571 ' HZ ' HG22 ' A' ' 29' ' ' VAL . 3.3 p90 -138.57 159.05 69.17 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.172 -0.467 . . . . 21.48 111.315 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.552 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 36.4 Cg_exo -60.98 136.62 66.75 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.625 2.217 . . . . 18.64 112.355 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -67.68 -36.2 80.26 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.924 -0.58 . . . . 25.32 111.48 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -79.24 2.11 22.38 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.725 0.639 . . . . 25.56 112.725 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 9.7 m-85 -102.81 -23.49 13.78 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.554 0.216 . . . . 21.91 110.852 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.479 HG12 HG22 ' A' ' 6' ' ' VAL . 30.9 m -120.63 139.43 47.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.274 -0.421 . . . . 20.47 110.364 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -112.97 133.29 55.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.345 -0.389 . . . . 24.52 110.503 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -54.74 137.76 43.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.334 -0.394 . . . . 36.5 110.436 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.431 HD11 HD12 ' A' ' 25' ' ' ILE . 64.7 mt -91.27 86.0 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.002 0.43 . . . . 29.5 110.764 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.426 ' HD3' ' C ' ' A' ' 58' ' ' LYS . 7.6 tmtm? . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.02 -0.991 . . . . 44.29 110.583 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.753 0.311 . . . . 33.03 111.029 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.03 159.02 16.35 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.103 0.478 . . . . 30.12 111.49 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.931 ' HB2' HG21 ' A' ' 29' ' ' VAL . 7.8 m-85 -131.34 153.36 49.69 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.528 -0.76 . . . . 30.11 111.079 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.545 ' HB ' HD11 ' A' ' 57' ' ' ILE . 17.2 tt -111.45 138.06 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.573 . . . . 30.57 109.607 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.461 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 25.1 t -80.78 121.02 33.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.431 -0.35 . . . . 31.15 110.744 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -104.77 -19.35 13.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.086 -0.506 . . . . 37.96 111.148 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -132.84 140.42 47.94 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.53 -0.305 . . . . 29.97 110.363 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.56 130.13 36.53 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.26 -0.427 . . . . 32.05 110.87 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.471 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 47.6 t80 -129.98 136.48 49.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.943 -0.571 . . . . 33.98 110.371 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.87 120.61 40.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.139 -0.482 . . . . 36.69 110.537 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.457 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -64.3 109.07 1.77 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.076 -0.511 . . . . 30.62 111.695 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.1 t -89.02 -36.35 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.63 -0.714 . . . . 30.56 109.747 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 43.3 m80 -92.19 175.02 7.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.767 -0.651 . . . . 29.61 110.621 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.2 -36.54 47.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.193 -0.458 . . . . 35.8 110.567 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 48' ' ' MET . 1.9 p30 -93.0 12.96 22.17 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.035 -0.53 . . . . 32.58 111.038 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.457 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 17.5 tp10 -91.54 129.98 37.43 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.801 -0.444 . . . . 36.11 109.801 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 19' ' ' THR . 0.4 OUTLIER -89.31 124.88 34.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.753 0.311 . . . . 30.74 111.328 -179.521 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.626 ' N ' HD13 ' A' ' 18' ' ' LEU . 32.9 m -81.49 86.13 6.38 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.107 -0.701 . . . . 30.81 109.107 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 53' ' ' PHE . 29.8 pt -87.28 135.31 25.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.396 -0.365 . . . . 30.39 111.51 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.3 mtp85 -119.06 138.19 53.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.136 -0.484 . . . . 29.61 110.165 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.3 t -45.32 122.72 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.894 0.378 . . . . 31.46 111.904 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.63 -18.77 34.59 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.824 -0.625 . . . . 30.6 113.567 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.49 ' HB3' HD11 ' A' ' 42' ' ' LEU . 32.6 mt-10 -76.09 155.19 34.97 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.365 0.582 . . . . 35.8 111.931 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.3 mt -115.53 125.75 72.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.45 -0.795 . . . . 30.38 109.749 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.754 ' CD1' HD22 ' A' ' 42' ' ' LEU . 5.5 mm -91.27 120.44 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 32.07 110.756 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.38 122.21 23.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.285 -0.416 . . . . 29.72 112.107 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 57.97 70.76 0.63 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.753 -0.658 . . . . 29.65 112.61 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.931 HG21 ' HB2' ' A' ' 4' ' ' TYR . 59.8 t -86.39 108.6 17.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.297 -0.41 . . . . 30.31 111.088 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -105.16 155.97 18.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.802 -0.635 . . . . 38.77 110.358 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HA ' HD13 ' A' ' 38' ' ' LEU . 69.0 mttm -82.06 127.75 33.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 32.94 110.264 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 tp -88.42 170.89 10.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 33.13 110.308 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -78.91 0.85 25.7 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.67 -0.241 . . . . 42.18 110.867 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.503 ' HB3' ' HD1' ' A' ' 37' ' ' TRP . 2.9 mp0 -104.55 116.17 31.61 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.565 -0.532 . . . . 38.11 109.565 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.92 121.82 10.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 30.43 110.991 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.42 14.78 56.67 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.862 -0.685 . . . . 30.13 113.031 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.503 ' HD1' ' HB3' ' A' ' 34' ' ' GLU . 92.5 m95 -134.01 132.28 39.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.156 0.503 . . . . 30.29 110.951 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 48' ' ' MET . 3.7 mm? -117.33 163.43 16.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.295 -0.866 . . . . 30.33 109.735 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 10.7 tp10 -123.48 119.81 31.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.774 -0.194 . . . . 38.59 110.482 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.461 ' HA3' HG22 ' A' ' 26' ' ' ILE . . . -153.09 161.51 29.67 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.468 -0.872 . . . . 29.85 113.514 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -95.15 106.61 18.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.084 0.468 . . . . 37.88 110.825 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.754 HD22 ' CD1' ' A' ' 26' ' ' ILE . 30.3 tp -132.93 142.13 48.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.668 -0.696 . . . . 30.38 110.073 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.3 m120 65.46 17.49 10.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.726 -0.67 . . . . 40.09 111.181 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.28 15.51 62.21 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 121.005 -0.617 . . . . 31.29 113.492 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -145.24 151.95 39.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.745 0.307 . . . . 44.74 110.44 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -95.31 119.04 33.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.11 -0.7 . . . . 33.12 109.11 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -145.73 150.01 22.19 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.554 -0.832 . . . . 29.77 113.079 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 22.8 ptp -78.62 145.46 34.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.718 0.294 . . . . 35.17 110.373 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 26' ' ' ILE . 3.4 p90 -143.2 157.64 59.81 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.024 -0.535 . . . . 30.17 111.179 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.54 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 27.2 Cg_exo -61.8 145.58 97.11 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.678 2.252 . . . . 30.28 112.821 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.95 -37.39 78.82 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.617 -0.719 . . . . 32.21 112.077 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -78.74 4.71 13.05 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.9 0.704 . . . . 34.54 112.9 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.561 ' HB3' HD11 ' A' ' 20' ' ' ILE . 13.2 m-85 -107.81 -24.23 11.76 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.491 0.186 . . . . 34.04 111.307 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.568 HG21 ' CE1' ' A' ' 49' ' ' PHE . 29.1 m -121.03 139.95 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 110.113 -0.329 . . . . 31.54 110.113 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -122.24 131.93 54.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.446 -0.343 . . . . 30.59 110.41 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -54.65 131.26 42.92 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.425 -0.352 . . . . 32.19 110.64 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.545 HD11 ' HB ' ' A' ' 5' ' ' ILE . 44.2 mt -87.41 84.54 2.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.071 0.462 . . . . 30.54 110.763 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 96.1 mttt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.084 -0.96 . . . . 40.63 110.882 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.754 0.311 . . . . 30.68 111.104 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -83.61 157.51 22.24 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.242 -0.435 . . . . 27.21 111.196 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.851 ' HB2' HG21 ' A' ' 29' ' ' VAL . 7.4 m-85 -134.16 151.92 51.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.829 -0.623 . . . . 24.84 110.81 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.664 ' HB ' HD11 ' A' ' 57' ' ' ILE . 13.8 tt -113.81 134.03 57.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.402 -0.592 . . . . 24.6 109.402 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 37.0 t -76.67 123.63 33.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.917 0.389 . . . . 16.73 110.828 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -106.49 -21.18 13.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.931 -0.577 . . . . 30.58 111.002 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.92 141.26 48.27 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.521 -0.308 . . . . 22.64 110.436 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -74.75 129.3 37.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 22.7 110.984 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.574 ' HB3' HG12 ' A' ' 20' ' ' ILE . 54.2 t80 -127.11 132.94 50.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.928 -0.578 . . . . 19.88 110.183 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -100.02 116.65 32.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.009 -0.541 . . . . 26.05 110.638 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.83 107.33 0.96 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.016 -0.538 . . . . 26.15 111.143 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.7 t -77.66 -39.35 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.925 -0.58 . . . . 31.71 109.83 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.722 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 46.5 m-70 -98.31 178.15 5.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.753 -0.658 . . . . 37.29 110.712 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -81.71 -27.13 34.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.033 -0.531 . . . . 45.18 111.092 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -92.09 5.87 48.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.511 -0.313 . . . . 35.42 111.098 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.722 ' HG2' ' HB2' ' A' ' 14' ' ' HIS . 40.3 mm-40 -94.42 135.35 35.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 110.013 -0.366 . . . . 26.24 110.013 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.44 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -89.6 125.7 35.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.94 -0.573 . . . . 23.56 110.835 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.3 m -83.08 86.18 7.05 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.32 -0.622 . . . . 22.84 109.32 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.574 HG12 ' HB3' ' A' ' 10' ' ' TYR . 43.4 pt -84.7 136.82 21.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.161 -0.472 . . . . 24.6 111.906 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -119.8 137.78 53.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.862 -0.608 . . . . 18.72 110.187 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.5 t -45.72 122.51 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.078 0.399 . . . . 17.47 112.078 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.14 -18.22 36.63 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.846 -0.616 . . . . 18.82 113.69 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.49 ' HB3' HD11 ' A' ' 42' ' ' LEU . 32.8 mt-10 -78.31 152.76 32.24 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.395 0.598 . . . . 16.59 112.107 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.5 mm -112.38 125.23 69.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.493 -0.776 . . . . 24.6 109.743 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.592 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 40.4 mt -96.98 125.03 50.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 24.6 110.782 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.531 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 78.2 ttt180 -75.55 125.88 29.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.775 -0.648 . . . . 21.55 112.422 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 54.41 68.74 0.81 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.697 -0.683 . . . . 24.05 112.413 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.851 HG21 ' HB2' ' A' ' 4' ' ' TYR . 91.6 t -88.43 107.94 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 26.15 110.839 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -108.4 164.6 12.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.844 -0.616 . . . . 42.51 110.623 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HA ' HD23 ' A' ' 38' ' ' LEU . 40.4 ttmt -90.59 133.46 35.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.289 -0.414 . . . . 33.31 110.517 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.463 HD21 ' HB2' ' A' ' 39' ' ' GLU . 94.5 mt -96.17 -177.77 4.1 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.976 -0.556 . . . . 37.71 110.955 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -81.83 -0.2 42.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.309 -0.405 . . . . 40.38 111.226 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 31.6 mt-10 -103.38 115.88 31.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.745 -0.465 . . . . 38.54 109.745 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -58.12 118.46 5.47 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.258 -0.428 . . . . 33.27 110.575 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 93.85 14.15 53.12 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.936 -0.65 . . . . 28.28 113.012 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.481 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 80.9 m95 -133.75 132.72 40.87 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.125 0.488 . . . . 23.14 110.704 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.598 ' O ' ' HA ' ' A' ' 48' ' ' MET . 94.7 mt -120.08 166.6 13.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.272 -0.876 . . . . 23.91 110.087 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.463 ' HB2' HD21 ' A' ' 32' ' ' LEU . 14.0 tp10 -125.97 120.61 30.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.55 -0.296 . . . . 43.4 110.636 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.16 163.36 31.43 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.729 -0.748 . . . . 20.08 113.118 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 27' ' ' ARG . 1.9 tm-20 -95.05 103.79 15.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.037 0.446 . . . . 32.1 110.462 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.501 ' CD2' HG22 ' A' ' 20' ' ' ILE . 45.8 tp -129.82 140.71 50.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.535 -0.757 . . . . 22.89 110.113 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 65.0 18.26 11.43 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.032 -0.531 . . . . 30.74 111.192 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.2 14.36 66.74 Favored Glycine 0 C--N 1.341 0.815 0 C-N-CA 120.992 -0.623 . . . . 33.01 113.331 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -140.94 149.29 41.65 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.826 0.346 . . . . 45.68 110.8 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -94.8 115.26 27.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.928 -0.767 . . . . 38.71 108.928 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.9 -176.54 14.69 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.259 -0.972 . . . . 23.54 113.613 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.598 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 54.8 mtt -111.62 133.77 53.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.491 -0.355 . . . . 33.81 110.162 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.514 ' HZ ' HG22 ' A' ' 29' ' ' VAL . 4.8 p90 -136.51 156.92 76.13 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.273 -0.422 . . . . 21.48 111.473 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.591 ' HG2' ' HB2' ' A' ' 53' ' ' PHE . 19.6 Cg_endo -58.99 136.56 74.2 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.741 2.294 . . . . 18.64 112.436 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.75 -38.18 83.12 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.791 -0.641 . . . . 25.32 111.849 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -78.29 4.74 12.03 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.808 0.67 . . . . 25.56 112.808 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.591 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 5.3 m-85 -105.25 -22.33 13.08 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.494 0.188 . . . . 21.91 110.996 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 18.3 m -117.36 141.07 37.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.467 -0.333 . . . . 20.47 110.65 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.4 ' O ' HG22 ' A' ' 5' ' ' ILE . 17.5 tppt? -113.63 125.24 53.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 24.52 110.306 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -51.69 141.47 16.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.439 -0.346 . . . . 36.5 110.993 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.664 HD11 ' HB ' ' A' ' 5' ' ' ILE . 39.4 mm -85.97 93.32 3.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.167 -0.47 . . . . 29.5 110.458 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.099 -0.953 . . . . 44.29 110.824 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.746 0.307 . . . . 30.68 111.186 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.41 149.03 25.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.023 0.44 . . . . 27.21 111.132 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.86 ' HB2' HG21 ' A' ' 29' ' ' VAL . 6.8 m-85 -129.04 152.73 48.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.626 -0.715 . . . . 24.84 110.709 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.406 ' HB ' HD11 ' A' ' 57' ' ' ILE . 18.2 tt -114.84 136.36 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 24.6 109.703 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.561 ' CG2' HD11 ' A' ' 26' ' ' ILE . 36.8 t -74.29 122.06 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 16.73 110.83 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.43 ' HG3' ' CD2' ' A' ' 8' ' ' TYR . 11.9 pt-20 -103.1 -20.76 14.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.914 -0.584 . . . . 30.58 111.065 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.43 ' CD2' ' HG3' ' A' ' 7' ' ' GLU . 61.2 m-85 -134.52 141.86 46.84 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.844 0.354 . . . . 22.64 110.653 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -79.22 127.57 32.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.038 -0.528 . . . . 22.7 110.441 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.498 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 34.8 t80 -125.47 137.12 53.97 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.381 -0.372 . . . . 19.88 111.019 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -94.82 119.12 32.87 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.063 -0.517 . . . . 26.05 110.38 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.512 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -66.46 103.38 1.03 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.273 -0.421 . . . . 26.15 111.469 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.07 -33.78 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.887 -0.597 . . . . 31.71 110.265 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.514 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 53.0 m80 -90.52 178.2 6.16 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.93 -0.577 . . . . 37.29 109.968 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.58 -46.05 20.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.665 -0.243 . . . . 45.18 110.693 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.13 -22.26 52.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.25 -0.432 . . . . 35.42 110.84 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 14' ' ' HIS . 16.0 tp10 -52.71 125.53 16.99 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.898 0.38 . . . . 26.24 110.908 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.39 127.61 36.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.934 -0.575 . . . . 23.56 110.61 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.8 m -80.92 86.28 6.09 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.005 -0.739 . . . . 22.84 109.005 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.684 HD11 ' HB3' ' A' ' 53' ' ' PHE . 23.8 pt -91.6 137.3 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.002 0.429 . . . . 24.6 111.794 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -118.38 139.18 51.77 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.862 -0.608 . . . . 18.72 109.966 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.403 HG22 ' CA ' ' A' ' 8' ' ' TYR . 40.6 t -47.57 124.76 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 111.994 0.368 . . . . 17.47 111.994 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.77 -18.24 37.7 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.848 -0.614 . . . . 18.82 113.527 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.742 ' HB3' HD11 ' A' ' 42' ' ' LEU . 41.7 mt-10 -78.14 153.59 31.95 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 117.263 0.531 . . . . 16.59 111.821 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.0 pt -112.65 125.93 69.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.665 -0.698 . . . . 24.6 110.245 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.634 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 3.9 mp -97.49 124.87 50.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.47 . . . . 24.6 110.405 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.521 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 40.2 ttm180 -78.46 127.58 32.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.265 -0.425 . . . . 21.55 112.032 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 61.5 t30 57.37 67.33 0.99 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.671 -0.695 . . . . 24.05 112.09 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.86 HG21 ' HB2' ' A' ' 4' ' ' TYR . 76.1 t -91.12 108.39 19.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 26.15 110.864 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -110.89 167.1 10.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.896 -0.593 . . . . 42.51 110.929 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -92.67 135.64 33.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.945 -0.571 . . . . 33.31 110.333 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.553 HD21 ' HB2' ' A' ' 39' ' ' GLU . 95.1 mt -96.16 -177.42 3.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 37.71 110.987 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -81.41 -0.19 40.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.267 -0.424 . . . . 40.38 111.349 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HB3' ' HD1' ' A' ' 37' ' ' TRP . 38.6 mt-10 -105.57 121.6 44.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.84 -0.43 . . . . 38.54 109.84 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.0 117.83 5.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.039 -0.528 . . . . 33.27 110.767 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 94.44 11.23 57.38 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.003 -0.618 . . . . 28.28 113.123 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.505 ' C ' HD12 ' A' ' 38' ' ' LEU . 69.6 m95 -130.29 129.0 42.69 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.168 0.509 . . . . 23.14 111.103 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 48' ' ' MET . 8.0 mp -121.45 168.64 11.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.316 -0.856 . . . . 23.91 109.982 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.553 ' HB2' HD21 ' A' ' 32' ' ' LEU . 10.8 tp10 -127.05 123.04 36.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.487 -0.324 . . . . 43.4 110.877 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.438 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -155.49 163.41 31.6 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.622 -0.799 . . . . 20.08 113.42 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 27' ' ' ARG . 22.9 mt-10 -97.5 104.36 16.38 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.843 0.354 . . . . 32.1 110.921 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.742 HD11 ' HB3' ' A' ' 24' ' ' GLU . 43.1 tp -128.24 138.29 52.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 22.89 110.387 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.405 ' OD1' ' HG ' ' A' ' 42' ' ' LEU . 19.8 m120 63.37 21.95 13.04 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.893 -0.594 . . . . 30.74 111.21 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.7 12.79 76.98 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 121.007 -0.616 . . . . 33.01 113.476 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -135.32 144.53 46.76 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.819 0.342 . . . . 45.68 110.502 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -92.23 114.3 26.8 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.246 -1.02 . . . . 38.71 108.246 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.56 154.4 25.15 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.807 -1.187 . . . . 23.54 114.316 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.592 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 37.7 ttm -81.44 137.72 35.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.857 -0.671 . . . . 33.81 110.134 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' A' ' 26' ' ' ILE . 3.0 p90 -140.69 159.81 61.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.437 -0.347 . . . . 21.48 111.213 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.564 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 34.1 Cg_exo -61.03 145.9 98.46 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.688 2.259 . . . . 18.64 112.839 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.484 ' HA ' HD13 ' A' ' 38' ' ' LEU . 24.3 t70 -67.45 -38.4 84.44 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.734 -0.666 . . . . 25.32 111.997 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -85.67 9.32 16.58 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.37 0.507 . . . . 25.56 112.37 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.684 ' HB3' HD11 ' A' ' 20' ' ' ILE . 9.1 m-85 -105.11 -24.42 12.77 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.553 0.216 . . . . 21.91 110.432 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 20.2 m -115.45 137.8 47.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.21 -0.45 . . . . 20.47 109.927 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -115.64 124.2 50.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.4 -0.364 . . . . 24.52 110.591 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 38.0 tt0 -55.68 132.08 48.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.322 -0.399 . . . . 36.5 110.671 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.406 HD11 ' HB ' ' A' ' 5' ' ' ILE . 45.8 mt -93.5 75.64 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.205 0.526 . . . . 29.5 110.386 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.56 -0.734 . . . . 44.29 110.881 -179.893 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.724 0.297 . . . . 33.03 111.344 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.71 157.26 19.68 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.155 -0.475 . . . . 30.12 111.093 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.835 ' HB2' HG21 ' A' ' 29' ' ' VAL . 8.1 m-85 -133.2 151.51 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.864 -0.607 . . . . 30.11 110.88 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 55' ' ' LYS . 15.4 tt -109.56 137.03 43.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.339 -0.615 . . . . 30.57 109.339 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.584 HG21 ' HB ' ' A' ' 20' ' ' ILE . 37.4 t -79.94 119.03 28.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.879 0.371 . . . . 31.15 110.798 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -102.58 -20.04 14.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.993 -0.549 . . . . 37.96 110.976 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -130.62 138.01 49.9 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.565 -0.289 . . . . 29.97 110.634 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -75.02 127.64 33.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 32.05 110.594 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.489 ' HB3' HG12 ' A' ' 20' ' ' ILE . 68.1 t80 -117.82 132.78 56.4 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.185 -0.461 . . . . 33.98 110.317 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -93.68 154.71 17.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 36.69 110.759 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.46 116.02 6.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 30.62 110.51 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.55 -27.91 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.92 -0.582 . . . . 30.56 110.445 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.65 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 52.0 m80 -148.54 -179.22 6.8 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.123 -0.49 . . . . 29.61 110.177 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -76.32 -29.32 57.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 35.8 110.841 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -94.09 6.78 47.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.371 -0.377 . . . . 32.58 111.524 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.65 ' HG2' ' HB2' ' A' ' 14' ' ' HIS . 45.0 mm-40 -95.95 131.66 42.08 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 110.238 -0.282 . . . . 36.11 110.238 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -88.69 123.83 33.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 30.74 111.129 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 37.0 m -81.62 84.91 6.64 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.081 -0.711 . . . . 30.81 109.081 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 53' ' ' PHE . 35.1 pt -90.06 142.64 12.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.746 -0.661 . . . . 30.39 111.743 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.417 ' N ' ' HD3' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -121.2 142.5 49.84 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.126 -0.488 . . . . 29.61 110.107 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -49.5 124.78 2.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 112.014 0.376 . . . . 31.46 112.014 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.1 -16.67 45.74 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.864 -0.607 . . . . 30.6 113.686 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.0 156.68 25.79 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 117.468 0.634 . . . . 35.8 112.018 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.9 mm -113.82 127.9 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.364 -0.834 . . . . 30.38 110.124 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.59 HD12 HG11 ' A' ' 54' ' ' VAL . 36.6 mt -98.46 125.75 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 32.07 110.834 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.573 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 75.8 mtm180 -71.77 124.5 24.94 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.833 -0.621 . . . . 29.72 112.553 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 49.37 72.68 0.29 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.65 -0.705 . . . . 29.65 112.491 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.835 HG21 ' HB2' ' A' ' 4' ' ' TYR . 71.6 t -86.59 109.0 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 30.31 110.325 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -105.42 158.96 16.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.81 -0.632 . . . . 38.77 110.688 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -90.18 134.17 34.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.701 -0.481 . . . . 32.94 109.701 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.444 HD11 ' HG2' ' A' ' 48' ' ' MET . 91.1 mt -97.16 -177.55 3.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.401 -0.363 . . . . 33.13 111.19 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.9 2.57 33.77 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.257 -0.428 . . . . 42.18 111.214 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 4.8 mp0 -105.73 116.31 31.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.318 -0.623 . . . . 38.11 109.318 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.78 118.02 5.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.263 -0.426 . . . . 30.43 110.651 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 96.17 9.14 57.28 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.899 -0.667 . . . . 30.13 113.408 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 73.4 m95 -130.98 130.54 43.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.245 0.545 . . . . 30.29 111.087 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 48' ' ' MET . 6.6 mp -120.74 168.79 11.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.121 -0.945 . . . . 30.33 109.663 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.426 ' HB2' HD21 ' A' ' 32' ' ' LEU . 40.1 tt0 -128.21 123.96 35.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.647 0.26 . . . . 38.59 110.732 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.448 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -151.26 160.18 28.56 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.754 -0.736 . . . . 29.85 112.829 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 3.3 mp0 -97.2 102.93 14.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.068 0.461 . . . . 37.88 110.946 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.553 ' CD2' HG22 ' A' ' 20' ' ' ILE . 54.9 tp -125.81 138.12 53.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.65 -0.704 . . . . 30.38 109.989 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 62.5 21.15 12.43 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.091 -0.504 . . . . 40.09 111.471 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.93 9.46 80.72 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 120.937 -0.649 . . . . 31.29 113.6 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -132.18 141.39 49.08 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.687 0.28 . . . . 44.74 110.407 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -91.86 114.69 27.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.617 -0.882 . . . . 33.12 108.617 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.26 179.91 16.94 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.267 -0.968 . . . . 29.77 113.509 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.585 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 77.3 mtp -111.2 134.89 52.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.441 -0.379 . . . . 35.17 110.227 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.513 ' CE2' HD13 ' A' ' 26' ' ' ILE . 2.0 p90 -135.36 159.09 73.04 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.151 -0.477 . . . . 30.17 110.999 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 33.6 Cg_exo -61.06 148.74 91.95 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.708 2.272 . . . . 30.28 112.815 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.43 -39.06 85.44 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.761 -0.654 . . . . 32.21 111.794 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -87.35 15.3 6.6 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.307 0.484 . . . . 34.54 112.307 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.586 ' HB3' HD11 ' A' ' 20' ' ' ILE . 4.9 m-85 -106.71 -24.98 11.94 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 120.527 0.203 . . . . 34.04 110.603 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.59 HG11 HD12 ' A' ' 26' ' ' ILE . 28.2 m -124.31 144.81 32.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.178 -0.464 . . . . 31.54 110.54 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' O ' HG22 ' A' ' 5' ' ' ILE . 63.6 tttm -122.03 128.74 51.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 30.59 110.108 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -52.83 136.28 34.34 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.62 0.248 . . . . 32.19 110.788 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.578 HG23 ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -84.1 103.75 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.371 0.605 . . . . 30.54 110.375 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.135 -0.936 . . . . 40.63 110.745 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.73 0.3 . . . . 33.03 111.156 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -79.95 150.78 30.38 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.989 0.423 . . . . 30.12 111.497 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.858 ' HB2' HG21 ' A' ' 29' ' ' VAL . 10.4 m-85 -130.37 151.79 50.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.613 -0.721 . . . . 30.11 110.72 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.4 tt -120.07 124.35 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 30.57 109.89 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 25.3 t -63.82 129.65 27.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 31.15 111.319 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -109.92 -25.31 10.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.656 -0.702 . . . . 37.96 110.428 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -132.79 139.19 47.41 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.288 -0.415 . . . . 29.97 110.283 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -69.0 141.96 54.76 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.331 -0.395 . . . . 32.05 111.029 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -135.95 126.07 26.22 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.232 -0.44 . . . . 33.98 110.855 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -82.59 117.38 22.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 36.69 111.321 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.94 104.89 3.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.939 -0.573 . . . . 30.62 110.945 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.6 t -85.95 -37.26 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.797 -0.638 . . . . 30.56 110.169 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.602 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 55.3 m-70 -89.59 174.11 7.94 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.96 -0.564 . . . . 29.61 110.795 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -81.19 -31.34 34.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.117 -0.492 . . . . 35.8 110.965 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -100.0 16.74 22.96 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.493 -0.321 . . . . 32.58 110.724 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 14' ' ' HIS . 22.6 tt0 -96.93 125.94 41.71 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.906 -0.405 . . . . 36.11 109.906 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.687 HD12 ' CD1' ' A' ' 49' ' ' PHE . 35.3 mt -79.94 133.5 36.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.863 0.363 . . . . 30.74 111.064 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 m -87.17 55.16 3.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.848 -0.614 . . . . 30.81 110.527 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.553 HG22 HD22 ' A' ' 42' ' ' LEU . 22.1 pt -48.81 120.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 112.546 0.573 . . . . 30.39 112.546 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -113.43 136.46 52.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.394 -0.821 . . . . 29.61 109.292 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -43.09 122.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.733 0.301 . . . . 31.46 111.715 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.42 -18.41 38.57 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.075 -0.583 . . . . 30.6 113.813 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.428 ' HB3' HD11 ' A' ' 42' ' ' LEU . 41.8 mt-10 -80.03 147.28 31.57 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 117.554 0.677 . . . . 35.8 111.534 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 25' ' ' ILE . 4.4 mp -111.79 127.79 68.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.805 -0.634 . . . . 30.38 110.311 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.53 HG21 ' CE1' ' A' ' 49' ' ' PHE . 3.9 mp -96.07 122.28 47.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.28 -0.418 . . . . 32.07 110.287 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.569 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 22.0 mmm180 -74.31 127.74 33.76 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.083 -0.508 . . . . 29.72 112.073 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 52.39 73.42 0.34 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.816 -0.629 . . . . 29.65 112.176 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.858 HG21 ' HB2' ' A' ' 4' ' ' TYR . 55.9 t -88.77 110.57 21.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.973 -0.558 . . . . 30.31 111.507 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -102.48 154.97 18.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.699 -0.682 . . . . 38.77 109.923 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.455 ' HA ' HD23 ' A' ' 38' ' ' LEU . 86.1 tttt -80.48 123.35 28.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.953 0.406 . . . . 32.94 110.988 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.1 tp -77.83 162.77 26.64 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.774 -0.648 . . . . 33.13 110.068 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -61.75 -28.81 69.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.487 -0.324 . . . . 42.18 110.79 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -83.95 129.87 34.91 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.805 0.336 . . . . 38.11 110.761 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.61 122.42 16.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.864 -0.607 . . . . 30.43 109.675 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 94.06 18.04 38.36 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 30.13 112.342 -178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -134.46 135.18 42.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.105 0.479 . . . . 30.29 110.484 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 48' ' ' MET . 81.0 mt -124.73 161.71 25.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.345 -0.843 . . . . 30.33 110.022 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.43 119.45 28.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.103 -0.332 . . . . 38.59 110.103 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.504 ' O ' HD11 ' A' ' 18' ' ' LEU . . . -157.23 165.67 33.38 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.417 -0.897 . . . . 29.85 113.405 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.569 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 2.0 tm-20 -86.79 109.38 19.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.942 0.401 . . . . 37.88 110.079 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.591 ' HB3' HD13 ' A' ' 18' ' ' LEU . 57.8 tp -132.03 134.09 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.665 -0.698 . . . . 30.38 110.371 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 64.18 21.39 12.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.922 -0.581 . . . . 40.09 111.398 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.61 18.66 59.73 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 120.97 -0.633 . . . . 31.29 113.553 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -144.45 150.91 38.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.777 0.322 . . . . 44.74 110.645 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.8 tpp180 -94.19 115.98 28.33 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.989 -0.745 . . . . 33.12 108.989 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.499 ' HA3' ' HG ' ' A' ' 18' ' ' LEU . . . -141.07 -170.83 12.32 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.322 -0.942 . . . . 29.77 113.442 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.594 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 45.8 mtt -119.07 138.05 53.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.547 -0.326 . . . . 35.17 110.158 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.687 ' CD1' HD12 ' A' ' 18' ' ' LEU . 4.5 p90 -143.23 158.92 57.26 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 30.17 111.475 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.515 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 37.6 Cg_exo -57.35 141.46 94.79 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.817 2.344 . . . . 30.28 112.941 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -75.45 -39.04 59.3 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.563 -0.744 . . . . 32.21 111.453 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -76.35 -3.98 39.74 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.741 0.645 . . . . 34.54 112.741 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 6.9 m-85 -93.7 -34.15 13.36 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 110.336 -0.246 . . . . 34.04 110.336 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.655 HG21 ' HE2' ' A' ' 49' ' ' PHE . 24.7 m -102.72 143.55 14.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.198 -0.456 . . . . 31.54 110.214 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -109.99 130.44 55.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.355 -0.384 . . . . 30.59 110.808 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -52.0 132.21 32.3 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.127 -0.488 . . . . 32.19 110.582 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.9 mt -92.51 81.68 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.044 0.45 . . . . 30.54 110.437 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.037 -0.982 . . . . 40.63 111.217 -179.926 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.422 HG23 ' HE1' ' A' ' 4' ' ' TYR . 7.8 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.729 0.3 . . . . 33.03 111.364 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -80.65 149.82 29.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.152 -0.476 . . . . 30.12 110.734 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.865 ' HB2' HG21 ' A' ' 29' ' ' VAL . 9.0 m-85 -128.87 151.37 49.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.81 -0.632 . . . . 30.11 110.891 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.3 tt -116.9 126.46 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 30.57 109.75 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.541 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 34.8 t -68.19 128.52 31.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.963 0.411 . . . . 31.15 110.918 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -110.14 -22.82 11.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.702 -0.681 . . . . 37.96 110.77 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -133.43 140.8 47.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.413 -0.358 . . . . 29.97 110.389 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -72.28 136.5 46.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.319 -0.4 . . . . 32.05 110.71 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.51 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 63.5 t80 -137.43 128.61 27.78 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.278 -0.419 . . . . 33.98 111.093 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.45 ' HA ' HG23 ' A' ' 19' ' ' THR . 6.1 p-10 -79.97 157.15 26.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.868 -0.605 . . . . 36.69 110.463 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.08 95.59 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.372 -0.376 . . . . 30.62 111.158 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.12 -37.2 46.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.071 -0.513 . . . . 30.56 109.83 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.594 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 91.5 m-70 -93.38 165.86 12.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.721 -0.672 . . . . 29.61 110.724 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -74.6 -33.78 62.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 35.8 110.885 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.63 17.31 15.13 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.148 -0.478 . . . . 32.58 110.901 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.594 ' HB2' ' HB2' ' A' ' 14' ' ' HIS . 21.3 tt0 -97.77 128.47 44.44 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.99 -0.374 . . . . 36.11 109.99 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.567 ' HG ' ' HA3' ' A' ' 47' ' ' GLY . 6.6 mt -82.75 130.34 35.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 30.74 111.181 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 11' ' ' ASP . 11.4 m -86.81 64.96 8.78 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.971 -0.558 . . . . 30.81 109.703 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.576 HG22 HD22 ' A' ' 42' ' ' LEU . 30.0 pt -60.94 127.4 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 112.629 0.603 . . . . 30.39 112.629 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -115.14 138.42 50.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.625 -0.716 . . . . 29.61 109.663 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.4 125.37 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.728 0.299 . . . . 31.46 111.794 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.86 -19.72 40.51 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.053 -0.594 . . . . 30.6 113.456 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -76.3 146.6 38.79 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 117.254 0.527 . . . . 35.8 111.639 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.4 pt -109.18 125.16 66.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.852 -0.613 . . . . 30.38 110.147 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.647 HG21 ' CE1' ' A' ' 49' ' ' PHE . 6.1 mm -94.97 119.87 43.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 32.07 110.636 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 88.8 mtm180 -75.75 127.69 33.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 29.72 112.007 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.9 t30 53.07 73.37 0.36 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.798 -0.637 . . . . 29.65 112.133 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.865 HG21 ' HB2' ' A' ' 4' ' ' TYR . 66.4 t -91.85 110.15 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 30.31 111.189 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -107.64 162.82 13.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.868 -0.605 . . . . 38.77 110.546 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.515 ' HA ' HD23 ' A' ' 38' ' ' LEU . 5.7 mmmt -90.14 128.66 36.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 32.94 110.861 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 39' ' ' GLU . 92.8 mt -90.14 179.41 5.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.033 -0.53 . . . . 33.13 110.866 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.09 -3.51 45.7 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.252 -0.431 . . . . 42.18 111.179 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 35.3 mt-10 -100.93 119.08 38.19 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.798 -0.445 . . . . 38.11 109.798 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -60.93 117.65 5.72 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.303 -0.408 . . . . 30.43 110.274 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.08 17.45 34.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.024 -0.608 . . . . 30.13 112.4 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 99.3 m95 -133.55 132.3 40.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.137 0.494 . . . . 30.29 111.016 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 48' ' ' MET . 83.5 mt -119.87 160.91 21.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.317 -0.856 . . . . 30.33 109.936 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.541 ' HB2' HD21 ' A' ' 32' ' ' LEU . 9.1 tp10 -122.92 117.56 25.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.574 0.226 . . . . 38.59 110.674 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.13 164.64 32.45 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.499 -0.857 . . . . 29.85 113.418 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 3.5 mp0 -92.13 117.06 29.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.06 0.457 . . . . 37.88 111.104 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.576 HD22 HG22 ' A' ' 20' ' ' ILE . 55.5 tp -131.87 130.5 41.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.59 -0.732 . . . . 30.38 110.308 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 60.99 26.09 16.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.94 -0.573 . . . . 40.09 111.54 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.37 15.29 69.25 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.715 -0.755 . . . . 31.29 113.954 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -139.02 145.49 39.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.853 0.327 . . . . 44.74 110.422 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -95.46 120.0 34.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.558 -0.534 . . . . 33.12 109.558 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.567 ' HA3' ' HG ' ' A' ' 18' ' ' LEU . . . -149.34 155.42 26.3 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.293 -0.956 . . . . 29.77 113.669 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.618 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 24.8 ptt? -80.96 140.49 35.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.955 0.407 . . . . 35.17 110.9 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.647 ' CE1' HG21 ' A' ' 26' ' ' ILE . 6.1 p90 -141.63 162.68 45.48 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.933 -0.576 . . . . 30.17 111.095 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.564 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 25.9 Cg_exo -62.73 144.07 93.23 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.779 2.32 . . . . 30.28 112.971 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.6 -39.41 67.33 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.728 -0.669 . . . . 32.21 111.84 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -79.83 0.37 31.27 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.061 0.763 . . . . 34.54 113.061 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 9.6 m-85 -98.18 -31.22 12.2 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.494 0.188 . . . . 34.04 110.669 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 25.6 m -110.08 135.14 50.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.401 -0.363 . . . . 31.54 110.53 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -107.09 127.71 53.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 30.59 110.495 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 37.6 tt0 -57.61 136.31 56.78 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.446 -0.343 . . . . 32.19 110.668 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.4 mt -93.82 84.79 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 30.54 110.602 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.132 -0.937 . . . . 40.63 110.89 -179.954 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.816 0.341 . . . . 30.68 111.129 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -88.29 156.91 18.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.166 -0.47 . . . . 27.21 111.368 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.829 ' HB2' HG21 ' A' ' 29' ' ' VAL . 8.9 m-85 -133.38 152.97 51.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.505 -0.771 . . . . 24.84 110.578 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.5 tt -117.84 129.75 73.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.064 -0.516 . . . . 24.6 109.691 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.566 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 21.9 t -69.26 127.18 30.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.369 -0.378 . . . . 16.73 111.316 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.482 ' HG3' ' CD2' ' A' ' 8' ' ' TYR . 14.2 pt-20 -109.48 -19.16 13.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.885 -0.598 . . . . 30.58 110.839 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.482 ' CD2' ' HG3' ' A' ' 7' ' ' GLU . 30.8 m-85 -133.08 142.87 48.96 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.488 -0.323 . . . . 22.64 110.181 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -77.28 129.34 35.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.413 -0.358 . . . . 22.7 110.752 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.486 ' HB3' HG12 ' A' ' 20' ' ' ILE . 77.8 t80 -124.46 130.71 52.97 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.292 -0.413 . . . . 19.88 110.664 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -93.33 113.12 25.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.881 -0.6 . . . . 26.05 110.318 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.89 106.97 1.11 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.049 -0.523 . . . . 26.15 111.326 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -83.76 -36.13 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.757 -0.656 . . . . 31.71 110.177 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -94.02 176.37 6.36 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.891 -0.595 . . . . 37.29 110.596 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -81.3 -33.54 32.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 45.18 110.905 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -80.8 -28.23 36.35 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.363 -0.381 . . . . 35.42 110.552 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.42 134.46 57.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.27 -0.423 . . . . 26.24 111.114 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.634 HD12 ' CD1' ' A' ' 49' ' ' PHE . 28.9 mt -92.42 132.68 36.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.566 -0.743 . . . . 23.56 110.562 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.6 m -84.26 78.91 9.7 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.299 -0.63 . . . . 22.84 109.299 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.668 HG22 ' HG ' ' A' ' 42' ' ' LEU . 33.1 pt -78.42 133.41 30.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.935 0.398 . . . . 24.6 111.752 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -118.24 138.29 52.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 18.72 109.902 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.405 HG22 ' CA ' ' A' ' 8' ' ' TYR . 39.0 t -44.99 120.98 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.283 -0.417 . . . . 17.47 111.743 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.13 -21.01 25.4 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.046 -0.597 . . . . 18.82 113.633 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.618 ' HB3' HD21 ' A' ' 42' ' ' LEU . 39.1 mt-10 -76.32 154.48 35.01 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 117.343 0.572 . . . . 16.59 111.676 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.5 mt -117.29 127.72 74.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.528 -0.76 . . . . 24.6 110.16 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.626 HG21 ' CZ ' ' A' ' 49' ' ' PHE . 4.0 mp -94.94 125.44 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 24.6 110.393 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.607 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 7.7 mpt_? -80.0 125.49 29.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.482 . . . . 21.55 111.851 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.07 65.87 0.95 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.804 -0.634 . . . . 24.05 111.779 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.829 HG21 ' HB2' ' A' ' 4' ' ' TYR . 61.8 t -87.59 105.54 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.841 -0.618 . . . . 26.15 111.238 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -107.37 161.48 14.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.792 -0.64 . . . . 42.51 110.441 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HA ' HD23 ' A' ' 38' ' ' LEU . 39.1 ttmt -84.68 132.14 34.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 33.31 110.468 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.9 tp -91.01 171.01 9.56 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.865 -0.607 . . . . 37.71 110.331 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -77.13 -1.71 30.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.629 0.252 . . . . 40.38 110.855 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 42.3 mt-10 -103.67 122.49 45.15 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.646 -0.501 . . . . 38.54 109.646 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -60.86 117.9 6.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 33.27 110.461 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.05 15.39 45.24 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.99 -0.624 . . . . 28.28 112.833 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 85.6 m95 -132.54 132.47 42.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.163 0.506 . . . . 23.14 111.153 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 48' ' ' MET . 98.0 mt -118.79 162.25 18.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.262 -0.881 . . . . 23.91 110.021 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -123.09 118.36 27.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.577 -0.283 . . . . 43.4 110.439 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.466 ' O ' HD11 ' A' ' 18' ' ' LEU . . . -162.12 170.96 37.91 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.615 -0.802 . . . . 20.08 113.523 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 34.6 mt-10 -94.09 105.86 17.85 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.918 0.39 . . . . 32.1 110.46 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.668 ' HG ' HG22 ' A' ' 20' ' ' ILE . 3.1 tm? -124.49 130.44 52.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.879 -0.601 . . . . 22.89 110.065 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.516 ' HB2' HD13 ' A' ' 42' ' ' LEU . 66.6 t30 64.14 25.1 13.62 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.025 -0.534 . . . . 30.74 110.939 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.38 13.87 79.66 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 121.003 -0.617 . . . . 33.01 113.299 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -130.86 140.22 50.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.851 0.358 . . . . 45.68 110.736 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -91.4 114.03 26.46 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.485 -0.932 . . . . 38.71 108.485 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.541 ' HA3' ' HG ' ' A' ' 18' ' ' LEU . . . -151.19 -168.97 16.34 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.031 -1.081 . . . . 23.54 114.018 -178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.617 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 50.7 mtt -111.77 138.72 47.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.499 -0.351 . . . . 33.81 110.661 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.634 ' CD1' HD12 ' A' ' 18' ' ' LEU . 4.6 p90 -140.59 153.42 68.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 21.48 111.35 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HG2' ' HB2' ' A' ' 53' ' ' PHE . 9.9 Cg_endo -54.05 135.76 65.0 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.87 2.38 . . . . 18.64 112.691 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -67.9 -38.08 82.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.686 -0.688 . . . . 25.32 112.104 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -81.64 5.59 17.75 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.685 0.624 . . . . 25.56 112.685 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.519 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 9.8 m-85 -102.56 -24.82 13.76 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.494 0.188 . . . . 21.91 110.601 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 31.0 m -116.5 137.19 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.307 -0.406 . . . . 20.47 110.401 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -111.24 129.16 56.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 24.52 110.344 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -50.46 141.36 12.25 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.404 -0.362 . . . . 36.5 110.996 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.7 mt -95.33 89.77 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 29.5 110.751 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.55 -0.738 . . . . 44.29 110.879 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.603 0.24 . . . . 33.03 111.034 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.1 152.04 22.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.13 0.49 . . . . 30.12 111.783 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.917 ' HB2' HG21 ' A' ' 29' ' ' VAL . 7.6 m-85 -130.91 152.6 50.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.396 -0.82 . . . . 30.11 110.702 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 55' ' ' LYS . 6.5 tp -113.31 132.93 60.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.937 -0.574 . . . . 30.57 109.804 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.591 ' CG2' HD11 ' A' ' 26' ' ' ILE . 40.5 t -74.42 123.52 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.91 0.386 . . . . 31.15 110.703 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.475 ' HG3' ' CD2' ' A' ' 8' ' ' TYR . 12.5 pt-20 -104.34 -21.18 13.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 37.96 111.113 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.475 ' CD2' ' HG3' ' A' ' 7' ' ' GLU . 60.9 m-85 -133.14 142.52 48.71 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.856 0.36 . . . . 29.97 110.827 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -77.57 128.46 34.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 32.05 110.371 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.505 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 53.0 t80 -128.67 135.98 50.01 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.753 0.311 . . . . 33.98 111.13 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -96.9 119.85 36.16 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.003 -0.544 . . . . 36.69 110.562 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.18 105.17 1.32 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.275 -0.42 . . . . 30.62 111.107 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -87.05 -36.94 10.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.887 -0.597 . . . . 30.56 110.035 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.574 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 52.8 m-70 -89.21 -179.77 5.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.887 -0.597 . . . . 29.61 110.305 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -78.84 -45.82 19.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.502 -0.317 . . . . 35.8 111.029 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -77.93 -23.28 48.66 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.572 -0.286 . . . . 32.58 111.007 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.574 ' HG2' ' HB2' ' A' ' 14' ' ' HIS . 29.6 mm-40 -52.99 132.22 37.32 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.992 0.425 . . . . 36.11 111.012 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.517 HD11 ' HB3' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -95.5 129.01 42.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.639 -0.71 . . . . 30.74 110.589 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.8 m -82.99 86.11 7.05 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.992 -0.744 . . . . 30.81 108.992 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.651 HD11 ' HB3' ' A' ' 53' ' ' PHE . 36.1 pt -87.71 137.59 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 120.92 0.39 . . . . 30.39 111.895 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -116.51 135.55 53.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.811 -0.631 . . . . 29.61 109.974 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -47.21 124.41 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.935 0.398 . . . . 31.46 111.634 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.25 -16.31 42.07 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.763 -0.653 . . . . 30.6 113.322 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.418 ' HB3' HD11 ' A' ' 42' ' ' LEU . 15.6 mm-40 -82.2 150.0 27.6 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 117.278 0.539 . . . . 35.8 111.643 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.1 mt -109.17 128.02 65.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.666 -0.697 . . . . 30.38 110.14 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.591 HD11 ' CG2' ' A' ' 6' ' ' VAL . 4.2 mp -97.03 126.46 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.444 . . . . 32.07 110.58 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.442 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 83.9 mtp180 -76.51 125.75 29.77 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.075 -0.511 . . . . 29.72 112.172 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.2 t30 55.2 69.9 0.69 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.726 -0.67 . . . . 29.65 112.241 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.917 HG21 ' HB2' ' A' ' 4' ' ' TYR . 89.0 t -88.44 106.61 16.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.984 -0.553 . . . . 30.31 110.511 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -103.96 160.22 15.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.874 -0.603 . . . . 38.77 110.88 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.42 ' HA ' ' CD2' ' A' ' 38' ' ' LEU . 63.0 mttp -90.84 132.12 36.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 32.94 110.07 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 39' ' ' GLU . 93.8 mt -94.68 178.67 5.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 33.13 110.871 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.58 0.89 31.97 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.29 -0.414 . . . . 42.18 111.013 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.465 ' HB3' ' HD1' ' A' ' 37' ' ' TRP . 36.1 mt-10 -104.49 120.4 41.17 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.426 -0.583 . . . . 38.11 109.426 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -61.02 118.1 6.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 30.43 110.77 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 94.6 11.87 56.44 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.011 -0.614 . . . . 30.13 113.066 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.596 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 55.3 m95 -129.97 129.88 44.33 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.148 0.499 . . . . 30.29 111.208 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 48' ' ' MET . 90.1 mt -121.96 165.94 15.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.355 -0.839 . . . . 30.33 109.997 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.499 ' HB2' HD21 ' A' ' 32' ' ' LEU . 9.1 tp10 -126.08 122.07 34.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.611 -0.268 . . . . 38.59 110.612 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.465 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -154.76 162.37 30.76 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.635 -0.793 . . . . 29.85 113.283 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.442 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 3.1 mp0 -96.89 104.99 17.05 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.024 0.44 . . . . 37.88 110.945 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.517 ' HB3' HD11 ' A' ' 18' ' ' LEU . 53.0 tp -130.67 138.05 49.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.657 -0.702 . . . . 30.38 110.1 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 67.65 18.99 9.87 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.975 -0.557 . . . . 40.09 110.951 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.47 14.88 67.38 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 120.886 -0.673 . . . . 31.29 113.466 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -142.51 149.06 38.65 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.8 0.334 . . . . 44.74 110.377 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -92.82 116.3 28.91 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.704 -0.85 . . . . 33.12 108.704 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.1 151.75 22.75 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.036 -1.078 . . . . 29.77 114.011 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 62.0 ttp -81.44 135.57 35.64 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.242 -0.479 . . . . 35.17 110.312 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.565 ' CE2' HG21 ' A' ' 26' ' ' ILE . 6.0 p90 -139.49 158.53 68.33 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 30.17 111.236 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.562 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 34.8 Cg_exo -59.01 141.28 98.17 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.672 2.248 . . . . 30.28 112.721 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.31 -36.7 79.72 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.693 -0.685 . . . . 32.21 111.575 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -83.18 4.55 26.21 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.33 0.493 . . . . 34.54 112.33 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.651 ' HB3' HD11 ' A' ' 20' ' ' ILE . 9.2 m-85 -101.3 -21.69 14.81 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 120.621 0.248 . . . . 34.04 110.466 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 24.3 m -120.51 141.62 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.205 -0.452 . . . . 31.54 109.994 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.403 ' O ' HG22 ' A' ' 5' ' ' ILE . 88.4 tttt -116.14 129.07 56.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.388 -0.369 . . . . 30.59 110.689 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -55.14 129.45 38.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.415 -0.357 . . . . 32.19 110.102 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.4 mt -87.65 81.0 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.02 0.438 . . . . 30.54 110.765 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.0 tttm . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.072 -0.966 . . . . 40.63 111.026 -179.763 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.711 0.291 . . . . 30.68 111.325 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -85.62 154.52 21.64 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.226 -0.443 . . . . 27.21 110.748 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.81 ' HB2' HG21 ' A' ' 29' ' ' VAL . 8.3 m-85 -127.95 151.58 48.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 24.84 111.24 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.65 ' HB ' HD11 ' A' ' 57' ' ' ILE . 6.5 tp -112.34 133.2 58.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.667 -0.697 . . . . 24.6 109.328 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 38.3 t -77.34 124.18 35.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.806 0.336 . . . . 16.73 110.791 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.474 ' C ' HG22 ' A' ' 22' ' ' VAL . 19.4 mm-40 -108.44 -17.46 13.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.992 -0.549 . . . . 30.58 111.166 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.492 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 73.9 m-85 -133.71 141.29 47.49 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.673 0.273 . . . . 22.64 110.674 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -77.49 128.35 34.06 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.301 -0.409 . . . . 22.7 110.69 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.463 ' CD1' ' HG3' ' A' ' 50' ' ' PRO . 40.1 t80 -125.81 136.28 52.94 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.492 -0.322 . . . . 19.88 110.841 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -94.17 119.48 33.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.086 -0.506 . . . . 26.05 110.898 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -69.53 104.99 2.49 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.102 -0.499 . . . . 26.15 111.089 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.4 t -89.59 -34.87 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.748 -0.66 . . . . 31.71 110.138 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 43.7 m80 -90.91 172.06 8.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.906 -0.588 . . . . 37.29 110.514 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.68 -36.95 50.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 45.18 110.392 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -92.76 15.37 14.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.135 -0.484 . . . . 35.42 110.901 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.501 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 23.0 tp10 -92.53 127.84 38.17 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.911 -0.404 . . . . 26.24 109.911 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -86.39 124.95 33.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 23.56 111.139 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.2 m -81.18 83.75 6.73 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.274 -0.639 . . . . 22.84 109.274 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.508 ' HB ' ' CG2' ' A' ' 6' ' ' VAL . 38.0 pt -85.42 132.88 30.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.042 0.448 . . . . 24.6 111.709 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 -119.28 138.75 52.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.87 -0.604 . . . . 18.72 110.181 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.474 HG22 ' C ' ' A' ' 7' ' ' GLU . 46.2 t -44.25 120.97 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.841 0.353 . . . . 17.47 111.898 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.51 -19.52 28.79 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.87 -0.604 . . . . 18.82 113.613 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HB3' HD11 ' A' ' 42' ' ' LEU . 35.2 mt-10 -76.19 150.43 37.11 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 117.308 0.554 . . . . 16.59 111.981 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.6 mt -111.81 124.47 68.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.475 -0.784 . . . . 24.6 109.682 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.587 HG21 ' CE2' ' A' ' 49' ' ' PHE . 30.0 mt -97.12 123.15 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 24.6 110.403 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -75.71 133.57 40.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.028 -0.533 . . . . 21.55 112.067 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.7 p30 46.42 71.44 0.3 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.53 -0.759 . . . . 24.05 112.564 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.81 HG21 ' HB2' ' A' ' 4' ' ' TYR . 85.3 t -88.26 110.46 21.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.785 -0.643 . . . . 26.15 110.834 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HG2' ' N ' ' A' ' 31' ' ' LYS . 25.9 ttpp -107.0 160.9 15.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.745 -0.661 . . . . 42.51 110.482 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.404 ' N ' ' HG2' ' A' ' 30' ' ' LYS . 98.3 mttt -88.81 132.41 34.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 33.31 110.03 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 39' ' ' GLU . 95.9 mt -92.34 -179.98 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 37.71 111.166 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -81.36 -0.51 41.55 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.125 -0.489 . . . . 40.38 111.167 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -105.71 120.51 41.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.693 -0.484 . . . . 38.54 109.693 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -59.75 117.88 5.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.465 . . . . 33.27 110.638 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.26 13.02 50.25 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.939 -0.648 . . . . 28.28 112.963 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -131.38 130.13 42.23 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.139 0.495 . . . . 23.14 111.154 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.629 ' O ' ' HA ' ' A' ' 48' ' ' MET . 6.4 mp -119.71 164.39 16.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.295 -0.866 . . . . 23.91 109.525 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HB2' HD21 ' A' ' 32' ' ' LEU . 13.4 tp10 -126.38 122.6 35.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.638 0.256 . . . . 43.4 111.069 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.08 162.47 30.94 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.832 -0.699 . . . . 20.08 112.991 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -96.34 104.87 16.86 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.113 0.482 . . . . 32.1 111.026 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' A' ' 24' ' ' GLU . 59.8 tp -125.53 137.61 53.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.579 -0.737 . . . . 22.89 109.933 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 63.61 21.92 12.93 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.992 -0.549 . . . . 30.74 110.913 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.98 12.93 80.41 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 120.902 -0.666 . . . . 33.01 113.233 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -133.38 142.15 48.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.796 0.332 . . . . 45.68 110.287 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -93.96 114.77 27.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.91 -0.774 . . . . 38.71 108.91 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.53 153.99 25.68 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.299 -0.953 . . . . 23.54 113.344 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.629 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 22.7 ptt? -79.23 145.66 33.47 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.683 0.278 . . . . 33.81 110.369 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.587 ' CE2' HG21 ' A' ' 26' ' ' ILE . 3.8 p90 -143.99 155.66 58.81 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.256 -0.429 . . . . 21.48 111.22 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.574 ' HG2' ' HB2' ' A' ' 53' ' ' PHE . 14.5 Cg_endo -57.55 148.96 69.91 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.755 2.303 . . . . 18.64 112.99 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -73.36 -41.3 63.59 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.443 -0.799 . . . . 25.32 112.791 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -82.53 11.26 5.89 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.991 0.738 . . . . 25.56 112.991 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.574 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 16.3 m-85 -107.38 -27.2 10.61 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.57 0.224 . . . . 21.91 110.778 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 27.5 m -116.88 139.86 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 116.323 -0.398 . . . . 20.47 110.39 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.424 ' O ' HG22 ' A' ' 5' ' ' ILE . 44.4 mmtm -118.37 127.44 53.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.371 -0.377 . . . . 24.52 110.528 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.634 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . 12.8 pt-20 -60.92 131.97 52.37 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.542 -0.299 . . . . 36.5 110.411 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.65 HD11 ' HB ' ' A' ' 5' ' ' ILE . 22.4 mt -87.73 85.59 2.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.114 0.483 . . . . 29.5 110.762 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.445 -0.788 . . . . 44.29 110.856 -179.917 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.749 0.309 . . . . 30.68 111.021 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -84.64 154.57 22.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.275 -0.42 . . . . 27.21 111.306 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.919 ' HB2' HG21 ' A' ' 29' ' ' VAL . 6.4 m-85 -130.76 151.4 51.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.772 -0.649 . . . . 24.84 110.917 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.424 HD13 ' CD1' ' A' ' 25' ' ' ILE . 3.4 tp -113.69 128.09 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.689 -0.687 . . . . 24.6 109.63 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.518 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 29.8 t -73.89 124.37 31.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.422 -0.354 . . . . 16.73 110.794 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.439 ' C ' HG22 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -107.79 -18.95 13.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.028 -0.533 . . . . 30.58 110.929 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -130.49 140.54 50.52 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.706 0.288 . . . . 22.64 110.672 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 21' ' ' ARG . 34.6 m-20 -76.33 131.5 39.23 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.266 -0.424 . . . . 22.7 110.564 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.432 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 44.5 t80 -132.08 131.56 42.5 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.501 -0.318 . . . . 19.88 110.834 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -95.02 119.84 34.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.94 -0.573 . . . . 26.05 110.604 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.454 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -65.08 107.25 1.47 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.013 -0.54 . . . . 26.15 111.56 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.1 p -87.8 -36.47 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.779 -0.646 . . . . 31.71 109.95 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 29.7 m80 -90.37 172.84 8.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.837 -0.62 . . . . 37.29 110.422 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.81 -35.61 43.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.323 -0.399 . . . . 45.18 110.303 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -92.28 9.39 34.11 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.08 -0.509 . . . . 35.42 110.986 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.454 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 22.7 tp10 -87.28 126.78 35.05 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.906 -0.405 . . . . 26.24 109.906 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.644 HD21 ' HB3' ' A' ' 42' ' ' LEU . 11.0 tp -84.92 126.53 33.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 23.56 110.753 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.5 m -83.12 88.44 6.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.887 -0.597 . . . . 22.84 109.394 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.555 HG22 HD22 ' A' ' 42' ' ' LEU . 33.0 pt -89.07 131.06 37.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.813 0.34 . . . . 24.6 111.237 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 9' ' ' ASP . 25.2 mmm180 -117.12 138.78 51.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.154 -0.475 . . . . 18.72 110.105 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.439 HG22 ' C ' ' A' ' 7' ' ' GLU . 48.3 t -45.42 122.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.391 -0.368 . . . . 17.47 111.791 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.82 -18.97 39.5 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.052 -0.594 . . . . 18.82 113.575 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' HB3' HD11 ' A' ' 42' ' ' LEU . 18.2 mm-40 -77.16 147.46 36.49 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.286 0.543 . . . . 16.59 112.264 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.431 HD12 HD11 ' A' ' 57' ' ' ILE . 47.6 mm -107.7 123.02 62.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.462 -0.79 . . . . 24.6 109.894 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.545 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 41.0 mt -95.18 124.18 47.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.389 -0.369 . . . . 24.6 110.535 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.491 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -74.53 128.37 35.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.901 -0.59 . . . . 21.55 112.245 -178.463 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 50.64 70.92 0.46 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.698 -0.683 . . . . 24.05 112.401 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.919 HG21 ' HB2' ' A' ' 4' ' ' TYR . 73.0 t -87.52 107.5 17.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.981 -0.554 . . . . 26.15 110.741 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -103.74 157.08 17.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.719 -0.673 . . . . 42.51 110.475 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -89.27 129.9 35.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.414 . . . . 33.31 109.966 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 39' ' ' GLU . 87.9 mt -91.17 178.33 6.01 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.345 -0.389 . . . . 37.71 111.031 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -79.92 0.96 29.14 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.216 -0.447 . . . . 40.38 111.082 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 3.8 mp0 -105.65 122.0 45.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.463 -0.569 . . . . 38.54 109.463 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -61.55 116.93 5.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.174 -0.466 . . . . 33.27 110.435 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 96.41 12.54 51.04 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.907 -0.663 . . . . 28.28 113.006 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.506 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 44.7 m95 -130.26 129.59 43.49 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.168 0.509 . . . . 23.14 111.088 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.619 ' O ' ' HA ' ' A' ' 48' ' ' MET . 85.1 mt -120.07 165.49 14.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.277 -0.874 . . . . 23.91 109.781 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.531 ' HB2' HD21 ' A' ' 32' ' ' LEU . 38.7 tt0 -126.68 121.63 32.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.694 -0.23 . . . . 43.4 110.783 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.93 164.89 32.96 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.527 -0.844 . . . . 20.08 113.433 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.688 ' HG3' ' HG2' ' A' ' 46' ' ' ARG . 2.9 mp0 -94.1 106.08 18.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.769 0.318 . . . . 32.1 110.59 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.644 ' HB3' HD21 ' A' ' 18' ' ' LEU . 40.1 tp -130.61 137.18 49.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 22.89 110.251 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 64.55 19.73 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 30.74 111.218 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.74 13.5 72.38 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 121.021 -0.609 . . . . 33.01 113.453 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.1 mmt180 -136.3 145.31 45.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.909 0.385 . . . . 45.68 110.739 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.688 ' HG2' ' HG3' ' A' ' 41' ' ' GLU . 31.9 mtp180 -92.69 116.4 28.98 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.914 -0.772 . . . . 38.71 108.914 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.19 -175.14 15.99 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.116 -1.04 . . . . 23.54 113.31 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.619 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.2 ptp -112.7 139.68 48.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.943 -0.392 . . . . 33.81 109.943 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.571 ' HZ ' HG22 ' A' ' 29' ' ' VAL . 3.3 p90 -138.57 159.05 69.17 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.172 -0.467 . . . . 21.48 111.315 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.552 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 36.4 Cg_exo -60.98 136.62 66.75 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.625 2.217 . . . . 18.64 112.355 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -67.68 -36.2 80.26 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.924 -0.58 . . . . 25.32 111.48 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -79.24 2.11 22.38 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.725 0.639 . . . . 25.56 112.725 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 9.7 m-85 -102.81 -23.49 13.78 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.554 0.216 . . . . 21.91 110.852 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.479 HG12 HG22 ' A' ' 6' ' ' VAL . 30.9 m -120.63 139.43 47.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.274 -0.421 . . . . 20.47 110.364 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -112.97 133.29 55.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.345 -0.389 . . . . 24.52 110.503 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -54.74 137.76 43.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.334 -0.394 . . . . 36.5 110.436 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.431 HD11 HD12 ' A' ' 25' ' ' ILE . 64.7 mt -91.27 86.0 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.002 0.43 . . . . 29.5 110.764 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.426 ' HD3' ' C ' ' A' ' 58' ' ' LYS . 7.6 tmtm? . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.02 -0.991 . . . . 44.29 110.583 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.753 0.311 . . . . 33.03 111.029 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.03 159.02 16.35 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.103 0.478 . . . . 30.12 111.49 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.931 ' HB2' HG21 ' A' ' 29' ' ' VAL . 7.8 m-85 -131.34 153.36 49.69 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.528 -0.76 . . . . 30.11 111.079 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.545 ' HB ' HD11 ' A' ' 57' ' ' ILE . 17.2 tt -111.45 138.06 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.573 . . . . 30.57 109.607 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.461 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 25.1 t -80.78 121.02 33.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.431 -0.35 . . . . 31.15 110.744 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -104.77 -19.35 13.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.086 -0.506 . . . . 37.96 111.148 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -132.84 140.42 47.94 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.53 -0.305 . . . . 29.97 110.363 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.56 130.13 36.53 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.26 -0.427 . . . . 32.05 110.87 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.471 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 47.6 t80 -129.98 136.48 49.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.943 -0.571 . . . . 33.98 110.371 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.87 120.61 40.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.139 -0.482 . . . . 36.69 110.537 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.457 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -64.3 109.07 1.77 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.076 -0.511 . . . . 30.62 111.695 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.1 t -89.02 -36.35 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.63 -0.714 . . . . 30.56 109.747 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 43.3 m80 -92.19 175.02 7.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.767 -0.651 . . . . 29.61 110.621 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.2 -36.54 47.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.193 -0.458 . . . . 35.8 110.567 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 48' ' ' MET . 1.9 p30 -93.0 12.96 22.17 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.035 -0.53 . . . . 32.58 111.038 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.457 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 17.5 tp10 -91.54 129.98 37.43 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.801 -0.444 . . . . 36.11 109.801 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 19' ' ' THR . 0.4 OUTLIER -89.31 124.88 34.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.753 0.311 . . . . 30.74 111.328 -179.521 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.626 ' N ' HD13 ' A' ' 18' ' ' LEU . 32.9 m -81.49 86.13 6.38 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.107 -0.701 . . . . 30.81 109.107 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 53' ' ' PHE . 29.8 pt -87.28 135.31 25.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.396 -0.365 . . . . 30.39 111.51 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.3 mtp85 -119.06 138.19 53.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.136 -0.484 . . . . 29.61 110.165 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.3 t -45.32 122.72 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.894 0.378 . . . . 31.46 111.904 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.63 -18.77 34.59 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.824 -0.625 . . . . 30.6 113.567 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.49 ' HB3' HD11 ' A' ' 42' ' ' LEU . 32.6 mt-10 -76.09 155.19 34.97 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.365 0.582 . . . . 35.8 111.931 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.3 mt -115.53 125.75 72.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.45 -0.795 . . . . 30.38 109.749 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.754 ' CD1' HD22 ' A' ' 42' ' ' LEU . 5.5 mm -91.27 120.44 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 32.07 110.756 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.38 122.21 23.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.285 -0.416 . . . . 29.72 112.107 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 57.97 70.76 0.63 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.753 -0.658 . . . . 29.65 112.61 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.931 HG21 ' HB2' ' A' ' 4' ' ' TYR . 59.8 t -86.39 108.6 17.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.297 -0.41 . . . . 30.31 111.088 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -105.16 155.97 18.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.802 -0.635 . . . . 38.77 110.358 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HA ' HD13 ' A' ' 38' ' ' LEU . 69.0 mttm -82.06 127.75 33.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 32.94 110.264 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 tp -88.42 170.89 10.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 33.13 110.308 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -78.91 0.85 25.7 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.67 -0.241 . . . . 42.18 110.867 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.503 ' HB3' ' HD1' ' A' ' 37' ' ' TRP . 2.9 mp0 -104.55 116.17 31.61 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.565 -0.532 . . . . 38.11 109.565 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.92 121.82 10.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 30.43 110.991 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.42 14.78 56.67 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.862 -0.685 . . . . 30.13 113.031 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.503 ' HD1' ' HB3' ' A' ' 34' ' ' GLU . 92.5 m95 -134.01 132.28 39.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.156 0.503 . . . . 30.29 110.951 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 48' ' ' MET . 3.7 mm? -117.33 163.43 16.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.295 -0.866 . . . . 30.33 109.735 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 10.7 tp10 -123.48 119.81 31.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.774 -0.194 . . . . 38.59 110.482 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.461 ' HA3' HG22 ' A' ' 26' ' ' ILE . . . -153.09 161.51 29.67 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.468 -0.872 . . . . 29.85 113.514 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -95.15 106.61 18.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.084 0.468 . . . . 37.88 110.825 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.754 HD22 ' CD1' ' A' ' 26' ' ' ILE . 30.3 tp -132.93 142.13 48.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.668 -0.696 . . . . 30.38 110.073 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.3 m120 65.46 17.49 10.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.726 -0.67 . . . . 40.09 111.181 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.28 15.51 62.21 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 121.005 -0.617 . . . . 31.29 113.492 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -145.24 151.95 39.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.745 0.307 . . . . 44.74 110.44 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -95.31 119.04 33.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.11 -0.7 . . . . 33.12 109.11 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -145.73 150.01 22.19 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.554 -0.832 . . . . 29.77 113.079 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 22.8 ptp -78.62 145.46 34.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.718 0.294 . . . . 35.17 110.373 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 26' ' ' ILE . 3.4 p90 -143.2 157.64 59.81 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.024 -0.535 . . . . 30.17 111.179 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.54 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 27.2 Cg_exo -61.8 145.58 97.11 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.678 2.252 . . . . 30.28 112.821 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.95 -37.39 78.82 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.617 -0.719 . . . . 32.21 112.077 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -78.74 4.71 13.05 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.9 0.704 . . . . 34.54 112.9 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.561 ' HB3' HD11 ' A' ' 20' ' ' ILE . 13.2 m-85 -107.81 -24.23 11.76 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.491 0.186 . . . . 34.04 111.307 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.568 HG21 ' CE1' ' A' ' 49' ' ' PHE . 29.1 m -121.03 139.95 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 110.113 -0.329 . . . . 31.54 110.113 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -122.24 131.93 54.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.446 -0.343 . . . . 30.59 110.41 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -54.65 131.26 42.92 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.425 -0.352 . . . . 32.19 110.64 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.545 HD11 ' HB ' ' A' ' 5' ' ' ILE . 44.2 mt -87.41 84.54 2.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.071 0.462 . . . . 30.54 110.763 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 96.1 mttt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.084 -0.96 . . . . 40.63 110.882 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.754 0.311 . . . . 30.68 111.104 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -83.61 157.51 22.24 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.242 -0.435 . . . . 27.210000000000001 111.196 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.851 ' HB2' HG21 ' A' ' 29' ' ' VAL . 7.4 m-85 -134.16 151.92 51.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.829 -0.623 . . . . 24.84 110.81 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.664 ' HB ' HD11 ' A' ' 57' ' ' ILE . 13.8 tt -113.81 134.03 57.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.402 -0.592 . . . . 24.600000000000001 109.402 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 37.0 t -76.67 123.63 33.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.917 0.389 . . . . 16.73 110.828 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -106.49 -21.18 13.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.931 -0.577 . . . . 30.579999999999998 111.002 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.92 141.26 48.27 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.521 -0.308 . . . . 22.640000000000001 110.436 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -74.75 129.3 37.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 22.699999999999999 110.984 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.574 ' HB3' HG12 ' A' ' 20' ' ' ILE . 54.2 t80 -127.11 132.94 50.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.928 -0.578 . . . . 19.879999999999999 110.183 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -100.02 116.65 32.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.009 -0.541 . . . . 26.050000000000001 110.638 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.83 107.33 0.96 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.016 -0.538 . . . . 26.149999999999999 111.143 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.7 t -77.66 -39.35 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.925 -0.58 . . . . 31.710000000000001 109.83 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.722 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 46.5 m-70 -98.31 178.15 5.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.753 -0.658 . . . . 37.289999999999999 110.712 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -81.71 -27.13 34.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.033 -0.531 . . . . 45.18 111.092 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -92.09 5.87 48.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.511 -0.313 . . . . 35.420000000000002 111.098 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.722 ' HG2' ' HB2' ' A' ' 14' ' ' HIS . 40.3 mm-40 -94.42 135.35 35.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 110.013 -0.366 . . . . 26.239999999999998 110.013 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.44 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -89.6 125.7 35.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.94 -0.573 . . . . 23.559999999999999 110.835 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.3 m -83.08 86.18 7.05 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.32 -0.622 . . . . 22.84 109.32 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.574 HG12 ' HB3' ' A' ' 10' ' ' TYR . 43.4 pt -84.7 136.82 21.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.161 -0.472 . . . . 24.600000000000001 111.906 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -119.8 137.78 53.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.862 -0.608 . . . . 18.719999999999999 110.187 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.5 t -45.72 122.51 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.078 0.399 . . . . 17.469999999999999 112.078 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.14 -18.22 36.63 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.846 -0.616 . . . . 18.82 113.69 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.49 ' HB3' HD11 ' A' ' 42' ' ' LEU . 32.8 mt-10 -78.31 152.76 32.24 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.395 0.598 . . . . 16.59 112.107 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.5 mm -112.38 125.23 69.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.493 -0.776 . . . . 24.600000000000001 109.743 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.592 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 40.4 mt -96.98 125.03 50.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 24.600000000000001 110.782 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.531 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 78.2 ttt180 -75.55 125.88 29.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.775 -0.648 . . . . 21.550000000000001 112.422 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 54.41 68.74 0.81 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.697 -0.683 . . . . 24.050000000000001 112.413 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.851 HG21 ' HB2' ' A' ' 4' ' ' TYR . 91.6 t -88.43 107.94 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 26.149999999999999 110.839 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -108.4 164.6 12.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.844 -0.616 . . . . 42.509999999999998 110.623 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HA ' HD23 ' A' ' 38' ' ' LEU . 40.4 ttmt -90.59 133.46 35.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.289 -0.414 . . . . 33.310000000000002 110.517 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.463 HD21 ' HB2' ' A' ' 39' ' ' GLU . 94.5 mt -96.17 -177.77 4.1 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.976 -0.556 . . . . 37.710000000000001 110.955 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -81.83 -0.2 42.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.309 -0.405 . . . . 40.380000000000003 111.226 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 31.6 mt-10 -103.38 115.88 31.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.745 -0.465 . . . . 38.539999999999999 109.745 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -58.12 118.46 5.47 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.258 -0.428 . . . . 33.270000000000003 110.575 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 93.85 14.15 53.12 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.936 -0.65 . . . . 28.280000000000001 113.012 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.481 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 80.9 m95 -133.75 132.72 40.87 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.125 0.488 . . . . 23.140000000000001 110.704 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.598 ' O ' ' HA ' ' A' ' 48' ' ' MET . 94.7 mt -120.08 166.6 13.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.272 -0.876 . . . . 23.91 110.087 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.463 ' HB2' HD21 ' A' ' 32' ' ' LEU . 14.0 tp10 -125.97 120.61 30.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.55 -0.296 . . . . 43.399999999999999 110.636 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.16 163.36 31.43 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.729 -0.748 . . . . 20.079999999999998 113.118 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 27' ' ' ARG . 1.9 tm-20 -95.05 103.79 15.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.037 0.446 . . . . 32.100000000000001 110.462 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.501 ' CD2' HG22 ' A' ' 20' ' ' ILE . 45.8 tp -129.82 140.71 50.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.535 -0.757 . . . . 22.890000000000001 110.113 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 65.0 18.26 11.43 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.032 -0.531 . . . . 30.739999999999998 111.192 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.2 14.36 66.74 Favored Glycine 0 C--N 1.341 0.815 0 C-N-CA 120.992 -0.623 . . . . 33.009999999999998 113.331 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -140.94 149.29 41.65 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.826 0.346 . . . . 45.68 110.8 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -94.8 115.26 27.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.928 -0.767 . . . . 38.710000000000001 108.928 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.9 -176.54 14.69 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.259 -0.972 . . . . 23.539999999999999 113.613 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.598 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 54.8 mtt -111.62 133.77 53.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.491 -0.355 . . . . 33.810000000000002 110.162 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.514 ' HZ ' HG22 ' A' ' 29' ' ' VAL . 4.8 p90 -136.51 156.92 76.13 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.273 -0.422 . . . . 21.48 111.473 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.591 ' HG2' ' HB2' ' A' ' 53' ' ' PHE . 19.6 Cg_endo -58.99 136.56 74.2 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.741 2.294 . . . . 18.640000000000001 112.436 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.75 -38.18 83.12 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.791 -0.641 . . . . 25.32 111.849 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -78.29 4.74 12.03 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.808 0.67 . . . . 25.559999999999999 112.808 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.591 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 5.3 m-85 -105.25 -22.33 13.08 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.494 0.188 . . . . 21.91 110.996 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 18.3 m -117.36 141.07 37.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.467 -0.333 . . . . 20.469999999999999 110.65 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.4 ' O ' HG22 ' A' ' 5' ' ' ILE . 17.5 tppt? -113.63 125.24 53.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 24.52 110.306 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -51.69 141.47 16.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.439 -0.346 . . . . 36.5 110.993 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.664 HD11 ' HB ' ' A' ' 5' ' ' ILE . 39.4 mm -85.97 93.32 3.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.167 -0.47 . . . . 29.5 110.458 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.099 -0.953 . . . . 44.289999999999999 110.824 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.746 0.307 . . . . 30.68 111.186 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.41 149.03 25.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.023 0.44 . . . . 27.210000000000001 111.132 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.86 ' HB2' HG21 ' A' ' 29' ' ' VAL . 6.8 m-85 -129.04 152.73 48.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.626 -0.715 . . . . 24.84 110.709 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.406 ' HB ' HD11 ' A' ' 57' ' ' ILE . 18.2 tt -114.84 136.36 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 24.600000000000001 109.703 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.561 ' CG2' HD11 ' A' ' 26' ' ' ILE . 36.8 t -74.29 122.06 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 16.73 110.83 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.43 ' HG3' ' CD2' ' A' ' 8' ' ' TYR . 11.9 pt-20 -103.1 -20.76 14.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.914 -0.584 . . . . 30.579999999999998 111.065 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.43 ' CD2' ' HG3' ' A' ' 7' ' ' GLU . 61.2 m-85 -134.52 141.86 46.84 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.844 0.354 . . . . 22.640000000000001 110.653 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -79.22 127.57 32.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.038 -0.528 . . . . 22.699999999999999 110.441 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.498 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 34.8 t80 -125.47 137.12 53.97 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.381 -0.372 . . . . 19.879999999999999 111.019 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -94.82 119.12 32.87 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.063 -0.517 . . . . 26.050000000000001 110.38 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.512 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -66.46 103.38 1.03 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.273 -0.421 . . . . 26.149999999999999 111.469 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.07 -33.78 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.887 -0.597 . . . . 31.710000000000001 110.265 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.514 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 53.0 m80 -90.52 178.2 6.16 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.93 -0.577 . . . . 37.289999999999999 109.968 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.58 -46.05 20.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.665 -0.243 . . . . 45.18 110.693 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.13 -22.26 52.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.25 -0.432 . . . . 35.420000000000002 110.84 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 14' ' ' HIS . 16.0 tp10 -52.71 125.53 16.99 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.898 0.38 . . . . 26.239999999999998 110.908 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.39 127.61 36.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.934 -0.575 . . . . 23.559999999999999 110.61 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.8 m -80.92 86.28 6.09 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.005 -0.739 . . . . 22.84 109.005 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.684 HD11 ' HB3' ' A' ' 53' ' ' PHE . 23.8 pt -91.6 137.3 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.002 0.429 . . . . 24.600000000000001 111.794 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -118.38 139.18 51.77 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.862 -0.608 . . . . 18.719999999999999 109.966 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.403 HG22 ' CA ' ' A' ' 8' ' ' TYR . 40.6 t -47.57 124.76 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 111.994 0.368 . . . . 17.469999999999999 111.994 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.77 -18.24 37.7 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.848 -0.614 . . . . 18.82 113.527 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.742 ' HB3' HD11 ' A' ' 42' ' ' LEU . 41.7 mt-10 -78.14 153.59 31.95 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 117.263 0.531 . . . . 16.59 111.821 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.0 pt -112.65 125.93 69.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.665 -0.698 . . . . 24.600000000000001 110.245 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.634 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 3.9 mp -97.49 124.87 50.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.47 . . . . 24.600000000000001 110.405 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.521 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 40.2 ttm180 -78.46 127.58 32.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.265 -0.425 . . . . 21.550000000000001 112.032 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 61.5 t30 57.37 67.33 0.99 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.671 -0.695 . . . . 24.050000000000001 112.09 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.86 HG21 ' HB2' ' A' ' 4' ' ' TYR . 76.1 t -91.12 108.39 19.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 26.149999999999999 110.864 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -110.89 167.1 10.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.896 -0.593 . . . . 42.509999999999998 110.929 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -92.67 135.64 33.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.945 -0.571 . . . . 33.310000000000002 110.333 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.553 HD21 ' HB2' ' A' ' 39' ' ' GLU . 95.1 mt -96.16 -177.42 3.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 37.710000000000001 110.987 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -81.41 -0.19 40.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.267 -0.424 . . . . 40.380000000000003 111.349 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HB3' ' HD1' ' A' ' 37' ' ' TRP . 38.6 mt-10 -105.57 121.6 44.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.84 -0.43 . . . . 38.539999999999999 109.84 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.0 117.83 5.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.039 -0.528 . . . . 33.270000000000003 110.767 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 94.44 11.23 57.38 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.003 -0.618 . . . . 28.280000000000001 113.123 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.505 ' C ' HD12 ' A' ' 38' ' ' LEU . 69.6 m95 -130.29 129.0 42.69 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.168 0.509 . . . . 23.140000000000001 111.103 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 48' ' ' MET . 8.0 mp -121.45 168.64 11.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.316 -0.856 . . . . 23.91 109.982 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.553 ' HB2' HD21 ' A' ' 32' ' ' LEU . 10.8 tp10 -127.05 123.04 36.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.487 -0.324 . . . . 43.399999999999999 110.877 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.438 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -155.49 163.41 31.6 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.622 -0.799 . . . . 20.079999999999998 113.42 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 27' ' ' ARG . 22.9 mt-10 -97.5 104.36 16.38 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.843 0.354 . . . . 32.100000000000001 110.921 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.742 HD11 ' HB3' ' A' ' 24' ' ' GLU . 43.1 tp -128.24 138.29 52.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 22.890000000000001 110.387 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.405 ' OD1' ' HG ' ' A' ' 42' ' ' LEU . 19.8 m120 63.37 21.95 13.04 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.893 -0.594 . . . . 30.739999999999998 111.21 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.7 12.79 76.98 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 121.007 -0.616 . . . . 33.009999999999998 113.476 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -135.32 144.53 46.76 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.819 0.342 . . . . 45.68 110.502 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -92.23 114.3 26.8 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.246 -1.02 . . . . 38.710000000000001 108.246 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.56 154.4 25.15 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.807 -1.187 . . . . 23.539999999999999 114.316 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.592 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 37.7 ttm -81.44 137.72 35.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.857 -0.671 . . . . 33.810000000000002 110.134 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' A' ' 26' ' ' ILE . 3.0 p90 -140.69 159.81 61.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.437 -0.347 . . . . 21.48 111.213 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.564 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 34.1 Cg_exo -61.03 145.9 98.46 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.688 2.259 . . . . 18.640000000000001 112.839 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.484 ' HA ' HD13 ' A' ' 38' ' ' LEU . 24.3 t70 -67.45 -38.4 84.44 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.734 -0.666 . . . . 25.32 111.997 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -85.67 9.32 16.58 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.37 0.507 . . . . 25.559999999999999 112.37 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.684 ' HB3' HD11 ' A' ' 20' ' ' ILE . 9.1 m-85 -105.11 -24.42 12.77 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.553 0.216 . . . . 21.91 110.432 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 20.2 m -115.45 137.8 47.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.21 -0.45 . . . . 20.469999999999999 109.927 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -115.64 124.2 50.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.4 -0.364 . . . . 24.52 110.591 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 38.0 tt0 -55.68 132.08 48.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.322 -0.399 . . . . 36.5 110.671 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.406 HD11 ' HB ' ' A' ' 5' ' ' ILE . 45.8 mt -93.5 75.64 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.205 0.526 . . . . 29.5 110.386 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.56 -0.734 . . . . 44.289999999999999 110.881 -179.893 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.724 0.297 . . . . 33.030000000000001 111.344 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.71 157.26 19.68 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.155 -0.475 . . . . 30.120000000000001 111.093 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.835 ' HB2' HG21 ' A' ' 29' ' ' VAL . 8.1 m-85 -133.2 151.51 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.864 -0.607 . . . . 30.109999999999999 110.88 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 55' ' ' LYS . 15.4 tt -109.56 137.03 43.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.339 -0.615 . . . . 30.57 109.339 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.584 HG21 ' HB ' ' A' ' 20' ' ' ILE . 37.4 t -79.94 119.03 28.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.879 0.371 . . . . 31.149999999999999 110.798 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -102.58 -20.04 14.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.993 -0.549 . . . . 37.960000000000001 110.976 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -130.62 138.01 49.9 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.565 -0.289 . . . . 29.969999999999999 110.634 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -75.02 127.64 33.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 32.049999999999997 110.594 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.489 ' HB3' HG12 ' A' ' 20' ' ' ILE . 68.1 t80 -117.82 132.78 56.4 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.185 -0.461 . . . . 33.979999999999997 110.317 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -93.68 154.71 17.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 36.689999999999998 110.759 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.46 116.02 6.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 30.620000000000001 110.51 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.55 -27.91 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.92 -0.582 . . . . 30.559999999999999 110.445 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.65 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 52.0 m80 -148.54 -179.22 6.8 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.123 -0.49 . . . . 29.609999999999999 110.177 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -76.32 -29.32 57.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 35.799999999999997 110.841 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -94.09 6.78 47.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.371 -0.377 . . . . 32.579999999999998 111.524 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.65 ' HG2' ' HB2' ' A' ' 14' ' ' HIS . 45.0 mm-40 -95.95 131.66 42.08 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 110.238 -0.282 . . . . 36.109999999999999 110.238 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -88.69 123.83 33.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 30.739999999999998 111.129 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 37.0 m -81.62 84.91 6.64 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.081 -0.711 . . . . 30.809999999999999 109.081 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 53' ' ' PHE . 35.1 pt -90.06 142.64 12.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.746 -0.661 . . . . 30.390000000000001 111.743 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.417 ' HD3' ' N ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -121.2 142.5 49.84 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.126 -0.488 . . . . 29.609999999999999 110.107 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -49.5 124.78 2.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 112.014 0.376 . . . . 31.460000000000001 112.014 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.1 -16.67 45.74 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.864 -0.607 . . . . 30.600000000000001 113.686 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.0 156.68 25.79 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 117.468 0.634 . . . . 35.799999999999997 112.018 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.9 mm -113.82 127.9 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.364 -0.834 . . . . 30.379999999999999 110.124 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.59 HD12 HG11 ' A' ' 54' ' ' VAL . 36.6 mt -98.46 125.75 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 32.07 110.834 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.573 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 75.8 mtm180 -71.77 124.5 24.94 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.833 -0.621 . . . . 29.719999999999999 112.553 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 49.37 72.68 0.29 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.65 -0.705 . . . . 29.649999999999999 112.491 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.835 HG21 ' HB2' ' A' ' 4' ' ' TYR . 71.6 t -86.59 109.0 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 30.309999999999999 110.325 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -105.42 158.96 16.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.81 -0.632 . . . . 38.770000000000003 110.688 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -90.18 134.17 34.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.701 -0.481 . . . . 32.939999999999998 109.701 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.444 HD11 ' HG2' ' A' ' 48' ' ' MET . 91.1 mt -97.16 -177.55 3.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.401 -0.363 . . . . 33.130000000000003 111.19 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.9 2.57 33.77 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.257 -0.428 . . . . 42.18 111.214 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 4.8 mp0 -105.73 116.31 31.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.318 -0.623 . . . . 38.109999999999999 109.318 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.78 118.02 5.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.263 -0.426 . . . . 30.43 110.651 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 96.17 9.14 57.28 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.899 -0.667 . . . . 30.129999999999999 113.408 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 73.4 m95 -130.98 130.54 43.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.245 0.545 . . . . 30.289999999999999 111.087 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 48' ' ' MET . 6.6 mp -120.74 168.79 11.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.121 -0.945 . . . . 30.329999999999998 109.663 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.426 ' HB2' HD21 ' A' ' 32' ' ' LEU . 40.1 tt0 -128.21 123.96 35.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.647 0.26 . . . . 38.590000000000003 110.732 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.448 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -151.26 160.18 28.56 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.754 -0.736 . . . . 29.850000000000001 112.829 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 3.3 mp0 -97.2 102.93 14.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.068 0.461 . . . . 37.880000000000003 110.946 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.553 ' CD2' HG22 ' A' ' 20' ' ' ILE . 54.9 tp -125.81 138.12 53.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.65 -0.704 . . . . 30.379999999999999 109.989 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 62.5 21.15 12.43 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.091 -0.504 . . . . 40.090000000000003 111.471 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.93 9.46 80.72 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 120.937 -0.649 . . . . 31.289999999999999 113.6 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -132.18 141.39 49.08 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.687 0.28 . . . . 44.740000000000002 110.407 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -91.86 114.69 27.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.617 -0.882 . . . . 33.119999999999997 108.617 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.26 179.91 16.94 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.267 -0.968 . . . . 29.77 113.509 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.585 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 77.3 mtp -111.2 134.89 52.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.441 -0.379 . . . . 35.170000000000002 110.227 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.513 ' CE2' HD13 ' A' ' 26' ' ' ILE . 2.0 p90 -135.36 159.09 73.04 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.151 -0.477 . . . . 30.170000000000002 110.999 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 33.6 Cg_exo -61.06 148.74 91.95 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.708 2.272 . . . . 30.280000000000001 112.815 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.43 -39.06 85.44 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.761 -0.654 . . . . 32.210000000000001 111.794 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -87.35 15.3 6.6 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.307 0.484 . . . . 34.539999999999999 112.307 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.586 ' HB3' HD11 ' A' ' 20' ' ' ILE . 4.9 m-85 -106.71 -24.98 11.94 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 120.527 0.203 . . . . 34.039999999999999 110.603 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.59 HG11 HD12 ' A' ' 26' ' ' ILE . 28.2 m -124.31 144.81 32.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.178 -0.464 . . . . 31.539999999999999 110.54 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.458 ' O ' HG22 ' A' ' 5' ' ' ILE . 63.6 tttm -122.03 128.74 51.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 30.59 110.108 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -52.83 136.28 34.34 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.62 0.248 . . . . 32.189999999999998 110.788 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.578 HG23 ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -84.1 103.75 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.371 0.605 . . . . 30.539999999999999 110.375 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.135 -0.936 . . . . 40.630000000000003 110.745 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.73 0.3 . . . . 33.030000000000001 111.156 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -79.95 150.78 30.38 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.989 0.423 . . . . 30.120000000000001 111.497 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.858 ' HB2' HG21 ' A' ' 29' ' ' VAL . 10.4 m-85 -130.37 151.79 50.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.613 -0.721 . . . . 30.109999999999999 110.72 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.4 tt -120.07 124.35 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 30.57 109.89 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 25.3 t -63.82 129.65 27.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 31.149999999999999 111.319 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -109.92 -25.31 10.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.656 -0.702 . . . . 37.960000000000001 110.428 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -132.79 139.19 47.41 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.288 -0.415 . . . . 29.969999999999999 110.283 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -69.0 141.96 54.76 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.331 -0.395 . . . . 32.049999999999997 111.029 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -135.95 126.07 26.22 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.232 -0.44 . . . . 33.979999999999997 110.855 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -82.59 117.38 22.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 36.689999999999998 111.321 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.94 104.89 3.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.939 -0.573 . . . . 30.620000000000001 110.945 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.6 t -85.95 -37.26 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.797 -0.638 . . . . 30.559999999999999 110.169 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.602 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 55.3 m-70 -89.59 174.11 7.94 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.96 -0.564 . . . . 29.609999999999999 110.795 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -81.19 -31.34 34.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.117 -0.492 . . . . 35.799999999999997 110.965 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -100.0 16.74 22.96 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.493 -0.321 . . . . 32.579999999999998 110.724 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 14' ' ' HIS . 22.6 tt0 -96.93 125.94 41.71 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.906 -0.405 . . . . 36.109999999999999 109.906 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.687 HD12 ' CD1' ' A' ' 49' ' ' PHE . 35.3 mt -79.94 133.5 36.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.863 0.363 . . . . 30.739999999999998 111.064 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 m -87.17 55.16 3.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.848 -0.614 . . . . 30.809999999999999 110.527 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.553 HG22 HD22 ' A' ' 42' ' ' LEU . 22.1 pt -48.81 120.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 112.546 0.573 . . . . 30.390000000000001 112.546 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -113.43 136.46 52.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.394 -0.821 . . . . 29.609999999999999 109.292 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -43.09 122.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.733 0.301 . . . . 31.460000000000001 111.715 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.42 -18.41 38.57 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.075 -0.583 . . . . 30.600000000000001 113.813 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.428 ' HB3' HD11 ' A' ' 42' ' ' LEU . 41.8 mt-10 -80.03 147.28 31.57 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 117.554 0.677 . . . . 35.799999999999997 111.534 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 25' ' ' ILE . 4.4 mp -111.79 127.79 68.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.805 -0.634 . . . . 30.379999999999999 110.311 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.53 HG21 ' CE1' ' A' ' 49' ' ' PHE . 3.9 mp -96.07 122.28 47.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.28 -0.418 . . . . 32.07 110.287 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.569 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 22.0 mmm180 -74.31 127.74 33.76 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.083 -0.508 . . . . 29.719999999999999 112.073 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 52.39 73.42 0.34 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.816 -0.629 . . . . 29.649999999999999 112.176 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.858 HG21 ' HB2' ' A' ' 4' ' ' TYR . 55.9 t -88.77 110.57 21.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.973 -0.558 . . . . 30.309999999999999 111.507 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -102.48 154.97 18.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.699 -0.682 . . . . 38.770000000000003 109.923 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.455 ' HA ' HD23 ' A' ' 38' ' ' LEU . 86.1 tttt -80.48 123.35 28.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.953 0.406 . . . . 32.939999999999998 110.988 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.1 tp -77.83 162.77 26.64 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.774 -0.648 . . . . 33.130000000000003 110.068 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -61.75 -28.81 69.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.487 -0.324 . . . . 42.18 110.79 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -83.95 129.87 34.91 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.805 0.336 . . . . 38.109999999999999 110.761 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.61 122.42 16.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.864 -0.607 . . . . 30.43 109.675 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 94.06 18.04 38.36 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 30.129999999999999 112.342 -178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -134.46 135.18 42.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.105 0.479 . . . . 30.289999999999999 110.484 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 48' ' ' MET . 81.0 mt -124.73 161.71 25.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.345 -0.843 . . . . 30.329999999999998 110.022 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.43 119.45 28.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.103 -0.332 . . . . 38.590000000000003 110.103 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.504 ' O ' HD11 ' A' ' 18' ' ' LEU . . . -157.23 165.67 33.38 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.417 -0.897 . . . . 29.850000000000001 113.405 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.569 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 2.0 tm-20 -86.79 109.38 19.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.942 0.401 . . . . 37.880000000000003 110.079 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.591 ' HB3' HD13 ' A' ' 18' ' ' LEU . 57.8 tp -132.03 134.09 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.665 -0.698 . . . . 30.379999999999999 110.371 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 64.18 21.39 12.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.922 -0.581 . . . . 40.090000000000003 111.398 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.61 18.66 59.73 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 120.97 -0.633 . . . . 31.289999999999999 113.553 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -144.45 150.91 38.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.777 0.322 . . . . 44.740000000000002 110.645 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.8 tpp180 -94.19 115.98 28.33 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.989 -0.745 . . . . 33.119999999999997 108.989 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.499 ' HA3' ' HG ' ' A' ' 18' ' ' LEU . . . -141.07 -170.83 12.32 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.322 -0.942 . . . . 29.77 113.442 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.594 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 45.8 mtt -119.07 138.05 53.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.547 -0.326 . . . . 35.170000000000002 110.158 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.687 ' CD1' HD12 ' A' ' 18' ' ' LEU . 4.5 p90 -143.23 158.92 57.26 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 30.170000000000002 111.475 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.515 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 37.6 Cg_exo -57.35 141.46 94.79 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.817 2.344 . . . . 30.280000000000001 112.941 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -75.45 -39.04 59.3 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.563 -0.744 . . . . 32.210000000000001 111.453 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -76.35 -3.98 39.74 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.741 0.645 . . . . 34.539999999999999 112.741 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 6.9 m-85 -93.7 -34.15 13.36 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 110.336 -0.246 . . . . 34.039999999999999 110.336 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.655 HG21 ' HE2' ' A' ' 49' ' ' PHE . 24.7 m -102.72 143.55 14.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.198 -0.456 . . . . 31.539999999999999 110.214 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -109.99 130.44 55.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.355 -0.384 . . . . 30.59 110.808 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -52.0 132.21 32.3 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.127 -0.488 . . . . 32.189999999999998 110.582 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.9 mt -92.51 81.68 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.044 0.45 . . . . 30.539999999999999 110.437 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.037 -0.982 . . . . 40.630000000000003 111.217 -179.926 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.422 HG23 ' HE1' ' A' ' 4' ' ' TYR . 7.8 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.729 0.3 . . . . 33.030000000000001 111.364 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -80.65 149.82 29.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.152 -0.476 . . . . 30.120000000000001 110.734 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.865 ' HB2' HG21 ' A' ' 29' ' ' VAL . 9.0 m-85 -128.87 151.37 49.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.81 -0.632 . . . . 30.109999999999999 110.891 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.3 tt -116.9 126.46 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 30.57 109.75 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.541 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 34.8 t -68.19 128.52 31.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.963 0.411 . . . . 31.149999999999999 110.918 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -110.14 -22.82 11.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.702 -0.681 . . . . 37.960000000000001 110.77 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -133.43 140.8 47.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.413 -0.358 . . . . 29.969999999999999 110.389 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -72.28 136.5 46.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.319 -0.4 . . . . 32.049999999999997 110.71 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.51 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 63.5 t80 -137.43 128.61 27.78 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.278 -0.419 . . . . 33.979999999999997 111.093 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.45 ' HA ' HG23 ' A' ' 19' ' ' THR . 6.1 p-10 -79.97 157.15 26.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.868 -0.605 . . . . 36.689999999999998 110.463 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.08 95.59 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.372 -0.376 . . . . 30.620000000000001 111.158 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.12 -37.2 46.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.071 -0.513 . . . . 30.559999999999999 109.83 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.594 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 91.5 m-70 -93.38 165.86 12.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.721 -0.672 . . . . 29.609999999999999 110.724 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -74.6 -33.78 62.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 35.799999999999997 110.885 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.63 17.31 15.13 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.148 -0.478 . . . . 32.579999999999998 110.901 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.594 ' HB2' ' HB2' ' A' ' 14' ' ' HIS . 21.3 tt0 -97.77 128.47 44.44 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.99 -0.374 . . . . 36.109999999999999 109.99 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.567 ' HG ' ' HA3' ' A' ' 47' ' ' GLY . 6.6 mt -82.75 130.34 35.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 30.739999999999998 111.181 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 11' ' ' ASP . 11.4 m -86.81 64.96 8.78 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.971 -0.558 . . . . 30.809999999999999 109.703 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.576 HG22 HD22 ' A' ' 42' ' ' LEU . 30.0 pt -60.94 127.4 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 112.629 0.603 . . . . 30.390000000000001 112.629 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -115.14 138.42 50.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.625 -0.716 . . . . 29.609999999999999 109.663 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.4 125.37 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.728 0.299 . . . . 31.460000000000001 111.794 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.86 -19.72 40.51 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.053 -0.594 . . . . 30.600000000000001 113.456 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -76.3 146.6 38.79 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 117.254 0.527 . . . . 35.799999999999997 111.639 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.4 pt -109.18 125.16 66.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.852 -0.613 . . . . 30.379999999999999 110.147 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.647 HG21 ' CE1' ' A' ' 49' ' ' PHE . 6.1 mm -94.97 119.87 43.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 32.07 110.636 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 88.8 mtm180 -75.75 127.69 33.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 29.719999999999999 112.007 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.9 t30 53.07 73.37 0.36 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.798 -0.637 . . . . 29.649999999999999 112.133 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.865 HG21 ' HB2' ' A' ' 4' ' ' TYR . 66.4 t -91.85 110.15 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 30.309999999999999 111.189 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -107.64 162.82 13.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.868 -0.605 . . . . 38.770000000000003 110.546 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.515 ' HA ' HD23 ' A' ' 38' ' ' LEU . 5.7 mmmt -90.14 128.66 36.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 32.939999999999998 110.861 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 39' ' ' GLU . 92.8 mt -90.14 179.41 5.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.033 -0.53 . . . . 33.130000000000003 110.866 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.09 -3.51 45.7 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.252 -0.431 . . . . 42.18 111.179 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 35.3 mt-10 -100.93 119.08 38.19 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.798 -0.445 . . . . 38.109999999999999 109.798 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -60.93 117.65 5.72 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.303 -0.408 . . . . 30.43 110.274 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.08 17.45 34.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.024 -0.608 . . . . 30.129999999999999 112.4 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 99.3 m95 -133.55 132.3 40.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.137 0.494 . . . . 30.289999999999999 111.016 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 48' ' ' MET . 83.5 mt -119.87 160.91 21.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.317 -0.856 . . . . 30.329999999999998 109.936 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.541 ' HB2' HD21 ' A' ' 32' ' ' LEU . 9.1 tp10 -122.92 117.56 25.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.574 0.226 . . . . 38.590000000000003 110.674 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.13 164.64 32.45 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.499 -0.857 . . . . 29.850000000000001 113.418 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 3.5 mp0 -92.13 117.06 29.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.06 0.457 . . . . 37.880000000000003 111.104 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.576 HD22 HG22 ' A' ' 20' ' ' ILE . 55.5 tp -131.87 130.5 41.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.59 -0.732 . . . . 30.379999999999999 110.308 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 60.99 26.09 16.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.94 -0.573 . . . . 40.090000000000003 111.54 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.37 15.29 69.25 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.715 -0.755 . . . . 31.289999999999999 113.954 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -139.02 145.49 39.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.853 0.327 . . . . 44.740000000000002 110.422 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -95.46 120.0 34.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.558 -0.534 . . . . 33.119999999999997 109.558 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.567 ' HA3' ' HG ' ' A' ' 18' ' ' LEU . . . -149.34 155.42 26.3 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.293 -0.956 . . . . 29.77 113.669 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.618 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 24.8 ptt? -80.96 140.49 35.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.955 0.407 . . . . 35.170000000000002 110.9 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.647 ' CE1' HG21 ' A' ' 26' ' ' ILE . 6.1 p90 -141.63 162.68 45.48 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.933 -0.576 . . . . 30.170000000000002 111.095 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.564 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 25.9 Cg_exo -62.73 144.07 93.23 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.779 2.32 . . . . 30.280000000000001 112.971 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.6 -39.41 67.33 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.728 -0.669 . . . . 32.210000000000001 111.84 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -79.83 0.37 31.27 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.061 0.763 . . . . 34.539999999999999 113.061 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 9.6 m-85 -98.18 -31.22 12.2 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.494 0.188 . . . . 34.039999999999999 110.669 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 25.6 m -110.08 135.14 50.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.401 -0.363 . . . . 31.539999999999999 110.53 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -107.09 127.71 53.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 30.59 110.495 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 37.6 tt0 -57.61 136.31 56.78 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.446 -0.343 . . . . 32.189999999999998 110.668 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.4 mt -93.82 84.79 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 30.539999999999999 110.602 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.132 -0.937 . . . . 40.630000000000003 110.89 -179.954 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.816 0.341 . . . . 30.68 111.129 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -88.29 156.91 18.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.166 -0.47 . . . . 27.210000000000001 111.368 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.829 ' HB2' HG21 ' A' ' 29' ' ' VAL . 8.9 m-85 -133.38 152.97 51.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.505 -0.771 . . . . 24.84 110.578 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.5 tt -117.84 129.75 73.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.064 -0.516 . . . . 24.600000000000001 109.691 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.566 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 21.9 t -69.26 127.18 30.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.369 -0.378 . . . . 16.73 111.316 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.482 ' HG3' ' CD2' ' A' ' 8' ' ' TYR . 14.2 pt-20 -109.48 -19.16 13.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.885 -0.598 . . . . 30.579999999999998 110.839 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.482 ' CD2' ' HG3' ' A' ' 7' ' ' GLU . 30.8 m-85 -133.08 142.87 48.96 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.488 -0.323 . . . . 22.640000000000001 110.181 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -77.28 129.34 35.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.413 -0.358 . . . . 22.699999999999999 110.752 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.486 ' HB3' HG12 ' A' ' 20' ' ' ILE . 77.8 t80 -124.46 130.71 52.97 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.292 -0.413 . . . . 19.879999999999999 110.664 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -93.33 113.12 25.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.881 -0.6 . . . . 26.050000000000001 110.318 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.89 106.97 1.11 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.049 -0.523 . . . . 26.149999999999999 111.326 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -83.76 -36.13 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.757 -0.656 . . . . 31.710000000000001 110.177 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -94.02 176.37 6.36 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.891 -0.595 . . . . 37.289999999999999 110.596 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -81.3 -33.54 32.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 45.18 110.905 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -80.8 -28.23 36.35 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.363 -0.381 . . . . 35.420000000000002 110.552 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.42 134.46 57.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.27 -0.423 . . . . 26.239999999999998 111.114 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.634 HD12 ' CD1' ' A' ' 49' ' ' PHE . 28.9 mt -92.42 132.68 36.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.566 -0.743 . . . . 23.559999999999999 110.562 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.6 m -84.26 78.91 9.7 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.299 -0.63 . . . . 22.84 109.299 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.668 HG22 ' HG ' ' A' ' 42' ' ' LEU . 33.1 pt -78.42 133.41 30.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.935 0.398 . . . . 24.600000000000001 111.752 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -118.24 138.29 52.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 18.719999999999999 109.902 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.405 HG22 ' CA ' ' A' ' 8' ' ' TYR . 39.0 t -44.99 120.98 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.283 -0.417 . . . . 17.469999999999999 111.743 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.13 -21.01 25.4 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.046 -0.597 . . . . 18.82 113.633 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.618 ' HB3' HD21 ' A' ' 42' ' ' LEU . 39.1 mt-10 -76.32 154.48 35.01 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 117.343 0.572 . . . . 16.59 111.676 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.5 mt -117.29 127.72 74.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.528 -0.76 . . . . 24.600000000000001 110.16 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.626 HG21 ' CZ ' ' A' ' 49' ' ' PHE . 4.0 mp -94.94 125.44 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 24.600000000000001 110.393 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.607 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 7.7 mpt_? -80.0 125.49 29.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.482 . . . . 21.550000000000001 111.851 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.07 65.87 0.95 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.804 -0.634 . . . . 24.050000000000001 111.779 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.829 HG21 ' HB2' ' A' ' 4' ' ' TYR . 61.8 t -87.59 105.54 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.841 -0.618 . . . . 26.149999999999999 111.238 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -107.37 161.48 14.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.792 -0.64 . . . . 42.509999999999998 110.441 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HA ' HD23 ' A' ' 38' ' ' LEU . 39.1 ttmt -84.68 132.14 34.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 33.310000000000002 110.468 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.9 tp -91.01 171.01 9.56 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.865 -0.607 . . . . 37.710000000000001 110.331 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -77.13 -1.71 30.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.629 0.252 . . . . 40.380000000000003 110.855 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 42.3 mt-10 -103.67 122.49 45.15 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.646 -0.501 . . . . 38.539999999999999 109.646 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -60.86 117.9 6.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 33.270000000000003 110.461 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.05 15.39 45.24 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.99 -0.624 . . . . 28.280000000000001 112.833 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 85.6 m95 -132.54 132.47 42.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.163 0.506 . . . . 23.140000000000001 111.153 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 48' ' ' MET . 98.0 mt -118.79 162.25 18.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.262 -0.881 . . . . 23.91 110.021 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -123.09 118.36 27.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.577 -0.283 . . . . 43.399999999999999 110.439 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.466 ' O ' HD11 ' A' ' 18' ' ' LEU . . . -162.12 170.96 37.91 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.615 -0.802 . . . . 20.079999999999998 113.523 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 34.6 mt-10 -94.09 105.86 17.85 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.918 0.39 . . . . 32.100000000000001 110.46 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.668 ' HG ' HG22 ' A' ' 20' ' ' ILE . 3.1 tm? -124.49 130.44 52.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.879 -0.601 . . . . 22.890000000000001 110.065 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.516 ' HB2' HD13 ' A' ' 42' ' ' LEU . 66.6 t30 64.14 25.1 13.62 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.025 -0.534 . . . . 30.739999999999998 110.939 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.38 13.87 79.66 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 121.003 -0.617 . . . . 33.009999999999998 113.299 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -130.86 140.22 50.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.851 0.358 . . . . 45.68 110.736 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -91.4 114.03 26.46 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.485 -0.932 . . . . 38.710000000000001 108.485 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.541 ' HA3' ' HG ' ' A' ' 18' ' ' LEU . . . -151.19 -168.97 16.34 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.031 -1.081 . . . . 23.539999999999999 114.018 -178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.617 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 50.7 mtt -111.77 138.72 47.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.499 -0.351 . . . . 33.810000000000002 110.661 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.634 ' CD1' HD12 ' A' ' 18' ' ' LEU . 4.6 p90 -140.59 153.42 68.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 21.48 111.35 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HG2' ' HB2' ' A' ' 53' ' ' PHE . 9.9 Cg_endo -54.05 135.76 65.0 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.87 2.38 . . . . 18.640000000000001 112.691 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -67.9 -38.08 82.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.686 -0.688 . . . . 25.32 112.104 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -81.64 5.59 17.75 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.685 0.624 . . . . 25.559999999999999 112.685 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.519 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 9.8 m-85 -102.56 -24.82 13.76 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.494 0.188 . . . . 21.91 110.601 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 31.0 m -116.5 137.19 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.307 -0.406 . . . . 20.469999999999999 110.401 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -111.24 129.16 56.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 24.52 110.344 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -50.46 141.36 12.25 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.404 -0.362 . . . . 36.5 110.996 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.7 mt -95.33 89.77 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 29.5 110.751 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.55 -0.738 . . . . 44.289999999999999 110.879 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.603 0.24 . . . . 33.030000000000001 111.034 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.1 152.04 22.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.13 0.49 . . . . 30.120000000000001 111.783 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.917 ' HB2' HG21 ' A' ' 29' ' ' VAL . 7.6 m-85 -130.91 152.6 50.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.396 -0.82 . . . . 30.109999999999999 110.702 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 55' ' ' LYS . 6.5 tp -113.31 132.93 60.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.937 -0.574 . . . . 30.57 109.804 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.591 ' CG2' HD11 ' A' ' 26' ' ' ILE . 40.5 t -74.42 123.52 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.91 0.386 . . . . 31.149999999999999 110.703 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.475 ' HG3' ' CD2' ' A' ' 8' ' ' TYR . 12.5 pt-20 -104.34 -21.18 13.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 37.960000000000001 111.113 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.475 ' CD2' ' HG3' ' A' ' 7' ' ' GLU . 60.9 m-85 -133.14 142.52 48.71 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.856 0.36 . . . . 29.969999999999999 110.827 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -77.57 128.46 34.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 32.049999999999997 110.371 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.505 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 53.0 t80 -128.67 135.98 50.01 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.753 0.311 . . . . 33.979999999999997 111.13 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -96.9 119.85 36.16 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.003 -0.544 . . . . 36.689999999999998 110.562 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.18 105.17 1.32 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.275 -0.42 . . . . 30.620000000000001 111.107 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -87.05 -36.94 10.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.887 -0.597 . . . . 30.559999999999999 110.035 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.574 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 52.8 m-70 -89.21 -179.77 5.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.887 -0.597 . . . . 29.609999999999999 110.305 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -78.84 -45.82 19.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.502 -0.317 . . . . 35.799999999999997 111.029 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -77.93 -23.28 48.66 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.572 -0.286 . . . . 32.579999999999998 111.007 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.574 ' HG2' ' HB2' ' A' ' 14' ' ' HIS . 29.6 mm-40 -52.99 132.22 37.32 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.992 0.425 . . . . 36.109999999999999 111.012 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.517 HD11 ' HB3' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -95.5 129.01 42.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.639 -0.71 . . . . 30.739999999999998 110.589 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.8 m -82.99 86.11 7.05 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.992 -0.744 . . . . 30.809999999999999 108.992 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.651 HD11 ' HB3' ' A' ' 53' ' ' PHE . 36.1 pt -87.71 137.59 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 120.92 0.39 . . . . 30.390000000000001 111.895 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -116.51 135.55 53.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.811 -0.631 . . . . 29.609999999999999 109.974 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -47.21 124.41 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.935 0.398 . . . . 31.460000000000001 111.634 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.25 -16.31 42.07 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.763 -0.653 . . . . 30.600000000000001 113.322 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.418 ' HB3' HD11 ' A' ' 42' ' ' LEU . 15.6 mm-40 -82.2 150.0 27.6 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 117.278 0.539 . . . . 35.799999999999997 111.643 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.1 mt -109.17 128.02 65.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.666 -0.697 . . . . 30.379999999999999 110.14 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.591 HD11 ' CG2' ' A' ' 6' ' ' VAL . 4.2 mp -97.03 126.46 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.444 . . . . 32.07 110.58 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.442 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 83.9 mtp180 -76.51 125.75 29.77 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.075 -0.511 . . . . 29.719999999999999 112.172 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.2 t30 55.2 69.9 0.69 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.726 -0.67 . . . . 29.649999999999999 112.241 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.917 HG21 ' HB2' ' A' ' 4' ' ' TYR . 89.0 t -88.44 106.61 16.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.984 -0.553 . . . . 30.309999999999999 110.511 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -103.96 160.22 15.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.874 -0.603 . . . . 38.770000000000003 110.88 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.42 ' HA ' ' CD2' ' A' ' 38' ' ' LEU . 63.0 mttp -90.84 132.12 36.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 32.939999999999998 110.07 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 39' ' ' GLU . 93.8 mt -94.68 178.67 5.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 33.130000000000003 110.871 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.58 0.89 31.97 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.29 -0.414 . . . . 42.18 111.013 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.465 ' HB3' ' HD1' ' A' ' 37' ' ' TRP . 36.1 mt-10 -104.49 120.4 41.17 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.426 -0.583 . . . . 38.109999999999999 109.426 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -61.02 118.1 6.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 30.43 110.77 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 94.6 11.87 56.44 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.011 -0.614 . . . . 30.129999999999999 113.066 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.596 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 55.3 m95 -129.97 129.88 44.33 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.148 0.499 . . . . 30.289999999999999 111.208 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 48' ' ' MET . 90.1 mt -121.96 165.94 15.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.355 -0.839 . . . . 30.329999999999998 109.997 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.499 ' HB2' HD21 ' A' ' 32' ' ' LEU . 9.1 tp10 -126.08 122.07 34.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.611 -0.268 . . . . 38.590000000000003 110.612 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.465 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -154.76 162.37 30.76 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.635 -0.793 . . . . 29.850000000000001 113.283 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.442 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 3.1 mp0 -96.89 104.99 17.05 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.024 0.44 . . . . 37.880000000000003 110.945 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.517 ' CD2' HG22 ' A' ' 20' ' ' ILE . 53.0 tp -130.67 138.05 49.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.657 -0.702 . . . . 30.379999999999999 110.1 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 67.65 18.99 9.87 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.975 -0.557 . . . . 40.090000000000003 110.951 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.47 14.88 67.38 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 120.886 -0.673 . . . . 31.289999999999999 113.466 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -142.51 149.06 38.65 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.8 0.334 . . . . 44.740000000000002 110.377 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -92.82 116.3 28.91 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.704 -0.85 . . . . 33.119999999999997 108.704 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.1 151.75 22.75 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.036 -1.078 . . . . 29.77 114.011 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 62.0 ttp -81.44 135.57 35.64 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.242 -0.479 . . . . 35.170000000000002 110.312 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.565 ' CE2' HG21 ' A' ' 26' ' ' ILE . 6.0 p90 -139.49 158.53 68.33 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 30.170000000000002 111.236 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.562 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 34.8 Cg_exo -59.01 141.28 98.17 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.672 2.248 . . . . 30.280000000000001 112.721 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.31 -36.7 79.72 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.693 -0.685 . . . . 32.210000000000001 111.575 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -83.18 4.55 26.21 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.33 0.493 . . . . 34.539999999999999 112.33 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.651 ' HB3' HD11 ' A' ' 20' ' ' ILE . 9.2 m-85 -101.3 -21.69 14.81 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 120.621 0.248 . . . . 34.039999999999999 110.466 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 24.3 m -120.51 141.62 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.205 -0.452 . . . . 31.539999999999999 109.994 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.403 ' O ' HG22 ' A' ' 5' ' ' ILE . 88.4 tttt -116.14 129.07 56.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.388 -0.369 . . . . 30.59 110.689 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -55.14 129.45 38.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.415 -0.357 . . . . 32.189999999999998 110.102 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.4 mt -87.65 81.0 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.02 0.438 . . . . 30.539999999999999 110.765 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.0 tttm . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.072 -0.966 . . . . 40.630000000000003 111.026 -179.763 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.711 0.291 . . . . 30.68 111.325 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -85.62 154.52 21.64 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.226 -0.443 . . . . 27.210000000000001 110.748 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.81 ' HB2' HG21 ' A' ' 29' ' ' VAL . 8.3 m-85 -127.95 151.58 48.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 24.84 111.24 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.65 ' HB ' HD11 ' A' ' 57' ' ' ILE . 6.5 tp -112.34 133.2 58.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.667 -0.697 . . . . 24.600000000000001 109.328 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 38.3 t -77.34 124.18 35.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.806 0.336 . . . . 16.73 110.791 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.474 ' C ' HG22 ' A' ' 22' ' ' VAL . 19.4 mm-40 -108.44 -17.46 13.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.992 -0.549 . . . . 30.579999999999998 111.166 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.492 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 73.9 m-85 -133.71 141.29 47.49 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.673 0.273 . . . . 22.640000000000001 110.674 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -77.49 128.35 34.06 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.301 -0.409 . . . . 22.699999999999999 110.69 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.463 ' CD1' ' HG3' ' A' ' 50' ' ' PRO . 40.1 t80 -125.81 136.28 52.94 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.492 -0.322 . . . . 19.879999999999999 110.841 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -94.17 119.48 33.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.086 -0.506 . . . . 26.050000000000001 110.898 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -69.53 104.99 2.49 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.102 -0.499 . . . . 26.149999999999999 111.089 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.4 t -89.59 -34.87 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.748 -0.66 . . . . 31.710000000000001 110.138 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 43.7 m80 -90.91 172.06 8.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.906 -0.588 . . . . 37.289999999999999 110.514 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.68 -36.95 50.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 45.18 110.392 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -92.76 15.37 14.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.135 -0.484 . . . . 35.420000000000002 110.901 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.501 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 23.0 tp10 -92.53 127.84 38.17 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.911 -0.404 . . . . 26.239999999999998 109.911 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -86.39 124.95 33.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 23.559999999999999 111.139 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.2 m -81.18 83.75 6.73 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.274 -0.639 . . . . 22.84 109.274 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.508 ' HB ' ' CG2' ' A' ' 6' ' ' VAL . 38.0 pt -85.42 132.88 30.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.042 0.448 . . . . 24.600000000000001 111.709 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 -119.28 138.75 52.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.87 -0.604 . . . . 18.719999999999999 110.181 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.474 HG22 ' C ' ' A' ' 7' ' ' GLU . 46.2 t -44.25 120.97 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.841 0.353 . . . . 17.469999999999999 111.898 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.51 -19.52 28.79 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.87 -0.604 . . . . 18.82 113.613 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HB3' HD11 ' A' ' 42' ' ' LEU . 35.2 mt-10 -76.19 150.43 37.11 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 117.308 0.554 . . . . 16.59 111.981 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.6 mt -111.81 124.47 68.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.475 -0.784 . . . . 24.600000000000001 109.682 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.587 HG21 ' CE2' ' A' ' 49' ' ' PHE . 30.0 mt -97.12 123.15 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 24.600000000000001 110.403 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -75.71 133.57 40.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.028 -0.533 . . . . 21.550000000000001 112.067 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.7 p30 46.42 71.44 0.3 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.53 -0.759 . . . . 24.050000000000001 112.564 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.81 HG21 ' HB2' ' A' ' 4' ' ' TYR . 85.3 t -88.26 110.46 21.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.785 -0.643 . . . . 26.149999999999999 110.834 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HG2' ' N ' ' A' ' 31' ' ' LYS . 25.9 ttpp -107.0 160.9 15.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.745 -0.661 . . . . 42.509999999999998 110.482 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.404 ' N ' ' HG2' ' A' ' 30' ' ' LYS . 98.3 mttt -88.81 132.41 34.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 33.310000000000002 110.03 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 39' ' ' GLU . 95.9 mt -92.34 -179.98 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 37.710000000000001 111.166 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -81.36 -0.51 41.55 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.125 -0.489 . . . . 40.380000000000003 111.167 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -105.71 120.51 41.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.693 -0.484 . . . . 38.539999999999999 109.693 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -59.75 117.88 5.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.465 . . . . 33.270000000000003 110.638 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.26 13.02 50.25 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.939 -0.648 . . . . 28.280000000000001 112.963 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -131.38 130.13 42.23 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.139 0.495 . . . . 23.140000000000001 111.154 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.629 ' O ' ' HA ' ' A' ' 48' ' ' MET . 6.4 mp -119.71 164.39 16.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.295 -0.866 . . . . 23.91 109.525 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HB2' HD21 ' A' ' 32' ' ' LEU . 13.4 tp10 -126.38 122.6 35.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.638 0.256 . . . . 43.399999999999999 111.069 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.08 162.47 30.94 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.832 -0.699 . . . . 20.079999999999998 112.991 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -96.34 104.87 16.86 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.113 0.482 . . . . 32.100000000000001 111.026 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' A' ' 24' ' ' GLU . 59.8 tp -125.53 137.61 53.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.579 -0.737 . . . . 22.890000000000001 109.933 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 63.61 21.92 12.93 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.992 -0.549 . . . . 30.739999999999998 110.913 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.98 12.93 80.41 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 120.902 -0.666 . . . . 33.009999999999998 113.233 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -133.38 142.15 48.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.796 0.332 . . . . 45.68 110.287 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -93.96 114.77 27.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.91 -0.774 . . . . 38.710000000000001 108.91 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.53 153.99 25.68 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.299 -0.953 . . . . 23.539999999999999 113.344 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.629 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 22.7 ptt? -79.23 145.66 33.47 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.683 0.278 . . . . 33.810000000000002 110.369 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.587 ' CE2' HG21 ' A' ' 26' ' ' ILE . 3.8 p90 -143.99 155.66 58.81 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.256 -0.429 . . . . 21.48 111.22 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.574 ' HG2' ' HB2' ' A' ' 53' ' ' PHE . 14.5 Cg_endo -57.55 148.96 69.91 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.755 2.303 . . . . 18.640000000000001 112.99 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -73.36 -41.3 63.59 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.443 -0.799 . . . . 25.32 112.791 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -82.53 11.26 5.89 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.991 0.738 . . . . 25.559999999999999 112.991 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.574 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 16.3 m-85 -107.38 -27.2 10.61 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.57 0.224 . . . . 21.91 110.778 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 27.5 m -116.88 139.86 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 116.323 -0.398 . . . . 20.469999999999999 110.39 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.424 ' O ' HG22 ' A' ' 5' ' ' ILE . 44.4 mmtm -118.37 127.44 53.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.371 -0.377 . . . . 24.52 110.528 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.634 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . 12.8 pt-20 -60.92 131.97 52.37 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.542 -0.299 . . . . 36.5 110.411 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.65 HD11 ' HB ' ' A' ' 5' ' ' ILE . 22.4 mt -87.73 85.59 2.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.114 0.483 . . . . 29.5 110.762 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.445 -0.788 . . . . 44.289999999999999 110.856 -179.917 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.749 0.309 . . . . 30.68 111.021 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -84.64 154.57 22.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.275 -0.42 . . . . 27.210000000000001 111.306 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.919 ' HB2' HG21 ' A' ' 29' ' ' VAL . 6.4 m-85 -130.76 151.4 51.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.772 -0.649 . . . . 24.84 110.917 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.424 HD13 ' CD1' ' A' ' 25' ' ' ILE . 3.4 tp -113.69 128.09 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.689 -0.687 . . . . 24.600000000000001 109.63 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.518 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 29.8 t -73.89 124.37 31.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.422 -0.354 . . . . 16.73 110.794 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.439 ' C ' HG22 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -107.79 -18.95 13.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.028 -0.533 . . . . 30.579999999999998 110.929 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -130.49 140.54 50.52 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.706 0.288 . . . . 22.640000000000001 110.672 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 21' ' ' ARG . 34.6 m-20 -76.33 131.5 39.23 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.266 -0.424 . . . . 22.699999999999999 110.564 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.432 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 44.5 t80 -132.08 131.56 42.5 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.501 -0.318 . . . . 19.879999999999999 110.834 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -95.02 119.84 34.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.94 -0.573 . . . . 26.050000000000001 110.604 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.454 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -65.08 107.25 1.47 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.013 -0.54 . . . . 26.149999999999999 111.56 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.1 p -87.8 -36.47 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.779 -0.646 . . . . 31.710000000000001 109.95 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 29.7 m80 -90.37 172.84 8.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.837 -0.62 . . . . 37.289999999999999 110.422 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.81 -35.61 43.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.323 -0.399 . . . . 45.18 110.303 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -92.28 9.39 34.11 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.08 -0.509 . . . . 35.420000000000002 110.986 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.454 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 22.7 tp10 -87.28 126.78 35.05 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.906 -0.405 . . . . 26.239999999999998 109.906 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.644 HD21 ' HB3' ' A' ' 42' ' ' LEU . 11.0 tp -84.92 126.53 33.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 23.559999999999999 110.753 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.5 m -83.12 88.44 6.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.887 -0.597 . . . . 22.84 109.394 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.555 HG22 HD22 ' A' ' 42' ' ' LEU . 33.0 pt -89.07 131.06 37.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.813 0.34 . . . . 24.600000000000001 111.237 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 9' ' ' ASP . 25.2 mmm180 -117.12 138.78 51.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.154 -0.475 . . . . 18.719999999999999 110.105 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.439 HG22 ' C ' ' A' ' 7' ' ' GLU . 48.3 t -45.42 122.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.391 -0.368 . . . . 17.469999999999999 111.791 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.82 -18.97 39.5 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.052 -0.594 . . . . 18.82 113.575 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.458 ' HB3' HD11 ' A' ' 42' ' ' LEU . 18.2 mm-40 -77.16 147.46 36.49 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.286 0.543 . . . . 16.59 112.264 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.431 HD12 HD11 ' A' ' 57' ' ' ILE . 47.6 mm -107.7 123.02 62.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.462 -0.79 . . . . 24.600000000000001 109.894 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.545 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 41.0 mt -95.18 124.18 47.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.389 -0.369 . . . . 24.600000000000001 110.535 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.491 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -74.53 128.37 35.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.901 -0.59 . . . . 21.550000000000001 112.245 -178.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 50.64 70.92 0.46 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.698 -0.683 . . . . 24.050000000000001 112.401 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.919 HG21 ' HB2' ' A' ' 4' ' ' TYR . 73.0 t -87.52 107.5 17.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.981 -0.554 . . . . 26.149999999999999 110.741 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -103.74 157.08 17.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.719 -0.673 . . . . 42.509999999999998 110.475 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -89.27 129.9 35.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.414 . . . . 33.310000000000002 109.966 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 39' ' ' GLU . 87.9 mt -91.17 178.33 6.01 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.345 -0.389 . . . . 37.710000000000001 111.031 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -79.92 0.96 29.14 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.216 -0.447 . . . . 40.380000000000003 111.082 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 3.8 mp0 -105.65 122.0 45.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.463 -0.569 . . . . 38.539999999999999 109.463 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -61.55 116.93 5.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.174 -0.466 . . . . 33.270000000000003 110.435 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 96.41 12.54 51.04 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.907 -0.663 . . . . 28.280000000000001 113.006 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.506 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 44.7 m95 -130.26 129.59 43.49 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.168 0.509 . . . . 23.140000000000001 111.088 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.619 ' O ' ' HA ' ' A' ' 48' ' ' MET . 85.1 mt -120.07 165.49 14.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.277 -0.874 . . . . 23.91 109.781 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.531 ' HB2' HD21 ' A' ' 32' ' ' LEU . 38.7 tt0 -126.68 121.63 32.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.694 -0.23 . . . . 43.399999999999999 110.783 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.93 164.89 32.96 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.527 -0.844 . . . . 20.079999999999998 113.433 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.688 ' HG3' ' HG2' ' A' ' 46' ' ' ARG . 2.9 mp0 -94.1 106.08 18.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.769 0.318 . . . . 32.100000000000001 110.59 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.644 ' HB3' HD21 ' A' ' 18' ' ' LEU . 40.1 tp -130.61 137.18 49.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 22.890000000000001 110.251 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 64.55 19.73 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 30.739999999999998 111.218 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.74 13.5 72.38 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 121.021 -0.609 . . . . 33.009999999999998 113.453 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.1 mmt180 -136.3 145.31 45.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.909 0.385 . . . . 45.68 110.739 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.688 ' HG2' ' HG3' ' A' ' 41' ' ' GLU . 31.9 mtp180 -92.69 116.4 28.98 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.914 -0.772 . . . . 38.710000000000001 108.914 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.19 -175.14 15.99 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.116 -1.04 . . . . 23.539999999999999 113.31 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.619 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.2 ptp -112.7 139.68 48.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.943 -0.392 . . . . 33.810000000000002 109.943 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.571 ' HZ ' HG22 ' A' ' 29' ' ' VAL . 3.3 p90 -138.57 159.05 69.17 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.172 -0.467 . . . . 21.48 111.315 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.552 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 36.4 Cg_exo -60.98 136.62 66.75 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.625 2.217 . . . . 18.640000000000001 112.355 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -67.68 -36.2 80.26 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.924 -0.58 . . . . 25.32 111.48 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -79.24 2.11 22.38 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.725 0.639 . . . . 25.559999999999999 112.725 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 9.7 m-85 -102.81 -23.49 13.78 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.554 0.216 . . . . 21.91 110.852 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.479 HG12 HG22 ' A' ' 6' ' ' VAL . 30.9 m -120.63 139.43 47.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.274 -0.421 . . . . 20.469999999999999 110.364 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -112.97 133.29 55.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.345 -0.389 . . . . 24.52 110.503 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -54.74 137.76 43.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.334 -0.394 . . . . 36.5 110.436 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.431 HD11 HD12 ' A' ' 25' ' ' ILE . 64.7 mt -91.27 86.0 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.002 0.43 . . . . 29.5 110.764 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.426 ' HD3' ' C ' ' A' ' 58' ' ' LYS . 7.6 tmtm? . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.02 -0.991 . . . . 44.289999999999999 110.583 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.753 0.311 . . . . 33.030000000000001 111.029 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.03 159.02 16.35 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.103 0.478 . . . . 30.120000000000001 111.49 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.931 ' HB2' HG21 ' A' ' 29' ' ' VAL . 7.8 m-85 -131.34 153.36 49.69 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.528 -0.76 . . . . 30.109999999999999 111.079 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.545 ' HB ' HD11 ' A' ' 57' ' ' ILE . 17.2 tt -111.45 138.06 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.573 . . . . 30.57 109.607 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.461 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 25.1 t -80.78 121.02 33.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.431 -0.35 . . . . 31.149999999999999 110.744 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -104.77 -19.35 13.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.086 -0.506 . . . . 37.960000000000001 111.148 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -132.84 140.42 47.94 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.53 -0.305 . . . . 29.969999999999999 110.363 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.56 130.13 36.53 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.26 -0.427 . . . . 32.049999999999997 110.87 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.471 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 47.6 t80 -129.98 136.48 49.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.943 -0.571 . . . . 33.979999999999997 110.371 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.87 120.61 40.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.139 -0.482 . . . . 36.689999999999998 110.537 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.457 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -64.3 109.07 1.77 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.076 -0.511 . . . . 30.620000000000001 111.695 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.1 t -89.02 -36.35 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.63 -0.714 . . . . 30.559999999999999 109.747 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 43.3 m80 -92.19 175.02 7.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.767 -0.651 . . . . 29.609999999999999 110.621 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.2 -36.54 47.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.193 -0.458 . . . . 35.799999999999997 110.567 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 48' ' ' MET . 1.9 p30 -93.0 12.96 22.17 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.035 -0.53 . . . . 32.579999999999998 111.038 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.457 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 17.5 tp10 -91.54 129.98 37.43 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.801 -0.444 . . . . 36.109999999999999 109.801 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 19' ' ' THR . 0.4 OUTLIER -89.31 124.88 34.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.753 0.311 . . . . 30.739999999999998 111.328 -179.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.626 ' N ' HD13 ' A' ' 18' ' ' LEU . 32.9 m -81.49 86.13 6.38 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.107 -0.701 . . . . 30.809999999999999 109.107 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 53' ' ' PHE . 29.8 pt -87.28 135.31 25.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.396 -0.365 . . . . 30.390000000000001 111.51 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.3 mtp85 -119.06 138.19 53.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.136 -0.484 . . . . 29.609999999999999 110.165 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.3 t -45.32 122.72 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.894 0.378 . . . . 31.460000000000001 111.904 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.63 -18.77 34.59 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.824 -0.625 . . . . 30.600000000000001 113.567 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.49 ' HB3' HD11 ' A' ' 42' ' ' LEU . 32.6 mt-10 -76.09 155.19 34.97 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.365 0.582 . . . . 35.799999999999997 111.931 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.3 mt -115.53 125.75 72.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.45 -0.795 . . . . 30.379999999999999 109.749 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.754 ' CD1' HD22 ' A' ' 42' ' ' LEU . 5.5 mm -91.27 120.44 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 32.07 110.756 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.38 122.21 23.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.285 -0.416 . . . . 29.719999999999999 112.107 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 57.97 70.76 0.63 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.753 -0.658 . . . . 29.649999999999999 112.61 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.931 HG21 ' HB2' ' A' ' 4' ' ' TYR . 59.8 t -86.39 108.6 17.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.297 -0.41 . . . . 30.309999999999999 111.088 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -105.16 155.97 18.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.802 -0.635 . . . . 38.770000000000003 110.358 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HA ' HD13 ' A' ' 38' ' ' LEU . 69.0 mttm -82.06 127.75 33.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 32.939999999999998 110.264 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 tp -88.42 170.89 10.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 33.130000000000003 110.308 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -78.91 0.85 25.7 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.67 -0.241 . . . . 42.18 110.867 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.503 ' HB3' ' HD1' ' A' ' 37' ' ' TRP . 2.9 mp0 -104.55 116.17 31.61 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.565 -0.532 . . . . 38.109999999999999 109.565 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.92 121.82 10.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 30.43 110.991 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.42 14.78 56.67 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.862 -0.685 . . . . 30.129999999999999 113.031 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.503 ' HD1' ' HB3' ' A' ' 34' ' ' GLU . 92.5 m95 -134.01 132.28 39.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.156 0.503 . . . . 30.289999999999999 110.951 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 48' ' ' MET . 3.7 mm? -117.33 163.43 16.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.295 -0.866 . . . . 30.329999999999998 109.735 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 10.7 tp10 -123.48 119.81 31.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.774 -0.194 . . . . 38.590000000000003 110.482 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.461 ' HA3' HG22 ' A' ' 26' ' ' ILE . . . -153.09 161.51 29.67 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.468 -0.872 . . . . 29.850000000000001 113.514 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -95.15 106.61 18.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.084 0.468 . . . . 37.880000000000003 110.825 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.754 HD22 ' CD1' ' A' ' 26' ' ' ILE . 30.3 tp -132.93 142.13 48.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.668 -0.696 . . . . 30.379999999999999 110.073 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.437 ' ND2' ' HG ' ' A' ' 42' ' ' LEU . 54.8 m-80 65.46 17.49 10.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.726 -0.67 . . . . 40.090000000000003 111.181 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.28 15.51 62.21 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 121.005 -0.617 . . . . 31.289999999999999 113.492 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -145.24 151.95 39.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.745 0.307 . . . . 44.740000000000002 110.44 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -95.31 119.04 33.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.11 -0.7 . . . . 33.119999999999997 109.11 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -145.73 150.01 22.19 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.554 -0.832 . . . . 29.77 113.079 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 22.8 ptp -78.62 145.46 34.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.718 0.294 . . . . 35.170000000000002 110.373 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 26' ' ' ILE . 3.4 p90 -143.2 157.64 59.81 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.024 -0.535 . . . . 30.170000000000002 111.179 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.54 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 27.2 Cg_exo -61.8 145.58 97.11 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.678 2.252 . . . . 30.280000000000001 112.821 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.95 -37.39 78.82 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.617 -0.719 . . . . 32.210000000000001 112.077 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -78.74 4.71 13.05 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.9 0.704 . . . . 34.539999999999999 112.9 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.561 ' HB3' HD11 ' A' ' 20' ' ' ILE . 13.2 m-85 -107.81 -24.23 11.76 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.491 0.186 . . . . 34.039999999999999 111.307 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.568 HG21 ' CE1' ' A' ' 49' ' ' PHE . 29.1 m -121.03 139.95 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 110.113 -0.329 . . . . 31.539999999999999 110.113 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -122.24 131.93 54.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.446 -0.343 . . . . 30.59 110.41 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -54.65 131.26 42.92 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.425 -0.352 . . . . 32.189999999999998 110.64 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.545 HD11 ' HB ' ' A' ' 5' ' ' ILE . 44.2 mt -87.41 84.54 2.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.071 0.462 . . . . 30.539999999999999 110.763 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 96.1 mttt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.084 -0.96 . . . . 40.630000000000003 110.882 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.754 0.311 . . . . 30.68 111.104 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -83.61 157.51 22.24 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.242 -0.435 . . . . 27.210000000000001 111.196 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.851 ' HB2' HG21 ' A' ' 29' ' ' VAL . 7.4 m-85 -134.16 151.92 51.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.829 -0.623 . . . . 24.84 110.81 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.664 ' HB ' HD11 ' A' ' 57' ' ' ILE . 13.8 tt -113.81 134.03 57.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.402 -0.592 . . . . 24.600000000000001 109.402 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 37.0 t -76.67 123.63 33.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.917 0.389 . . . . 16.73 110.828 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -106.49 -21.18 13.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.931 -0.577 . . . . 30.579999999999998 111.002 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.92 141.26 48.27 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.521 -0.308 . . . . 22.640000000000001 110.436 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -74.75 129.3 37.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 22.699999999999999 110.984 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.574 ' HB3' HG12 ' A' ' 20' ' ' ILE . 54.2 t80 -127.11 132.94 50.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.928 -0.578 . . . . 19.879999999999999 110.183 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -100.02 116.65 32.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.009 -0.541 . . . . 26.050000000000001 110.638 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.83 107.33 0.96 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.016 -0.538 . . . . 26.149999999999999 111.143 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.7 t -77.66 -39.35 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.925 -0.58 . . . . 31.710000000000001 109.83 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.722 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 46.5 m-70 -98.31 178.15 5.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.753 -0.658 . . . . 37.289999999999999 110.712 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -81.71 -27.13 34.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.033 -0.531 . . . . 45.18 111.092 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -92.09 5.87 48.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.511 -0.313 . . . . 35.420000000000002 111.098 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.722 ' HG2' ' HB2' ' A' ' 14' ' ' HIS . 40.3 mm-40 -94.42 135.35 35.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 110.013 -0.366 . . . . 26.239999999999998 110.013 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.44 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -89.6 125.7 35.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.94 -0.573 . . . . 23.559999999999999 110.835 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.3 m -83.08 86.18 7.05 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.32 -0.622 . . . . 22.84 109.32 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.574 HG12 ' HB3' ' A' ' 10' ' ' TYR . 43.4 pt -84.7 136.82 21.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.161 -0.472 . . . . 24.600000000000001 111.906 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -119.8 137.78 53.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.862 -0.608 . . . . 18.719999999999999 110.187 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.5 t -45.72 122.51 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.078 0.399 . . . . 17.469999999999999 112.078 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.14 -18.22 36.63 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.846 -0.616 . . . . 18.82 113.69 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.49 ' HB3' HD11 ' A' ' 42' ' ' LEU . 32.8 mt-10 -78.31 152.76 32.24 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.395 0.598 . . . . 16.59 112.107 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.5 mm -112.38 125.23 69.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.493 -0.776 . . . . 24.600000000000001 109.743 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.592 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 40.4 mt -96.98 125.03 50.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 24.600000000000001 110.782 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.531 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 78.2 ttt180 -75.55 125.88 29.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.775 -0.648 . . . . 21.550000000000001 112.422 -178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 54.41 68.74 0.81 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.697 -0.683 . . . . 24.050000000000001 112.413 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.851 HG21 ' HB2' ' A' ' 4' ' ' TYR . 91.6 t -88.43 107.94 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 26.149999999999999 110.839 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -108.4 164.6 12.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.844 -0.616 . . . . 42.509999999999998 110.623 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HA ' HD23 ' A' ' 38' ' ' LEU . 40.4 ttmt -90.59 133.46 35.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.289 -0.414 . . . . 33.310000000000002 110.517 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.463 HD21 ' HB2' ' A' ' 39' ' ' GLU . 94.5 mt -96.17 -177.77 4.1 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.976 -0.556 . . . . 37.710000000000001 110.955 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -81.83 -0.2 42.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.309 -0.405 . . . . 40.380000000000003 111.226 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 31.6 mt-10 -103.38 115.88 31.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.745 -0.465 . . . . 38.539999999999999 109.745 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -58.12 118.46 5.47 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.258 -0.428 . . . . 33.270000000000003 110.575 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 93.85 14.15 53.12 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.936 -0.65 . . . . 28.280000000000001 113.012 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.481 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 80.9 m95 -133.75 132.72 40.87 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.125 0.488 . . . . 23.140000000000001 110.704 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.598 ' O ' ' HA ' ' A' ' 48' ' ' MET . 94.7 mt -120.08 166.6 13.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.272 -0.876 . . . . 23.91 110.087 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.463 ' HB2' HD21 ' A' ' 32' ' ' LEU . 14.0 tp10 -125.97 120.61 30.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.55 -0.296 . . . . 43.399999999999999 110.636 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.16 163.36 31.43 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.729 -0.748 . . . . 20.079999999999998 113.118 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 27' ' ' ARG . 1.9 tm-20 -95.05 103.79 15.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.037 0.446 . . . . 32.100000000000001 110.462 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.501 ' CD2' HG22 ' A' ' 20' ' ' ILE . 45.8 tp -129.82 140.71 50.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.535 -0.757 . . . . 22.890000000000001 110.113 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 65.0 18.26 11.43 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.032 -0.531 . . . . 30.739999999999998 111.192 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.2 14.36 66.74 Favored Glycine 0 C--N 1.341 0.815 0 C-N-CA 120.992 -0.623 . . . . 33.009999999999998 113.331 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -140.94 149.29 41.65 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.826 0.346 . . . . 45.68 110.8 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -94.8 115.26 27.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.928 -0.767 . . . . 38.710000000000001 108.928 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.9 -176.54 14.69 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.259 -0.972 . . . . 23.539999999999999 113.613 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.598 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 54.8 mtt -111.62 133.77 53.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.491 -0.355 . . . . 33.810000000000002 110.162 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.514 ' HZ ' HG22 ' A' ' 29' ' ' VAL . 4.8 p90 -136.51 156.92 76.13 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.273 -0.422 . . . . 21.48 111.473 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.591 ' HG2' ' HB2' ' A' ' 53' ' ' PHE . 19.6 Cg_endo -58.99 136.56 74.2 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.741 2.294 . . . . 18.640000000000001 112.436 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.75 -38.18 83.12 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.791 -0.641 . . . . 25.32 111.849 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -78.29 4.74 12.03 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.808 0.67 . . . . 25.559999999999999 112.808 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.591 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 5.3 m-85 -105.25 -22.33 13.08 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.494 0.188 . . . . 21.91 110.996 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 18.3 m -117.36 141.07 37.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.467 -0.333 . . . . 20.469999999999999 110.65 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.4 ' O ' HG22 ' A' ' 5' ' ' ILE . 17.5 tppt? -113.63 125.24 53.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 24.52 110.306 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -51.69 141.47 16.62 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.439 -0.346 . . . . 36.5 110.993 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.664 HD11 ' HB ' ' A' ' 5' ' ' ILE . 39.4 mm -85.97 93.32 3.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.167 -0.47 . . . . 29.5 110.458 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.099 -0.953 . . . . 44.289999999999999 110.824 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.746 0.307 . . . . 30.68 111.186 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.41 149.03 25.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.023 0.44 . . . . 27.210000000000001 111.132 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.86 ' HB2' HG21 ' A' ' 29' ' ' VAL . 6.8 m-85 -129.04 152.73 48.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.626 -0.715 . . . . 24.84 110.709 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.406 ' HB ' HD11 ' A' ' 57' ' ' ILE . 18.2 tt -114.84 136.36 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 24.600000000000001 109.703 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.561 ' CG2' HD11 ' A' ' 26' ' ' ILE . 36.8 t -74.29 122.06 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.879 0.371 . . . . 16.73 110.83 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.43 ' HG3' ' CD2' ' A' ' 8' ' ' TYR . 11.9 pt-20 -103.1 -20.76 14.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.914 -0.584 . . . . 30.579999999999998 111.065 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.43 ' CD2' ' HG3' ' A' ' 7' ' ' GLU . 61.2 m-85 -134.52 141.86 46.84 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.844 0.354 . . . . 22.640000000000001 110.653 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -79.22 127.57 32.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.038 -0.528 . . . . 22.699999999999999 110.441 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.498 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 34.8 t80 -125.47 137.12 53.97 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.381 -0.372 . . . . 19.879999999999999 111.019 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -94.82 119.12 32.87 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.063 -0.517 . . . . 26.050000000000001 110.38 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.512 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -66.46 103.38 1.03 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.273 -0.421 . . . . 26.149999999999999 111.469 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.07 -33.78 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.887 -0.597 . . . . 31.710000000000001 110.265 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.514 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 53.0 m80 -90.52 178.2 6.16 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.93 -0.577 . . . . 37.289999999999999 109.968 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -78.58 -46.05 20.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.665 -0.243 . . . . 45.18 110.693 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.13 -22.26 52.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.25 -0.432 . . . . 35.420000000000002 110.84 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 14' ' ' HIS . 16.0 tp10 -52.71 125.53 16.99 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.898 0.38 . . . . 26.239999999999998 110.908 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.39 127.61 36.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.934 -0.575 . . . . 23.559999999999999 110.61 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.8 m -80.92 86.28 6.09 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.005 -0.739 . . . . 22.84 109.005 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.684 HD11 ' HB3' ' A' ' 53' ' ' PHE . 23.8 pt -91.6 137.3 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.002 0.429 . . . . 24.600000000000001 111.794 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -118.38 139.18 51.77 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.862 -0.608 . . . . 18.719999999999999 109.966 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.403 HG22 ' CA ' ' A' ' 8' ' ' TYR . 40.6 t -47.57 124.76 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 111.994 0.368 . . . . 17.469999999999999 111.994 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.77 -18.24 37.7 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.848 -0.614 . . . . 18.82 113.527 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.742 ' HB3' HD11 ' A' ' 42' ' ' LEU . 41.7 mt-10 -78.14 153.59 31.95 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 117.263 0.531 . . . . 16.59 111.821 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.0 pt -112.65 125.93 69.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.665 -0.698 . . . . 24.600000000000001 110.245 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.634 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 3.9 mp -97.49 124.87 50.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.47 . . . . 24.600000000000001 110.405 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.521 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 40.2 ttm180 -78.46 127.58 32.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.265 -0.425 . . . . 21.550000000000001 112.032 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 61.5 t30 57.37 67.33 0.99 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.671 -0.695 . . . . 24.050000000000001 112.09 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.86 HG21 ' HB2' ' A' ' 4' ' ' TYR . 76.1 t -91.12 108.39 19.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.524 . . . . 26.149999999999999 110.864 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -110.89 167.1 10.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.896 -0.593 . . . . 42.509999999999998 110.929 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -92.67 135.64 33.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.945 -0.571 . . . . 33.310000000000002 110.333 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.553 HD21 ' HB2' ' A' ' 39' ' ' GLU . 95.1 mt -96.16 -177.42 3.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 37.710000000000001 110.987 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -81.41 -0.19 40.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.267 -0.424 . . . . 40.380000000000003 111.349 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HB3' ' HD1' ' A' ' 37' ' ' TRP . 38.6 mt-10 -105.57 121.6 44.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.84 -0.43 . . . . 38.539999999999999 109.84 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.0 117.83 5.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.039 -0.528 . . . . 33.270000000000003 110.767 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 94.44 11.23 57.38 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.003 -0.618 . . . . 28.280000000000001 113.123 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.505 ' C ' HD12 ' A' ' 38' ' ' LEU . 69.6 m95 -130.29 129.0 42.69 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.168 0.509 . . . . 23.140000000000001 111.103 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 48' ' ' MET . 8.0 mp -121.45 168.64 11.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.316 -0.856 . . . . 23.91 109.982 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.553 ' HB2' HD21 ' A' ' 32' ' ' LEU . 10.8 tp10 -127.05 123.04 36.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.487 -0.324 . . . . 43.399999999999999 110.877 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.438 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -155.49 163.41 31.6 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.622 -0.799 . . . . 20.079999999999998 113.42 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 27' ' ' ARG . 22.9 mt-10 -97.5 104.36 16.38 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.843 0.354 . . . . 32.100000000000001 110.921 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.742 HD11 ' HB3' ' A' ' 24' ' ' GLU . 43.1 tp -128.24 138.29 52.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 22.890000000000001 110.387 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.405 ' OD1' ' HG ' ' A' ' 42' ' ' LEU . 19.8 m120 63.37 21.95 13.04 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.893 -0.594 . . . . 30.739999999999998 111.21 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.7 12.79 76.98 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 121.007 -0.616 . . . . 33.009999999999998 113.476 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -135.32 144.53 46.76 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.819 0.342 . . . . 45.68 110.502 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -92.23 114.3 26.8 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.246 -1.02 . . . . 38.710000000000001 108.246 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.56 154.4 25.15 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.807 -1.187 . . . . 23.539999999999999 114.316 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.592 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 37.7 ttm -81.44 137.72 35.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.857 -0.671 . . . . 33.810000000000002 110.134 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' A' ' 26' ' ' ILE . 3.0 p90 -140.69 159.81 61.29 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.437 -0.347 . . . . 21.48 111.213 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.564 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 34.1 Cg_exo -61.03 145.9 98.46 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.688 2.259 . . . . 18.640000000000001 112.839 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.484 ' HA ' HD13 ' A' ' 38' ' ' LEU . 24.3 t70 -67.45 -38.4 84.44 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.734 -0.666 . . . . 25.32 111.997 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -85.67 9.32 16.58 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.37 0.507 . . . . 25.559999999999999 112.37 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.684 ' HB3' HD11 ' A' ' 20' ' ' ILE . 9.1 m-85 -105.11 -24.42 12.77 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.553 0.216 . . . . 21.91 110.432 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 20.2 m -115.45 137.8 47.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.21 -0.45 . . . . 20.469999999999999 109.927 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -115.64 124.2 50.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.4 -0.364 . . . . 24.52 110.591 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 38.0 tt0 -55.68 132.08 48.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.322 -0.399 . . . . 36.5 110.671 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.406 HD11 ' HB ' ' A' ' 5' ' ' ILE . 45.8 mt -93.5 75.64 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.205 0.526 . . . . 29.5 110.386 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 ttmm . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.56 -0.734 . . . . 44.289999999999999 110.881 -179.893 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.724 0.297 . . . . 33.030000000000001 111.344 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.71 157.26 19.68 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.155 -0.475 . . . . 30.120000000000001 111.093 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.835 ' HB2' HG21 ' A' ' 29' ' ' VAL . 8.1 m-85 -133.2 151.51 51.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.864 -0.607 . . . . 30.109999999999999 110.88 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 55' ' ' LYS . 15.4 tt -109.56 137.03 43.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.339 -0.615 . . . . 30.57 109.339 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.584 HG21 ' HB ' ' A' ' 20' ' ' ILE . 37.4 t -79.94 119.03 28.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.879 0.371 . . . . 31.149999999999999 110.798 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -102.58 -20.04 14.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.993 -0.549 . . . . 37.960000000000001 110.976 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -130.62 138.01 49.9 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.565 -0.289 . . . . 29.969999999999999 110.634 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -75.02 127.64 33.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 32.049999999999997 110.594 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.489 ' HB3' HG12 ' A' ' 20' ' ' ILE . 68.1 t80 -117.82 132.78 56.4 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.185 -0.461 . . . . 33.979999999999997 110.317 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -93.68 154.71 17.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 36.689999999999998 110.759 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.46 116.02 6.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 30.620000000000001 110.51 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.55 -27.91 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.92 -0.582 . . . . 30.559999999999999 110.445 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.65 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 52.0 m80 -148.54 -179.22 6.8 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.123 -0.49 . . . . 29.609999999999999 110.177 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -76.32 -29.32 57.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 35.799999999999997 110.841 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -94.09 6.78 47.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.371 -0.377 . . . . 32.579999999999998 111.524 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.65 ' HG2' ' HB2' ' A' ' 14' ' ' HIS . 45.0 mm-40 -95.95 131.66 42.08 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 110.238 -0.282 . . . . 36.109999999999999 110.238 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -88.69 123.83 33.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 30.739999999999998 111.129 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 37.0 m -81.62 84.91 6.64 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.081 -0.711 . . . . 30.809999999999999 109.081 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 53' ' ' PHE . 35.1 pt -90.06 142.64 12.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.746 -0.661 . . . . 30.390000000000001 111.743 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.417 ' HD3' ' N ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -121.2 142.5 49.84 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.126 -0.488 . . . . 29.609999999999999 110.107 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -49.5 124.78 2.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 112.014 0.376 . . . . 31.460000000000001 112.014 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.1 -16.67 45.74 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.864 -0.607 . . . . 30.600000000000001 113.686 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.0 156.68 25.79 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 117.468 0.634 . . . . 35.799999999999997 112.018 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.9 mm -113.82 127.9 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.364 -0.834 . . . . 30.379999999999999 110.124 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.59 HD12 HG11 ' A' ' 54' ' ' VAL . 36.6 mt -98.46 125.75 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 32.07 110.834 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.573 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 75.8 mtm180 -71.77 124.5 24.94 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.833 -0.621 . . . . 29.719999999999999 112.553 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 49.37 72.68 0.29 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.65 -0.705 . . . . 29.649999999999999 112.491 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.835 HG21 ' HB2' ' A' ' 4' ' ' TYR . 71.6 t -86.59 109.0 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 30.309999999999999 110.325 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -105.42 158.96 16.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.81 -0.632 . . . . 38.770000000000003 110.688 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -90.18 134.17 34.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.701 -0.481 . . . . 32.939999999999998 109.701 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.444 HD11 ' HG2' ' A' ' 48' ' ' MET . 91.1 mt -97.16 -177.55 3.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.401 -0.363 . . . . 33.130000000000003 111.19 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.9 2.57 33.77 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.257 -0.428 . . . . 42.18 111.214 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 4.8 mp0 -105.73 116.31 31.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.318 -0.623 . . . . 38.109999999999999 109.318 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.78 118.02 5.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.263 -0.426 . . . . 30.43 110.651 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 96.17 9.14 57.28 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.899 -0.667 . . . . 30.129999999999999 113.408 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 73.4 m95 -130.98 130.54 43.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.245 0.545 . . . . 30.289999999999999 111.087 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 48' ' ' MET . 6.6 mp -120.74 168.79 11.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.121 -0.945 . . . . 30.329999999999998 109.663 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.426 ' HB2' HD21 ' A' ' 32' ' ' LEU . 40.1 tt0 -128.21 123.96 35.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.647 0.26 . . . . 38.590000000000003 110.732 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.448 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -151.26 160.18 28.56 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.754 -0.736 . . . . 29.850000000000001 112.829 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 3.3 mp0 -97.2 102.93 14.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.068 0.461 . . . . 37.880000000000003 110.946 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.553 ' CD2' HG22 ' A' ' 20' ' ' ILE . 54.9 tp -125.81 138.12 53.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.65 -0.704 . . . . 30.379999999999999 109.989 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 62.5 21.15 12.43 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.091 -0.504 . . . . 40.090000000000003 111.471 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.93 9.46 80.72 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 120.937 -0.649 . . . . 31.289999999999999 113.6 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -132.18 141.39 49.08 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.687 0.28 . . . . 44.740000000000002 110.407 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -91.86 114.69 27.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.617 -0.882 . . . . 33.119999999999997 108.617 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.26 179.91 16.94 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.267 -0.968 . . . . 29.77 113.509 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.585 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 77.3 mtp -111.2 134.89 52.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.441 -0.379 . . . . 35.170000000000002 110.227 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.513 ' CE2' HD13 ' A' ' 26' ' ' ILE . 2.0 p90 -135.36 159.09 73.04 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.151 -0.477 . . . . 30.170000000000002 110.999 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 33.6 Cg_exo -61.06 148.74 91.95 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.708 2.272 . . . . 30.280000000000001 112.815 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.43 -39.06 85.44 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.761 -0.654 . . . . 32.210000000000001 111.794 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -87.35 15.3 6.6 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.307 0.484 . . . . 34.539999999999999 112.307 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.586 ' HB3' HD11 ' A' ' 20' ' ' ILE . 4.9 m-85 -106.71 -24.98 11.94 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 120.527 0.203 . . . . 34.039999999999999 110.603 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.59 HG11 HD12 ' A' ' 26' ' ' ILE . 28.2 m -124.31 144.81 32.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.178 -0.464 . . . . 31.539999999999999 110.54 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' O ' HG22 ' A' ' 5' ' ' ILE . 63.6 tttm -122.03 128.74 51.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 30.59 110.108 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -52.83 136.28 34.34 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.62 0.248 . . . . 32.189999999999998 110.788 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.578 HG23 ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -84.1 103.75 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.371 0.605 . . . . 30.539999999999999 110.375 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.135 -0.936 . . . . 40.630000000000003 110.745 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.73 0.3 . . . . 33.030000000000001 111.156 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -79.95 150.78 30.38 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.989 0.423 . . . . 30.120000000000001 111.497 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.858 ' HB2' HG21 ' A' ' 29' ' ' VAL . 10.4 m-85 -130.37 151.79 50.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.613 -0.721 . . . . 30.109999999999999 110.72 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.4 tt -120.07 124.35 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 30.57 109.89 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 25.3 t -63.82 129.65 27.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 31.149999999999999 111.319 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -109.92 -25.31 10.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.656 -0.702 . . . . 37.960000000000001 110.428 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -132.79 139.19 47.41 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.288 -0.415 . . . . 29.969999999999999 110.283 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -69.0 141.96 54.76 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.331 -0.395 . . . . 32.049999999999997 111.029 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -135.95 126.07 26.22 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.232 -0.44 . . . . 33.979999999999997 110.855 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -82.59 117.38 22.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 36.689999999999998 111.321 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.94 104.89 3.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.939 -0.573 . . . . 30.620000000000001 110.945 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.6 t -85.95 -37.26 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.797 -0.638 . . . . 30.559999999999999 110.169 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.602 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 55.3 m-70 -89.59 174.11 7.94 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.96 -0.564 . . . . 29.609999999999999 110.795 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -81.19 -31.34 34.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.117 -0.492 . . . . 35.799999999999997 110.965 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -100.0 16.74 22.96 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.493 -0.321 . . . . 32.579999999999998 110.724 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 14' ' ' HIS . 22.6 tt0 -96.93 125.94 41.71 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.906 -0.405 . . . . 36.109999999999999 109.906 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.687 HD12 ' CD1' ' A' ' 49' ' ' PHE . 35.3 mt -79.94 133.5 36.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.863 0.363 . . . . 30.739999999999998 111.064 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 m -87.17 55.16 3.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.848 -0.614 . . . . 30.809999999999999 110.527 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.553 HG22 HD22 ' A' ' 42' ' ' LEU . 22.1 pt -48.81 120.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 112.546 0.573 . . . . 30.390000000000001 112.546 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -113.43 136.46 52.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.394 -0.821 . . . . 29.609999999999999 109.292 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -43.09 122.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.733 0.301 . . . . 31.460000000000001 111.715 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.42 -18.41 38.57 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.075 -0.583 . . . . 30.600000000000001 113.813 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.428 ' HB3' HD11 ' A' ' 42' ' ' LEU . 41.8 mt-10 -80.03 147.28 31.57 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 117.554 0.677 . . . . 35.799999999999997 111.534 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 25' ' ' ILE . 4.4 mp -111.79 127.79 68.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.805 -0.634 . . . . 30.379999999999999 110.311 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.53 HG21 ' CE1' ' A' ' 49' ' ' PHE . 3.9 mp -96.07 122.28 47.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.28 -0.418 . . . . 32.07 110.287 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.569 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 22.0 mmm180 -74.31 127.74 33.76 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.083 -0.508 . . . . 29.719999999999999 112.073 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 52.39 73.42 0.34 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.816 -0.629 . . . . 29.649999999999999 112.176 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.858 HG21 ' HB2' ' A' ' 4' ' ' TYR . 55.9 t -88.77 110.57 21.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.973 -0.558 . . . . 30.309999999999999 111.507 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -102.48 154.97 18.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.699 -0.682 . . . . 38.770000000000003 109.923 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.455 ' HA ' HD23 ' A' ' 38' ' ' LEU . 86.1 tttt -80.48 123.35 28.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.953 0.406 . . . . 32.939999999999998 110.988 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.1 tp -77.83 162.77 26.64 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.774 -0.648 . . . . 33.130000000000003 110.068 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -61.75 -28.81 69.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.487 -0.324 . . . . 42.18 110.79 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -83.95 129.87 34.91 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.805 0.336 . . . . 38.109999999999999 110.761 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.61 122.42 16.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.864 -0.607 . . . . 30.43 109.675 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 94.06 18.04 38.36 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 30.129999999999999 112.342 -178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -134.46 135.18 42.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.105 0.479 . . . . 30.289999999999999 110.484 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.594 ' O ' ' HA ' ' A' ' 48' ' ' MET . 81.0 mt -124.73 161.71 25.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.345 -0.843 . . . . 30.329999999999998 110.022 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.43 119.45 28.29 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.103 -0.332 . . . . 38.590000000000003 110.103 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.504 ' O ' HD11 ' A' ' 18' ' ' LEU . . . -157.23 165.67 33.38 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.417 -0.897 . . . . 29.850000000000001 113.405 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.569 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 2.0 tm-20 -86.79 109.38 19.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.942 0.401 . . . . 37.880000000000003 110.079 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.591 ' HB3' HD13 ' A' ' 18' ' ' LEU . 57.8 tp -132.03 134.09 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.665 -0.698 . . . . 30.379999999999999 110.371 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 64.18 21.39 12.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.922 -0.581 . . . . 40.090000000000003 111.398 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.61 18.66 59.73 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 120.97 -0.633 . . . . 31.289999999999999 113.553 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -144.45 150.91 38.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.777 0.322 . . . . 44.740000000000002 110.645 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.8 tpp180 -94.19 115.98 28.33 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.989 -0.745 . . . . 33.119999999999997 108.989 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.499 ' HA3' ' HG ' ' A' ' 18' ' ' LEU . . . -141.07 -170.83 12.32 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.322 -0.942 . . . . 29.77 113.442 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.594 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 45.8 mtt -119.07 138.05 53.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.547 -0.326 . . . . 35.170000000000002 110.158 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.687 ' CD1' HD12 ' A' ' 18' ' ' LEU . 4.5 p90 -143.23 158.92 57.26 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 30.170000000000002 111.475 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.515 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 37.6 Cg_exo -57.35 141.46 94.79 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.817 2.344 . . . . 30.280000000000001 112.941 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -75.45 -39.04 59.3 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.563 -0.744 . . . . 32.210000000000001 111.453 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -76.35 -3.98 39.74 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.741 0.645 . . . . 34.539999999999999 112.741 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 6.9 m-85 -93.7 -34.15 13.36 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 110.336 -0.246 . . . . 34.039999999999999 110.336 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.655 HG21 ' HE2' ' A' ' 49' ' ' PHE . 24.7 m -102.72 143.55 14.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.198 -0.456 . . . . 31.539999999999999 110.214 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -109.99 130.44 55.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.355 -0.384 . . . . 30.59 110.808 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -52.0 132.21 32.3 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.127 -0.488 . . . . 32.189999999999998 110.582 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.9 mt -92.51 81.68 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.044 0.45 . . . . 30.539999999999999 110.437 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.037 -0.982 . . . . 40.630000000000003 111.217 -179.926 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.422 HG23 ' HE1' ' A' ' 4' ' ' TYR . 7.8 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.729 0.3 . . . . 33.030000000000001 111.364 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -80.65 149.82 29.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.152 -0.476 . . . . 30.120000000000001 110.734 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.865 ' HB2' HG21 ' A' ' 29' ' ' VAL . 9.0 m-85 -128.87 151.37 49.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.81 -0.632 . . . . 30.109999999999999 110.891 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.3 tt -116.9 126.46 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.025 -0.534 . . . . 30.57 109.75 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.541 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 34.8 t -68.19 128.52 31.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.963 0.411 . . . . 31.149999999999999 110.918 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -110.14 -22.82 11.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.702 -0.681 . . . . 37.960000000000001 110.77 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -133.43 140.8 47.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.413 -0.358 . . . . 29.969999999999999 110.389 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -72.28 136.5 46.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.319 -0.4 . . . . 32.049999999999997 110.71 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.51 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 63.5 t80 -137.43 128.61 27.78 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.278 -0.419 . . . . 33.979999999999997 111.093 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.45 ' HA ' HG23 ' A' ' 19' ' ' THR . 6.1 p-10 -79.97 157.15 26.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.868 -0.605 . . . . 36.689999999999998 110.463 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.08 95.59 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.372 -0.376 . . . . 30.620000000000001 111.158 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.12 -37.2 46.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.071 -0.513 . . . . 30.559999999999999 109.83 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.594 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 91.5 m-70 -93.38 165.86 12.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.721 -0.672 . . . . 29.609999999999999 110.724 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -74.6 -33.78 62.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 35.799999999999997 110.885 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.63 17.31 15.13 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.148 -0.478 . . . . 32.579999999999998 110.901 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.594 ' HB2' ' HB2' ' A' ' 14' ' ' HIS . 21.3 tt0 -97.77 128.47 44.44 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.99 -0.374 . . . . 36.109999999999999 109.99 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.567 ' HG ' ' HA3' ' A' ' 47' ' ' GLY . 6.6 mt -82.75 130.34 35.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.785 0.326 . . . . 30.739999999999998 111.181 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 11' ' ' ASP . 11.4 m -86.81 64.96 8.78 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.971 -0.558 . . . . 30.809999999999999 109.703 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.576 HG22 HD22 ' A' ' 42' ' ' LEU . 30.0 pt -60.94 127.4 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 112.629 0.603 . . . . 30.390000000000001 112.629 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -115.14 138.42 50.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.625 -0.716 . . . . 29.609999999999999 109.663 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.0 t -44.4 125.37 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.728 0.299 . . . . 31.460000000000001 111.794 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.86 -19.72 40.51 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.053 -0.594 . . . . 30.600000000000001 113.456 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -76.3 146.6 38.79 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 117.254 0.527 . . . . 35.799999999999997 111.639 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.4 pt -109.18 125.16 66.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.852 -0.613 . . . . 30.379999999999999 110.147 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.647 HG21 ' CE1' ' A' ' 49' ' ' PHE . 6.1 mm -94.97 119.87 43.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 32.07 110.636 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 88.8 mtm180 -75.75 127.69 33.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 29.719999999999999 112.007 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.9 t30 53.07 73.37 0.36 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.798 -0.637 . . . . 29.649999999999999 112.133 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.865 HG21 ' HB2' ' A' ' 4' ' ' TYR . 66.4 t -91.85 110.15 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 30.309999999999999 111.189 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -107.64 162.82 13.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.868 -0.605 . . . . 38.770000000000003 110.546 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.515 ' HA ' HD23 ' A' ' 38' ' ' LEU . 5.7 mmmt -90.14 128.66 36.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 32.939999999999998 110.861 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 39' ' ' GLU . 92.8 mt -90.14 179.41 5.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.033 -0.53 . . . . 33.130000000000003 110.866 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.09 -3.51 45.7 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.252 -0.431 . . . . 42.18 111.179 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 35.3 mt-10 -100.93 119.08 38.19 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.798 -0.445 . . . . 38.109999999999999 109.798 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -60.93 117.65 5.72 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.303 -0.408 . . . . 30.43 110.274 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.08 17.45 34.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.024 -0.608 . . . . 30.129999999999999 112.4 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 99.3 m95 -133.55 132.3 40.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.137 0.494 . . . . 30.289999999999999 111.016 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 48' ' ' MET . 83.5 mt -119.87 160.91 21.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.317 -0.856 . . . . 30.329999999999998 109.936 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.541 ' HB2' HD21 ' A' ' 32' ' ' LEU . 9.1 tp10 -122.92 117.56 25.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.574 0.226 . . . . 38.590000000000003 110.674 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.13 164.64 32.45 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.499 -0.857 . . . . 29.850000000000001 113.418 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 3.5 mp0 -92.13 117.06 29.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.06 0.457 . . . . 37.880000000000003 111.104 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.576 HD22 HG22 ' A' ' 20' ' ' ILE . 55.5 tp -131.87 130.5 41.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.59 -0.732 . . . . 30.379999999999999 110.308 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 60.99 26.09 16.07 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.94 -0.573 . . . . 40.090000000000003 111.54 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.37 15.29 69.25 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.715 -0.755 . . . . 31.289999999999999 113.954 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -139.02 145.49 39.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.853 0.327 . . . . 44.740000000000002 110.422 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -95.46 120.0 34.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.558 -0.534 . . . . 33.119999999999997 109.558 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.567 ' HA3' ' HG ' ' A' ' 18' ' ' LEU . . . -149.34 155.42 26.3 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.293 -0.956 . . . . 29.77 113.669 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.618 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 24.8 ptt? -80.96 140.49 35.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.955 0.407 . . . . 35.170000000000002 110.9 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.647 ' CE1' HG21 ' A' ' 26' ' ' ILE . 6.1 p90 -141.63 162.68 45.48 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.933 -0.576 . . . . 30.170000000000002 111.095 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.564 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 25.9 Cg_exo -62.73 144.07 93.23 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.779 2.32 . . . . 30.280000000000001 112.971 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.6 -39.41 67.33 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.728 -0.669 . . . . 32.210000000000001 111.84 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -79.83 0.37 31.27 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.061 0.763 . . . . 34.539999999999999 113.061 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 9.6 m-85 -98.18 -31.22 12.2 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.494 0.188 . . . . 34.039999999999999 110.669 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 25.6 m -110.08 135.14 50.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.401 -0.363 . . . . 31.539999999999999 110.53 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -107.09 127.71 53.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 30.59 110.495 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 4' ' ' TYR . 37.6 tt0 -57.61 136.31 56.78 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.446 -0.343 . . . . 32.189999999999998 110.668 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.4 mt -93.82 84.79 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 30.539999999999999 110.602 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.132 -0.937 . . . . 40.630000000000003 110.89 -179.954 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.816 0.341 . . . . 30.68 111.129 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -88.29 156.91 18.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.166 -0.47 . . . . 27.210000000000001 111.368 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.829 ' HB2' HG21 ' A' ' 29' ' ' VAL . 8.9 m-85 -133.38 152.97 51.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.505 -0.771 . . . . 24.84 110.578 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.5 tt -117.84 129.75 73.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.064 -0.516 . . . . 24.600000000000001 109.691 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.566 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 21.9 t -69.26 127.18 30.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.369 -0.378 . . . . 16.73 111.316 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.482 ' HG3' ' CD2' ' A' ' 8' ' ' TYR . 14.2 pt-20 -109.48 -19.16 13.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.885 -0.598 . . . . 30.579999999999998 110.839 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.482 ' CD2' ' HG3' ' A' ' 7' ' ' GLU . 30.8 m-85 -133.08 142.87 48.96 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.488 -0.323 . . . . 22.640000000000001 110.181 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -77.28 129.34 35.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.413 -0.358 . . . . 22.699999999999999 110.752 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.486 ' HB3' HG12 ' A' ' 20' ' ' ILE . 77.8 t80 -124.46 130.71 52.97 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.292 -0.413 . . . . 19.879999999999999 110.664 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -93.33 113.12 25.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.881 -0.6 . . . . 26.050000000000001 110.318 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.89 106.97 1.11 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.049 -0.523 . . . . 26.149999999999999 111.326 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -83.76 -36.13 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.757 -0.656 . . . . 31.710000000000001 110.177 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -94.02 176.37 6.36 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.891 -0.595 . . . . 37.289999999999999 110.596 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -81.3 -33.54 32.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 45.18 110.905 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -80.8 -28.23 36.35 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.363 -0.381 . . . . 35.420000000000002 110.552 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.42 134.46 57.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.27 -0.423 . . . . 26.239999999999998 111.114 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.634 HD12 ' CD1' ' A' ' 49' ' ' PHE . 28.9 mt -92.42 132.68 36.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.566 -0.743 . . . . 23.559999999999999 110.562 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.6 m -84.26 78.91 9.7 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.299 -0.63 . . . . 22.84 109.299 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.668 HG22 ' HG ' ' A' ' 42' ' ' LEU . 33.1 pt -78.42 133.41 30.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.935 0.398 . . . . 24.600000000000001 111.752 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -118.24 138.29 52.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 18.719999999999999 109.902 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.405 HG22 ' CA ' ' A' ' 8' ' ' TYR . 39.0 t -44.99 120.98 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.283 -0.417 . . . . 17.469999999999999 111.743 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.13 -21.01 25.4 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.046 -0.597 . . . . 18.82 113.633 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.618 ' HB3' HD21 ' A' ' 42' ' ' LEU . 39.1 mt-10 -76.32 154.48 35.01 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 117.343 0.572 . . . . 16.59 111.676 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.5 mt -117.29 127.72 74.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.528 -0.76 . . . . 24.600000000000001 110.16 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.626 HG21 ' CZ ' ' A' ' 49' ' ' PHE . 4.0 mp -94.94 125.44 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 24.600000000000001 110.393 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.607 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 7.7 mpt_? -80.0 125.49 29.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.482 . . . . 21.550000000000001 111.851 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.07 65.87 0.95 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.804 -0.634 . . . . 24.050000000000001 111.779 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.829 HG21 ' HB2' ' A' ' 4' ' ' TYR . 61.8 t -87.59 105.54 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.841 -0.618 . . . . 26.149999999999999 111.238 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -107.37 161.48 14.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.792 -0.64 . . . . 42.509999999999998 110.441 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HA ' HD23 ' A' ' 38' ' ' LEU . 39.1 ttmt -84.68 132.14 34.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 33.310000000000002 110.468 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.9 tp -91.01 171.01 9.56 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.865 -0.607 . . . . 37.710000000000001 110.331 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -77.13 -1.71 30.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.629 0.252 . . . . 40.380000000000003 110.855 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 42.3 mt-10 -103.67 122.49 45.15 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.646 -0.501 . . . . 38.539999999999999 109.646 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -60.86 117.9 6.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 33.270000000000003 110.461 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.05 15.39 45.24 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.99 -0.624 . . . . 28.280000000000001 112.833 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 85.6 m95 -132.54 132.47 42.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.163 0.506 . . . . 23.140000000000001 111.153 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 48' ' ' MET . 98.0 mt -118.79 162.25 18.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.262 -0.881 . . . . 23.91 110.021 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -123.09 118.36 27.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.577 -0.283 . . . . 43.399999999999999 110.439 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.466 ' O ' HD11 ' A' ' 18' ' ' LEU . . . -162.12 170.96 37.91 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.615 -0.802 . . . . 20.079999999999998 113.523 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 34.6 mt-10 -94.09 105.86 17.85 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.918 0.39 . . . . 32.100000000000001 110.46 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.668 ' HG ' HG22 ' A' ' 20' ' ' ILE . 3.1 tm? -124.49 130.44 52.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.879 -0.601 . . . . 22.890000000000001 110.065 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.516 ' HB2' HD13 ' A' ' 42' ' ' LEU . 66.6 t30 64.14 25.1 13.62 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.025 -0.534 . . . . 30.739999999999998 110.939 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.38 13.87 79.66 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 121.003 -0.617 . . . . 33.009999999999998 113.299 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -130.86 140.22 50.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.851 0.358 . . . . 45.68 110.736 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -91.4 114.03 26.46 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.485 -0.932 . . . . 38.710000000000001 108.485 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.541 ' HA3' ' HG ' ' A' ' 18' ' ' LEU . . . -151.19 -168.97 16.34 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.031 -1.081 . . . . 23.539999999999999 114.018 -178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.617 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 50.7 mtt -111.77 138.72 47.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.499 -0.351 . . . . 33.810000000000002 110.661 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.634 ' CD1' HD12 ' A' ' 18' ' ' LEU . 4.6 p90 -140.59 153.42 68.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 21.48 111.35 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HG2' ' HB2' ' A' ' 53' ' ' PHE . 9.9 Cg_endo -54.05 135.76 65.0 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.87 2.38 . . . . 18.640000000000001 112.691 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -67.9 -38.08 82.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.686 -0.688 . . . . 25.32 112.104 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -81.64 5.59 17.75 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.685 0.624 . . . . 25.559999999999999 112.685 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.519 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 9.8 m-85 -102.56 -24.82 13.76 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.494 0.188 . . . . 21.91 110.601 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 31.0 m -116.5 137.19 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.307 -0.406 . . . . 20.469999999999999 110.401 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -111.24 129.16 56.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 24.52 110.344 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -50.46 141.36 12.25 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.404 -0.362 . . . . 36.5 110.996 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.7 mt -95.33 89.77 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 29.5 110.751 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.55 -0.738 . . . . 44.289999999999999 110.879 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.603 0.24 . . . . 33.030000000000001 111.034 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.1 152.04 22.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.13 0.49 . . . . 30.120000000000001 111.783 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.917 ' HB2' HG21 ' A' ' 29' ' ' VAL . 7.6 m-85 -130.91 152.6 50.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.396 -0.82 . . . . 30.109999999999999 110.702 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 55' ' ' LYS . 6.5 tp -113.31 132.93 60.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.937 -0.574 . . . . 30.57 109.804 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.591 ' CG2' HD11 ' A' ' 26' ' ' ILE . 40.5 t -74.42 123.52 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.91 0.386 . . . . 31.149999999999999 110.703 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.475 ' HG3' ' CD2' ' A' ' 8' ' ' TYR . 12.5 pt-20 -104.34 -21.18 13.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.98 -0.555 . . . . 37.960000000000001 111.113 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.475 ' CD2' ' HG3' ' A' ' 7' ' ' GLU . 60.9 m-85 -133.14 142.52 48.71 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.856 0.36 . . . . 29.969999999999999 110.827 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -77.57 128.46 34.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 32.049999999999997 110.371 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.505 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 53.0 t80 -128.67 135.98 50.01 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.753 0.311 . . . . 33.979999999999997 111.13 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -96.9 119.85 36.16 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.003 -0.544 . . . . 36.689999999999998 110.562 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.18 105.17 1.32 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.275 -0.42 . . . . 30.620000000000001 111.107 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -87.05 -36.94 10.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.887 -0.597 . . . . 30.559999999999999 110.035 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.574 ' HB2' ' HG2' ' A' ' 17' ' ' GLU . 52.8 m-70 -89.21 -179.77 5.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.887 -0.597 . . . . 29.609999999999999 110.305 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -78.84 -45.82 19.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.502 -0.317 . . . . 35.799999999999997 111.029 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -77.93 -23.28 48.66 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.572 -0.286 . . . . 32.579999999999998 111.007 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.574 ' HG2' ' HB2' ' A' ' 14' ' ' HIS . 29.6 mm-40 -52.99 132.22 37.32 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.992 0.425 . . . . 36.109999999999999 111.012 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.517 HD11 ' HB3' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -95.5 129.01 42.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.639 -0.71 . . . . 30.739999999999998 110.589 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.8 m -82.99 86.11 7.05 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.992 -0.744 . . . . 30.809999999999999 108.992 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.651 HD11 ' HB3' ' A' ' 53' ' ' PHE . 36.1 pt -87.71 137.59 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 120.92 0.39 . . . . 30.390000000000001 111.895 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -116.51 135.55 53.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.811 -0.631 . . . . 29.609999999999999 109.974 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -47.21 124.41 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.935 0.398 . . . . 31.460000000000001 111.634 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.25 -16.31 42.07 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.763 -0.653 . . . . 30.600000000000001 113.322 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.418 ' HB3' HD11 ' A' ' 42' ' ' LEU . 15.6 mm-40 -82.2 150.0 27.6 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 117.278 0.539 . . . . 35.799999999999997 111.643 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.1 mt -109.17 128.02 65.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.666 -0.697 . . . . 30.379999999999999 110.14 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.591 HD11 ' CG2' ' A' ' 6' ' ' VAL . 4.2 mp -97.03 126.46 49.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.444 . . . . 32.07 110.58 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.442 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 83.9 mtp180 -76.51 125.75 29.77 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.075 -0.511 . . . . 29.719999999999999 112.172 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.2 t30 55.2 69.9 0.69 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.726 -0.67 . . . . 29.649999999999999 112.241 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.917 HG21 ' HB2' ' A' ' 4' ' ' TYR . 89.0 t -88.44 106.61 16.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.984 -0.553 . . . . 30.309999999999999 110.511 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -103.96 160.22 15.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.874 -0.603 . . . . 38.770000000000003 110.88 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.42 ' HA ' ' CD2' ' A' ' 38' ' ' LEU . 63.0 mttp -90.84 132.12 36.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 32.939999999999998 110.07 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 39' ' ' GLU . 93.8 mt -94.68 178.67 5.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 33.130000000000003 110.871 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.58 0.89 31.97 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.29 -0.414 . . . . 42.18 111.013 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.465 ' HB3' ' HD1' ' A' ' 37' ' ' TRP . 36.1 mt-10 -104.49 120.4 41.17 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.426 -0.583 . . . . 38.109999999999999 109.426 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -61.02 118.1 6.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 30.43 110.77 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 94.6 11.87 56.44 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.011 -0.614 . . . . 30.129999999999999 113.066 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.596 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 55.3 m95 -129.97 129.88 44.33 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.148 0.499 . . . . 30.289999999999999 111.208 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 48' ' ' MET . 90.1 mt -121.96 165.94 15.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.355 -0.839 . . . . 30.329999999999998 109.997 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.499 ' HB2' HD21 ' A' ' 32' ' ' LEU . 9.1 tp10 -126.08 122.07 34.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.611 -0.268 . . . . 38.590000000000003 110.612 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.465 ' HA3' ' CG2' ' A' ' 26' ' ' ILE . . . -154.76 162.37 30.76 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.635 -0.793 . . . . 29.850000000000001 113.283 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.442 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 3.1 mp0 -96.89 104.99 17.05 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.024 0.44 . . . . 37.880000000000003 110.945 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.517 ' CD2' HG22 ' A' ' 20' ' ' ILE . 53.0 tp -130.67 138.05 49.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.657 -0.702 . . . . 30.379999999999999 110.1 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 67.65 18.99 9.87 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.975 -0.557 . . . . 40.090000000000003 110.951 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.47 14.88 67.38 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 120.886 -0.673 . . . . 31.289999999999999 113.466 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -142.51 149.06 38.65 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.8 0.334 . . . . 44.740000000000002 110.377 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -92.82 116.3 28.91 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.704 -0.85 . . . . 33.119999999999997 108.704 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.1 151.75 22.75 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.036 -1.078 . . . . 29.77 114.011 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 62.0 ttp -81.44 135.57 35.64 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.242 -0.479 . . . . 35.170000000000002 110.312 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.565 ' CE2' HG21 ' A' ' 26' ' ' ILE . 6.0 p90 -139.49 158.53 68.33 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 30.170000000000002 111.236 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.562 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 34.8 Cg_exo -59.01 141.28 98.17 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.672 2.248 . . . . 30.280000000000001 112.721 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.31 -36.7 79.72 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.693 -0.685 . . . . 32.210000000000001 111.575 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -83.18 4.55 26.21 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.33 0.493 . . . . 34.539999999999999 112.33 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.651 ' HB3' HD11 ' A' ' 20' ' ' ILE . 9.2 m-85 -101.3 -21.69 14.81 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 120.621 0.248 . . . . 34.039999999999999 110.466 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 24.3 m -120.51 141.62 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 116.205 -0.452 . . . . 31.539999999999999 109.994 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.403 ' O ' HG22 ' A' ' 5' ' ' ILE . 88.4 tttt -116.14 129.07 56.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.388 -0.369 . . . . 30.59 110.689 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -55.14 129.45 38.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.415 -0.357 . . . . 32.189999999999998 110.102 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.4 mt -87.65 81.0 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.02 0.438 . . . . 30.539999999999999 110.765 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.0 tttm . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.072 -0.966 . . . . 40.630000000000003 111.026 -179.763 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.711 0.291 . . . . 30.68 111.325 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -85.62 154.52 21.64 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.226 -0.443 . . . . 27.210000000000001 110.748 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.81 ' HB2' HG21 ' A' ' 29' ' ' VAL . 8.3 m-85 -127.95 151.58 48.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 24.84 111.24 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.65 ' HB ' HD11 ' A' ' 57' ' ' ILE . 6.5 tp -112.34 133.2 58.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.667 -0.697 . . . . 24.600000000000001 109.328 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 38.3 t -77.34 124.18 35.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.806 0.336 . . . . 16.73 110.791 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.474 ' C ' HG22 ' A' ' 22' ' ' VAL . 19.4 mm-40 -108.44 -17.46 13.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.992 -0.549 . . . . 30.579999999999998 111.166 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.492 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 73.9 m-85 -133.71 141.29 47.49 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.673 0.273 . . . . 22.640000000000001 110.674 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -77.49 128.35 34.06 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.301 -0.409 . . . . 22.699999999999999 110.69 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.463 ' CD1' ' HG3' ' A' ' 50' ' ' PRO . 40.1 t80 -125.81 136.28 52.94 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.492 -0.322 . . . . 19.879999999999999 110.841 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -94.17 119.48 33.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.086 -0.506 . . . . 26.050000000000001 110.898 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -69.53 104.99 2.49 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.102 -0.499 . . . . 26.149999999999999 111.089 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.4 t -89.59 -34.87 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.748 -0.66 . . . . 31.710000000000001 110.138 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 43.7 m80 -90.91 172.06 8.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.906 -0.588 . . . . 37.289999999999999 110.514 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.68 -36.95 50.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 45.18 110.392 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -92.76 15.37 14.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.135 -0.484 . . . . 35.420000000000002 110.901 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.501 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 23.0 tp10 -92.53 127.84 38.17 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.911 -0.404 . . . . 26.239999999999998 109.911 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -86.39 124.95 33.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 23.559999999999999 111.139 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.2 m -81.18 83.75 6.73 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.274 -0.639 . . . . 22.84 109.274 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.508 ' HB ' ' CG2' ' A' ' 6' ' ' VAL . 38.0 pt -85.42 132.88 30.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.042 0.448 . . . . 24.600000000000001 111.709 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 -119.28 138.75 52.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.87 -0.604 . . . . 18.719999999999999 110.181 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.474 HG22 ' C ' ' A' ' 7' ' ' GLU . 46.2 t -44.25 120.97 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.841 0.353 . . . . 17.469999999999999 111.898 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.51 -19.52 28.79 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.87 -0.604 . . . . 18.82 113.613 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HB3' HD11 ' A' ' 42' ' ' LEU . 35.2 mt-10 -76.19 150.43 37.11 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 117.308 0.554 . . . . 16.59 111.981 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.6 mt -111.81 124.47 68.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.475 -0.784 . . . . 24.600000000000001 109.682 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.587 HG21 ' CE2' ' A' ' 49' ' ' PHE . 30.0 mt -97.12 123.15 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 24.600000000000001 110.403 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -75.71 133.57 40.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.028 -0.533 . . . . 21.550000000000001 112.067 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.7 p30 46.42 71.44 0.3 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.53 -0.759 . . . . 24.050000000000001 112.564 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.81 HG21 ' HB2' ' A' ' 4' ' ' TYR . 85.3 t -88.26 110.46 21.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.785 -0.643 . . . . 26.149999999999999 110.834 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HG2' ' N ' ' A' ' 31' ' ' LYS . 25.9 ttpp -107.0 160.9 15.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.745 -0.661 . . . . 42.509999999999998 110.482 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.404 ' N ' ' HG2' ' A' ' 30' ' ' LYS . 98.3 mttt -88.81 132.41 34.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 33.310000000000002 110.03 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 39' ' ' GLU . 95.9 mt -92.34 -179.98 5.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 37.710000000000001 111.166 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -81.36 -0.51 41.55 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.125 -0.489 . . . . 40.380000000000003 111.167 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -105.71 120.51 41.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.693 -0.484 . . . . 38.539999999999999 109.693 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -59.75 117.88 5.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.465 . . . . 33.270000000000003 110.638 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.26 13.02 50.25 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.939 -0.648 . . . . 28.280000000000001 112.963 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -131.38 130.13 42.23 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.139 0.495 . . . . 23.140000000000001 111.154 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.629 ' O ' ' HA ' ' A' ' 48' ' ' MET . 6.4 mp -119.71 164.39 16.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.295 -0.866 . . . . 23.91 109.525 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HB2' HD21 ' A' ' 32' ' ' LEU . 13.4 tp10 -126.38 122.6 35.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.638 0.256 . . . . 43.399999999999999 111.069 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.08 162.47 30.94 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.832 -0.699 . . . . 20.079999999999998 112.991 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -96.34 104.87 16.86 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.113 0.482 . . . . 32.100000000000001 111.026 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' A' ' 24' ' ' GLU . 59.8 tp -125.53 137.61 53.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.579 -0.737 . . . . 22.890000000000001 109.933 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 63.61 21.92 12.93 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.992 -0.549 . . . . 30.739999999999998 110.913 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.98 12.93 80.41 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 120.902 -0.666 . . . . 33.009999999999998 113.233 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -133.38 142.15 48.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.796 0.332 . . . . 45.68 110.287 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -93.96 114.77 27.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.91 -0.774 . . . . 38.710000000000001 108.91 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.53 153.99 25.68 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.299 -0.953 . . . . 23.539999999999999 113.344 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.629 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 22.7 ptt? -79.23 145.66 33.47 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.683 0.278 . . . . 33.810000000000002 110.369 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.587 ' CE2' HG21 ' A' ' 26' ' ' ILE . 3.8 p90 -143.99 155.66 58.81 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.256 -0.429 . . . . 21.48 111.22 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.574 ' HG2' ' HB2' ' A' ' 53' ' ' PHE . 14.5 Cg_endo -57.55 148.96 69.91 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.755 2.303 . . . . 18.640000000000001 112.99 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -73.36 -41.3 63.59 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.443 -0.799 . . . . 25.32 112.791 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -82.53 11.26 5.89 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.991 0.738 . . . . 25.559999999999999 112.991 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.574 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 16.3 m-85 -107.38 -27.2 10.61 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.57 0.224 . . . . 21.91 110.778 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 4' ' ' TYR . 27.5 m -116.88 139.86 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 116.323 -0.398 . . . . 20.469999999999999 110.39 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.424 ' O ' HG22 ' A' ' 5' ' ' ILE . 44.4 mmtm -118.37 127.44 53.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.371 -0.377 . . . . 24.52 110.528 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.634 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . 12.8 pt-20 -60.92 131.97 52.37 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.542 -0.299 . . . . 36.5 110.411 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.65 HD11 ' HB ' ' A' ' 5' ' ' ILE . 22.4 mt -87.73 85.59 2.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.114 0.483 . . . . 29.5 110.762 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.445 -0.788 . . . . 44.289999999999999 110.856 -179.917 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.749 0.309 . . . . 30.68 111.021 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -84.64 154.57 22.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.275 -0.42 . . . . 27.210000000000001 111.306 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.919 ' HB2' HG21 ' A' ' 29' ' ' VAL . 6.4 m-85 -130.76 151.4 51.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.772 -0.649 . . . . 24.84 110.917 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.424 HD13 ' CD1' ' A' ' 25' ' ' ILE . 3.4 tp -113.69 128.09 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.689 -0.687 . . . . 24.600000000000001 109.63 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.518 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 29.8 t -73.89 124.37 31.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.422 -0.354 . . . . 16.73 110.794 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.439 ' C ' HG22 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -107.79 -18.95 13.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.028 -0.533 . . . . 30.579999999999998 110.929 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -130.49 140.54 50.52 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.706 0.288 . . . . 22.640000000000001 110.672 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 21' ' ' ARG . 34.6 m-20 -76.33 131.5 39.23 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.266 -0.424 . . . . 22.699999999999999 110.564 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.432 ' CD2' ' HG2' ' A' ' 50' ' ' PRO . 44.5 t80 -132.08 131.56 42.5 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.501 -0.318 . . . . 19.879999999999999 110.834 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -95.02 119.84 34.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.94 -0.573 . . . . 26.050000000000001 110.604 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.454 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -65.08 107.25 1.47 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.013 -0.54 . . . . 26.149999999999999 111.56 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.1 p -87.8 -36.47 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.779 -0.646 . . . . 31.710000000000001 109.95 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 29.7 m80 -90.37 172.84 8.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.837 -0.62 . . . . 37.289999999999999 110.422 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.81 -35.61 43.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.323 -0.399 . . . . 45.18 110.303 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -92.28 9.39 34.11 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.08 -0.509 . . . . 35.420000000000002 110.986 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.454 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 22.7 tp10 -87.28 126.78 35.05 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.906 -0.405 . . . . 26.239999999999998 109.906 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.644 HD21 ' HB3' ' A' ' 42' ' ' LEU . 11.0 tp -84.92 126.53 33.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 23.559999999999999 110.753 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.5 m -83.12 88.44 6.89 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.887 -0.597 . . . . 22.84 109.394 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.555 HG22 HD22 ' A' ' 42' ' ' LEU . 33.0 pt -89.07 131.06 37.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.813 0.34 . . . . 24.600000000000001 111.237 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 9' ' ' ASP . 25.2 mmm180 -117.12 138.78 51.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.154 -0.475 . . . . 18.719999999999999 110.105 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.439 HG22 ' C ' ' A' ' 7' ' ' GLU . 48.3 t -45.42 122.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.391 -0.368 . . . . 17.469999999999999 111.791 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.82 -18.97 39.5 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.052 -0.594 . . . . 18.82 113.575 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' HB3' HD11 ' A' ' 42' ' ' LEU . 18.2 mm-40 -77.16 147.46 36.49 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 117.286 0.543 . . . . 16.59 112.264 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.431 HD12 HD11 ' A' ' 57' ' ' ILE . 47.6 mm -107.7 123.02 62.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.462 -0.79 . . . . 24.600000000000001 109.894 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.545 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 41.0 mt -95.18 124.18 47.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.389 -0.369 . . . . 24.600000000000001 110.535 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.491 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -74.53 128.37 35.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.901 -0.59 . . . . 21.550000000000001 112.245 -178.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 50.64 70.92 0.46 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.698 -0.683 . . . . 24.050000000000001 112.401 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.919 HG21 ' HB2' ' A' ' 4' ' ' TYR . 73.0 t -87.52 107.5 17.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.981 -0.554 . . . . 26.149999999999999 110.741 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -103.74 157.08 17.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.719 -0.673 . . . . 42.509999999999998 110.475 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -89.27 129.9 35.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.414 . . . . 33.310000000000002 109.966 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 39' ' ' GLU . 87.9 mt -91.17 178.33 6.01 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.345 -0.389 . . . . 37.710000000000001 111.031 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -79.92 0.96 29.14 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.216 -0.447 . . . . 40.380000000000003 111.082 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 37' ' ' TRP . 3.8 mp0 -105.65 122.0 45.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.463 -0.569 . . . . 38.539999999999999 109.463 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -61.55 116.93 5.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.174 -0.466 . . . . 33.270000000000003 110.435 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 50' ' ' PRO . . . 96.41 12.54 51.04 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.907 -0.663 . . . . 28.280000000000001 113.006 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.506 ' HB2' ' HB2' ' A' ' 34' ' ' GLU . 44.7 m95 -130.26 129.59 43.49 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.168 0.509 . . . . 23.140000000000001 111.088 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.619 ' O ' ' HA ' ' A' ' 48' ' ' MET . 85.1 mt -120.07 165.49 14.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.277 -0.874 . . . . 23.91 109.781 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.531 ' HB2' HD21 ' A' ' 32' ' ' LEU . 38.7 tt0 -126.68 121.63 32.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.694 -0.23 . . . . 43.399999999999999 110.783 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.93 164.89 32.96 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.527 -0.844 . . . . 20.079999999999998 113.433 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.688 ' HG3' ' HG2' ' A' ' 46' ' ' ARG . 2.9 mp0 -94.1 106.08 18.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.769 0.318 . . . . 32.100000000000001 110.59 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.644 ' HB3' HD21 ' A' ' 18' ' ' LEU . 40.1 tp -130.61 137.18 49.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 22.890000000000001 110.251 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 64.55 19.73 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 30.739999999999998 111.218 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.74 13.5 72.38 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 121.021 -0.609 . . . . 33.009999999999998 113.453 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.1 mmt180 -136.3 145.31 45.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.909 0.385 . . . . 45.68 110.739 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.688 ' HG2' ' HG3' ' A' ' 41' ' ' GLU . 31.9 mtp180 -92.69 116.4 28.98 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.914 -0.772 . . . . 38.710000000000001 108.914 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.19 -175.14 15.99 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.116 -1.04 . . . . 23.539999999999999 113.31 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.619 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 16.2 ptp -112.7 139.68 48.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.943 -0.392 . . . . 33.810000000000002 109.943 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.571 ' HZ ' HG22 ' A' ' 29' ' ' VAL . 3.3 p90 -138.57 159.05 69.17 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.172 -0.467 . . . . 21.48 111.315 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.552 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 36.4 Cg_exo -60.98 136.62 66.75 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.625 2.217 . . . . 18.640000000000001 112.355 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -67.68 -36.2 80.26 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.924 -0.58 . . . . 25.32 111.48 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -79.24 2.11 22.38 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.725 0.639 . . . . 25.559999999999999 112.725 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 50' ' ' PRO . 9.7 m-85 -102.81 -23.49 13.78 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.554 0.216 . . . . 21.91 110.852 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.479 HG12 HG22 ' A' ' 6' ' ' VAL . 30.9 m -120.63 139.43 47.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.274 -0.421 . . . . 20.469999999999999 110.364 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -112.97 133.29 55.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.345 -0.389 . . . . 24.52 110.503 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -54.74 137.76 43.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.334 -0.394 . . . . 36.5 110.436 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.431 HD11 HD12 ' A' ' 25' ' ' ILE . 64.7 mt -91.27 86.0 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.002 0.43 . . . . 29.5 110.764 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.426 ' HD3' ' C ' ' A' ' 58' ' ' LYS . 7.6 tmtm? . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.02 -0.991 . . . . 44.289999999999999 110.583 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.753 0.311 . . . . 33.030000000000001 111.029 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.03 159.02 16.35 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.103 0.478 . . . . 30.120000000000001 111.49 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.931 ' HB2' HG21 ' A' ' 29' ' ' VAL . 7.8 m-85 -131.34 153.36 49.69 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.528 -0.76 . . . . 30.109999999999999 111.079 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.545 ' HB ' HD11 ' A' ' 57' ' ' ILE . 17.2 tt -111.45 138.06 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.573 . . . . 30.57 109.607 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.461 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 25.1 t -80.78 121.02 33.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.431 -0.35 . . . . 31.149999999999999 110.744 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -104.77 -19.35 13.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.086 -0.506 . . . . 37.960000000000001 111.148 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -132.84 140.42 47.94 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.53 -0.305 . . . . 29.969999999999999 110.363 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -77.56 130.13 36.53 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.26 -0.427 . . . . 32.049999999999997 110.87 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.471 ' HB2' ' CD2' ' A' ' 53' ' ' PHE . 47.6 t80 -129.98 136.48 49.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.943 -0.571 . . . . 33.979999999999997 110.371 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.87 120.61 40.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.139 -0.482 . . . . 36.689999999999998 110.537 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.457 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . . . -64.3 109.07 1.77 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.076 -0.511 . . . . 30.620000000000001 111.695 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.1 t -89.02 -36.35 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.63 -0.714 . . . . 30.559999999999999 109.747 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 43.3 m80 -92.19 175.02 7.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.767 -0.651 . . . . 29.609999999999999 110.621 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -78.2 -36.54 47.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.193 -0.458 . . . . 35.799999999999997 110.567 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 48' ' ' MET . 1.9 p30 -93.0 12.96 22.17 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.035 -0.53 . . . . 32.579999999999998 111.038 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.457 ' CG ' ' HA ' ' A' ' 12' ' ' ALA . 17.5 tp10 -91.54 129.98 37.43 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.801 -0.444 . . . . 36.109999999999999 109.801 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 19' ' ' THR . 0.4 OUTLIER -89.31 124.88 34.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.753 0.311 . . . . 30.739999999999998 111.328 -179.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.626 ' N ' HD13 ' A' ' 18' ' ' LEU . 32.9 m -81.49 86.13 6.38 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.107 -0.701 . . . . 30.809999999999999 109.107 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 53' ' ' PHE . 29.8 pt -87.28 135.31 25.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.396 -0.365 . . . . 30.390000000000001 111.51 -178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.3 mtp85 -119.06 138.19 53.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.136 -0.484 . . . . 29.609999999999999 110.165 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.3 t -45.32 122.72 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.894 0.378 . . . . 31.460000000000001 111.904 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.63 -18.77 34.59 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.824 -0.625 . . . . 30.600000000000001 113.567 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.49 ' HB3' HD11 ' A' ' 42' ' ' LEU . 32.6 mt-10 -76.09 155.19 34.97 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.365 0.582 . . . . 35.799999999999997 111.931 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.3 mt -115.53 125.75 72.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.45 -0.795 . . . . 30.379999999999999 109.749 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.754 ' CD1' HD22 ' A' ' 42' ' ' LEU . 5.5 mm -91.27 120.44 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 32.07 110.756 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.38 122.21 23.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.285 -0.416 . . . . 29.719999999999999 112.107 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 57.97 70.76 0.63 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.753 -0.658 . . . . 29.649999999999999 112.61 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.931 HG21 ' HB2' ' A' ' 4' ' ' TYR . 59.8 t -86.39 108.6 17.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.297 -0.41 . . . . 30.309999999999999 111.088 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -105.16 155.97 18.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.802 -0.635 . . . . 38.770000000000003 110.358 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HA ' HD13 ' A' ' 38' ' ' LEU . 69.0 mttm -82.06 127.75 33.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 32.939999999999998 110.264 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 tp -88.42 170.89 10.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 33.130000000000003 110.308 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -78.91 0.85 25.7 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.67 -0.241 . . . . 42.18 110.867 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.503 ' HB3' ' HD1' ' A' ' 37' ' ' TRP . 2.9 mp0 -104.55 116.17 31.61 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.565 -0.532 . . . . 38.109999999999999 109.565 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.92 121.82 10.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 30.43 110.991 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.42 14.78 56.67 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.862 -0.685 . . . . 30.129999999999999 113.031 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.503 ' HD1' ' HB3' ' A' ' 34' ' ' GLU . 92.5 m95 -134.01 132.28 39.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.156 0.503 . . . . 30.289999999999999 110.951 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 48' ' ' MET . 3.7 mm? -117.33 163.43 16.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.295 -0.866 . . . . 30.329999999999998 109.735 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 10.7 tp10 -123.48 119.81 31.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.774 -0.194 . . . . 38.590000000000003 110.482 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.461 ' HA3' HG22 ' A' ' 26' ' ' ILE . . . -153.09 161.51 29.67 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.468 -0.872 . . . . 29.850000000000001 113.514 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -95.15 106.61 18.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.084 0.468 . . . . 37.880000000000003 110.825 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.754 HD22 ' CD1' ' A' ' 26' ' ' ILE . 30.3 tp -132.93 142.13 48.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.668 -0.696 . . . . 30.379999999999999 110.073 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.437 ' ND2' ' HG ' ' A' ' 42' ' ' LEU . 54.8 m-80 65.46 17.49 10.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.726 -0.67 . . . . 40.090000000000003 111.181 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.28 15.51 62.21 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 121.005 -0.617 . . . . 31.289999999999999 113.492 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -145.24 151.95 39.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.745 0.307 . . . . 44.740000000000002 110.44 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -95.31 119.04 33.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.11 -0.7 . . . . 33.119999999999997 109.11 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -145.73 150.01 22.19 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.554 -0.832 . . . . 29.77 113.079 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 38' ' ' LEU . 22.8 ptp -78.62 145.46 34.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.718 0.294 . . . . 35.170000000000002 110.373 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 26' ' ' ILE . 3.4 p90 -143.2 157.64 59.81 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.024 -0.535 . . . . 30.170000000000002 111.179 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.54 ' HB2' ' CD1' ' A' ' 53' ' ' PHE . 27.2 Cg_exo -61.8 145.58 97.11 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.678 2.252 . . . . 30.280000000000001 112.821 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.95 -37.39 78.82 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.617 -0.719 . . . . 32.210000000000001 112.077 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -78.74 4.71 13.05 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.9 0.704 . . . . 34.539999999999999 112.9 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.561 ' HB3' HD11 ' A' ' 20' ' ' ILE . 13.2 m-85 -107.81 -24.23 11.76 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.491 0.186 . . . . 34.039999999999999 111.307 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.568 HG21 ' CE1' ' A' ' 49' ' ' PHE . 29.1 m -121.03 139.95 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 110.113 -0.329 . . . . 31.539999999999999 110.113 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -122.24 131.93 54.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.446 -0.343 . . . . 30.59 110.41 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -54.65 131.26 42.92 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.425 -0.352 . . . . 32.189999999999998 110.64 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.545 HD11 ' HB ' ' A' ' 5' ' ' ILE . 44.2 mt -87.41 84.54 2.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.071 0.462 . . . . 30.539999999999999 110.763 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 96.1 mttt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.084 -0.96 . . . . 40.630000000000003 110.882 -179.992 . . . . . . . . 0 0 . 1 stop_ save_